Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3043747	s-beta-2	g/l (g/l)	11052	25416	0.00%
3043747	s-beta-2	— (—)	1962	2591	100.00%	Distribution not available
3043747	s-beta-2-fraktio	g/l (g/l)	1124	2313	0.00%
3043747	s-beta2	g/l (g/l)	1017	1772	0.00%
3043747	beta2-glob	g/l (g/l)	707	2810	0.00%
3043747	s-beta-2	g/l_______ (g/l)	619	1918	0.00%
3043747	beeta-2	g/l (g/l)	436	903	0.00%
3043747	s-b2glob	g/l (g/l)	411	877	0.00%
3043747	s-beta-2-fraktio	g/l_______ (g/l)	312	693	0.00%
3043747	s-beeta-2	g/l (g/l)	226	260	0.00%
3043747	beeta-2-gl	g/l (g/l)	86	98	0.00%
3043747	s-beta2-globuliini(valetietues-prot-fr)	g/l (g/l)	60	82	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, unspecified (mode), excluding more controls

1946

5282

2.74

323.31

2.1

1.9

3.78

3.69

g/l

1.25

1806

4816

Explicit Sepsis, including avohilmo

2129

7943

2.56

320.15

3.2

2.2

3.76

3.71

g/l

0.78

1948

7207

Disorders of lipoprotein metabolism and other lipidaemias

3246

9353

2.18

317.54

2.3

3.74

3.72

g/l

0.27

3000

8495

Septicaemia

2041

7553

2.60

317.06

3.2

2.1

3.76

3.70

g/l

0.86

1865

6775

Other heart diseases

1449

3030

3.22

311.83

2.4

2.1

3.72

3.65

g/l

0.61

1365

2805

Explicit Sepsis

2085

7846

2.55

311.29

3.2

2.1

3.76

3.71

g/l

0.69

1908

7116

Codeine

3155

7946

2.21

309.69

2.2

1.9

3.70

3.72

g/l

0.22

2920

7250

Heart failure, strict

2836

9129

2.27

308.07

2.3

2.4

3.79

3.72

g/l

1.25

2606

8220

Multiple myeloma, including Hilmo

921

744

23.90

307.65

16.4

1.4

3.75

3.74

g/l

0.02

907

658

Implicit bacterial Sepsis

2384

7456

2.94

307.65

2.9

2.1

3.80

3.71

g/l

1.39

2173

6733

Persons encountering health services for specific procedures and health care

3890

11177

2.11

307.65

2.7

2.1

3.64

3.76

g/l

4.03

3637

10161

Unspecified kidney failure

845

1800

5.47

307.65

2.6

2.2

3.77

3.72

g/l

0.42

796

1600

Fever of other and unknown origin

2696

7432

3.32

307.65

3.9

2.1

3.74

3.75

g/l

0.10

2514

6773

Iron deficiency anaemia

2121

8517

2.58

307.65

2.1

2.3

3.76

3.71

g/l

0.53

1916

7693

Other and unspecified anaemias

3437

8013

4.55

307.65

2.6

2.3

3.77

3.72

g/l

0.73

3174

7162

Renal failure

3937

8151

4.67

307.65

2.5

2.2

3.75

3.74

g/l

0.21

3698

7258

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3929

11926

2.27

307.65

3.1

2.0

3.77

3.69

g/l

1.69

3642

10889

Liquid cancers

2584

5381

5.28

307.65

7.5

1.4

3.59

3.75

g/l

2.01

2480

4814

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

610

464

27.59

307.65

19.6

1.5

3.49

3.74

g/l

0.88

601

404

Condition for Implicit Sepsis (Organ dysfunction codes)

3712

10731

2.50

307.65

2.4

2.2

3.71

g/l

0.06

3390

9825

Bacterial Sepsis

2669

7996

2.95

307.65

3.1

2.2

3.84

3.71

g/l

2.28

2434

7243

Heart failure, not strict

3765

9252

2.91

307.65

2.6

2.3

3.73

g/l

0.04

3479

8416

Multiple myeloma and malignant plasma cell neoplasms

929

865

20.10

307.65

16.3

1.6

3.75

g/l

0.00

914

774

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1096

795

29.99

307.65

7.5

1.3

3.87

3.73

g/l

0.71

1034

705

Implicit Sepsis

3665

10557

2.69

307.65

2.5

2.2

3.75

3.71

g/l

0.50

3336

9632

Liquid cancers, including Hilmo

2757

6118

4.48

307.65

7.1

1.4

3.59

3.75

g/l

2.22

2639

5482

Other systemic involvement of connective tissue (FG)

1563

3934

4.28

307.65

1.9

2.6

3.68

3.67

g/l

0.01

1435

3523

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6033

10330

4.25

307.65

2.5

2.2

3.74

3.72

g/l

0.36

5613

9360

ILD medications: immunosuppressive drugs

3524

8639

3.96

307.65

4.6

1.7

3.72

g/l

0.06

3348

7846

Implicit bacterial Sepsis, including avohilmo

2587

7887

2.92

307.65

2.8

2.2

3.80

3.71

g/l

1.31

2356

7139

All chronic kidney diseases

3985

7710

4.57

307.65

2.4

2.3

3.74

3.72

g/l

0.28

3758

6936

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

771

1406

6.81

307.65

3.4

2.2

4.37

3.63

g/l

11.47

715

1260

Polyneuropathies and other disorders of the peripheral nervous system

1854

4267

5.08

307.65

2.5

2.3

3.60

3.74

g/l

2.57

1708

3870

Infections, IBD-co-morbidities

698

711

7.38

307.65

4.3

2.2

3.59

3.81

g/l

1.43

651

652

General symptoms and signs

3879

8160

2.46

307.65

2.5

2.1

3.71

3.75

g/l

0.60

3600

7465

Inflammatory bowel disease treatment related agents

4704

10992

2.46

307.65

2.1

2.4

3.75

3.71

g/l

0.96

4371

9979

Heart failure and antihypertensive medication

1193

2045

4.07

307.65

2.3

2.6

3.75

3.74

g/l

0.07

1113

1860

ILD medications: prednisolone, methylprednisolone, prednisone

4696

9549

2.85

307.65

2.2

1.7

3.72

3.73

g/l

0.04

4354

8632

Pneumonias (Asthma/COPD co-morbidities)

3983

11782

2.29

307.65

3.1

2.0

3.76

3.69

g/l

1.42

3700

10753

Other and unspecified iron deficiency

1777

6681

2.83

307.65

2.0

2.4

3.78

3.69

g/l

1.45

1610

6016

Pneumonia, organism unspecified

3729

11288

2.35

307.65

3.1

2.0

3.77

3.70

g/l

1.31

3443

10298

Nutritional anaemias

2423

9829

2.48

307.65

2.1

2.4

3.75

3.72

g/l

0.43

2195

8878

Other systemic involvement of connective tissue

1593

5069

3.42

307.65

1.9

2.4

3.68

3.67

g/l

0.07

1464

4572

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3763

10413

2.54

307.65

2.4

2.2

3.71

g/l

0.06

3449

9551

Bacterial infection, other or unspecified, including avohilmo

3409

9168

3.27

307.65

3.3

2.1

3.83

3.69

g/l

3.71

3164

8254

Heart failure,strict

2602

7329

2.63

307.65

2.3

2.4

3.78

3.73

g/l

0.73

2397

6611

ILD medications

4923

9578

2.89

307.65

3.1

1.7

3.72

g/l

0.09

4582

8661

Erysipelas, including avohilmo

2982

10035

2.29

307.65

2.3

2.0

3.85

3.69

g/l

5.67

2758

9082

Examination and observation for other reasons

2474

4762

3.06

307.65

2.4

2.2

3.76

3.86

g/l

2.01

2302

4387

Other and unspecified polyneuropathies, also in other diseases

1718

3769

5.41

307.65

2.1

2.3

3.60

3.74

g/l

2.36

1579

3414

L04AX Other immunosuppressants

2800

9884

3.01

307.65

5.4

1.7

3.72

3.70

g/l

0.21

2650

9039

Anaemias

1130

642

12.18

307.65

2.4

1.2

3.70

3.62

g/l

0.70

1081

598

Autoimmune diseases excluding thyroid diseases, strict definition

3984

9728

2.30

307.65

2.0

2.5

3.76

3.73

g/l

0.39

3721

8840

Abnormal findings on examination of blood, without diagnosis

2341

8905

2.52

307.65

2.7

2.4

3.97

3.71

g/l

8.14

2183

8132

First line medication for Crohn's disease

4505

9447

2.66

307.65

3.1

1.6

3.70

3.73

g/l

0.47

4209

8543

Chronic kidney disease

2917

6013

5.45

307.65

2.3

3.73

3.75

g/l

0.24

2755

5327

Acute renal failure

1574

4123

4.29

307.65

2.8

2.2

3.75

3.73

g/l

0.10

1476

3674

Glomerular diseases

1238

3177

4.40

307.65

2.8

2.3

3.78

3.73

g/l

0.46

1177

2916

Systemic connective tissue disorders

2098

6554

3.49

307.65

2.0

2.4

3.67

3.69

g/l

0.27

1935

5901

Multiple myeloma

610

464

27.59

307.65

19.6

1.5

3.49

3.74

g/l

0.88

601

404

Osteopathies and chondropathies

2687

10085

2.57

307.65

3.0

2.2

3.63

3.72

g/l

1.77

2409

9191

Primary_lymphoid and hematopoietic malignant neoplasms

2187

4589

5.65

307.65

8.5

1.4

3.59

3.75

g/l

1.69

2118

4111

Implicit Sepsis, including avohilmo

3785

10783

2.63

307.65

2.5

2.2

3.73

3.71

g/l

0.17

3444

9871

Bacterial infection, other or unspecified

3197

8815

3.30

307.65

3.4

2.1

3.84

3.69

g/l

3.40

2961

7923

Autoimmune diseases excluding thyroid diseases

4125

10072

2.29

307.65

2.0

2.5

3.75

3.73

g/l

0.35

3852

9159

Other anaemias

3453

8069

4.52

307.65

2.5

2.3

3.78

3.72

g/l

0.75

3189

7216

Pain in limb

3375

9140

2.44

307.65

2.2

2.4

3.69

3.77

g/l

1.98

3123

8320

Malaise and fatigue

2562

6757

3.15

307.65

2.2

2.1

3.70

3.74

g/l

0.74

2326

6135

Influenza and pneumonia

4070

11515

2.25

307.65

3.1

2.0

3.75

3.69

g/l

0.95

3782

10516

All kidney diseases

4880

10654

3.24

307.65

2.4

2.2

3.71

g/l

0.01

4550

9681

Finngen Rheumatological endpoints

3353

8551

2.29

307.65

2.2

2.4

3.73

3.70

g/l

0.54

3110

7829

Aplastic and other anaemias

3609

8433

4.40

307.65

2.5

2.3

3.77

3.72

g/l

0.64

3332

7552

Dialysis, with operation codes

928

1903

5.65

307.65

3.8

2.2

3.67

3.76

g/l

0.81

883

1733

Other bacterial diseases

4466

11205

2.77

307.65

3.0

2.0

3.80

3.68

g/l

3.45

4155

10176

All pneumoniae

3993

11798

2.28

307.65

3.1

2.0

3.76

3.69

g/l

1.51

3712

10769

Glomerular disorders in diseases classified elsewhere

863

1991

5.01

307.65

2.8

2.3

3.78

3.77

g/l

0.07

819

1827

Renal tubulo-interstitial diseases

4766

10929

3.41

307.65

2.5

2.3

3.72

g/l

0.00

4422

9924

3555

9239

2.33

307.65

3.1

1.9

3.75

3.69

g/l

0.90

3307

8416

Tramadol

3309

7786

2.66

307.65

2.5

2.0

3.71

3.72

g/l

0.12

3048

7097

Oral corticosteroids

4599

10929

2.57

307.65

2.2

2.4

3.75

3.71

g/l

0.75

4282

9920

Metabolic disorders

3762

9841

2.38

307.65

2.4

2.2

3.71

g/l

0.04

3485

8958

Oedema, not elsewhere classified

1572

5254

3.10

307.65

2.3

2.1

3.74

g/l

0.01

1429

4752

Other soft tissue disorders, not elsewhere classified

3628

9228

2.31

307.65

2.3

2.4

3.68

3.77

g/l

2.63

3371

8397

Polyarthropathies

3260

7076

3.12

307.65

2.5

2.4

3.86

3.71

g/l

4.44

3050

6471

Other bacterial diseases, including avohilmo

4472

10771

2.71

307.65

2.9

2.0

3.77

3.68

g/l

2.71

4167

9778

Second line medication for Crohn's disease

2835

10096

2.98

307.65

5.3

1.7

3.72

3.70

g/l

0.22

2683

9232

Gout

1636

4635

3.28

307.65

3.2

2.4

3.89

3.74

g/l

2.00

1527

4194

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3555

9239

2.33

307.65

3.1

1.9

3.75

3.69

g/l

0.90

3307

8416

Nephropathy related operations

833

2084

4.56

307.02

3.9

2.3

3.62

3.74

g/l

1.36

797

1909

Medical observation and evaluation for suspected diseases and conditions

2315

4810

2.54

303.10

2.3

2.2

3.65

3.86

g/l

7.19

2098

4425

Gout, FINNGEN

1636

6155

2.85

301.81

3.2

2.3

3.89

3.73

g/l

2.46

1527

5551

Care involving dialysis

618

1249

5.82

298.63

2.5

2.1

3.66

3.78

g/l

0.94

587

1146

Autoimmune diseases related-to ILD

3234

13440

2.07

297.76

2.1

2.4

3.79

3.70

g/l

2.10

3009

12235

Pure hypercholesterolaemia

3015

9089

2.18

297.32

2.3

3.75

3.73

g/l

0.38

2787

8242

Hypertension, essential

2569

6380

2.35

293.80

2.2

2.3

3.79

3.65

g/l

3.65

2401

5821

All-cause Heart Failure

2771

9019

2.25

293.50

2.3

2.4

3.79

3.72

g/l

1.15

2547

8114

Osteoporosis

1518

5122

2.95

292.74

2.3

2.2

3.54

3.69

g/l

3.11

1316

4575

Hypertensive diseases (excluding secondary)

1534

3065

3.01

285.71

2.2

2.1

3.82

3.64

g/l

3.13

1448

2831

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4049

11347

1.95

284.77

2.2

2.4

3.73

g/l

0.01

3802

10253

Asthma, unspecified (mode)

2021

6047

2.50

280.90

2.1

1.9

3.77

3.69

g/l

1.15

1870

5503

Implicit viral Sepsis, including avohilmo

1519

5732

2.81

279.06

2.8

2.1

3.69

3.68

g/l

0.05

1388

5181

Dental caries

1218

3850

3.17

275.84

3.9

2.1

3.71

3.77

g/l

0.47

1132

3549

Reimbursement for rheumatic diseases

2346

10758

2.26

274.33

1.8

2.4

3.80

3.68

g/l

3.64

2195

9759

Diseases of oesophagus, stomach and duodenum

3819

11939

1.94

272.52

2.2

2.3

3.69

3.74

g/l

0.92

3490

10941

Provisional assignment of new diseases of uncertain etiology

2227

10027

2.30

270.70

2.9

2.1

3.66

3.72

g/l

0.93

2054

9123

Codes for special purposes

2229

10044

2.29

270.35

2.9

2.1

3.66

3.72

g/l

0.96

2055

9139

Other septicaemia, including avohilmo

1819

7113

2.53

268.77

2.9

2.0

3.72

3.69

g/l

0.34

1661

6365

Diseases of arteries, arterioles and capillaries (FINNGEN)

1004

1973

3.72

268.12

2.4

2.3

3.76

3.71

g/l

0.34

941

1800

Diverticular disease of intestine

2958

9031

2.11

267.44

2.5

2.3

3.73

3.77

g/l

0.46

2712

8226

Transplanted organ and tissue status

635

1430

5.04

267.19

5.8

2.2

3.38

3.80

g/l

9.27

616

1314

Opioids

3144

7980

2.08

265.90

2.5

1.9

3.69

3.72

g/l

0.34

2913

7282

Other septicaemia

1784

6986

2.54

265.77

2.9

2.0

3.72

3.69

g/l

0.33

1627

6241

Other arthritis (FG)

1323

4772

2.92

264.84

2.3

2.5

3.88

3.69

g/l

3.35

1234

4355

Certain infectious and parasitic diseases

3167

7839

2.07

261.97

2.5

1.9

3.71

3.70

g/l

0.16

2941

7101

Caries of dentine

1100

3474

3.26

260.69

3.8

2.1

3.73

3.77

g/l

0.29

1021

3210

Pain in joint

2130

5661

2.39

258.47

2.1

2.3

3.74

3.80

g/l

0.90

1947

5162

Dyspnoea

3426

13073

1.95

257.71

2.4

2.3

3.74

3.72

g/l

0.25

3146

11932

Hypertensive diseases

2487

6430

2.24

257.27

2.1

2.3

3.80

3.65

g/l

3.77

2325

5866

Hypertension

2482

6430

2.24

255.40

2.1

2.3

3.79

3.65

g/l

3.72

2320

5866

Codeine or tramadol medication

3953

11668

1.89

255.27

2.2

2.3

3.71

3.72

g/l

0.15

3652

10630

Acute tubulo-interstitial nephritis

2362

9357

2.21

255.09

2.4

2.3

3.73

3.71

g/l

0.28

2139

8427

GASTRO-related operations

2314

5100

2.33

253.97

2.3

1.9

3.69

3.74

g/l

0.63

2130

4677

Any gastric operation

2314

5100

2.33

253.97

2.3

1.9

3.69

3.74

g/l

0.63

2130

4677

Abnormalities of breathing

2936

8347

2.06

247.99

2.3

2.2

3.68

3.75

g/l

1.28

2713

7635

Covid-19 confirmed case

1757

7568

2.45

243.81

3.0

2.2

3.67

3.72

g/l

0.66

1608

6863

Other specific joint derangements/joint disorders

2436

7131

2.19

243.75

2.1

2.4

3.70

g/l

0.01

2236

6552

Erysipelas

2283

9310

2.20

243.67

2.3

2.1

3.89

3.71

g/l

4.60

2113

8407

Other diseases of blood and blood-forming organs, wide

1148

4042

3.07

243.67

3.4

2.3

3.64

3.71

g/l

0.46

1082

3684

Autoimmune diseases

3710

10112

1.91

243.64

2.1

2.5

3.71

3.73

g/l

0.31

3447

9195

Polymyalgia rheumatica

896

2757

3.64

243.27

1.9

2.4

3.73

3.72

g/l

0.12

809

2461

Pain, not elsewhere classified

1136

3969

3.00

240.55

2.7

2.1

3.59

3.70

g/l

1.78

1055

3617

Used for control exclusion in common control thyroid runs

3470

9259

1.93

237.62

2.2

2.5

3.67

3.75

g/l

1.75

3217

8427

Other heart diseases, wide

2903

8901

2.02

235.97

2.3

3.69

3.72

g/l

0.40

2712

8165

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

476

566

6.34

234.07

2.4

3.83

3.84

g/l

0.01

453

512

Asthma, excluding more controls

2307

5411

2.25

233.82

2.1

1.9

3.77

3.69

g/l

1.26

2154

4941

Persons encountering health services in other circumstances, wide

3976

11397

1.84

233.18

2.2

2.4

3.74

3.73

g/l

0.08

3718

10290

Low back pain

2722

9269

2.04

230.47

2.6

2.2

3.62

3.76

g/l

4.80

2516

8453

Oxycodone

1723

6365

2.42

229.52

4.7

2.0

3.65

3.74

g/l

1.02

1558

5757

Other specified/unspecified arthritis

1177

4324

2.87

227.89

2.2

2.4

3.88

3.68

g/l

3.39

1095

3954

Other diseases of intestines

3392

10213

1.89

223.49

2.3

2.2

3.66

3.75

g/l

2.34

3125

9359

L04AA Selective immunosuppressants

1026

3562

3.08

222.14

1.8

2.3

3.68

g/l

0.04

986

3281

Complications of surgical and medical care, not elsewhere classified

3585

13379

1.83

221.69

2.3

3.72

g/l

0.00

3294

12204

Cardiovascular diseases (excluding rheumatic etc)

1509

3412

2.59

215.05

2.2

2.0

3.75

3.63

g/l

1.72

1436

3163

Pain in throat and chest

2740

8306

2.00

215.05

2.3

2.2

3.68

3.75

g/l

1.44

2544

7594

Other disorders of fluid, electrolyte and acid-base balance

1453

5708

2.53

214.69

2.5

2.3

3.67

3.73

g/l

0.56

1319

5115

Asthma (only as main-diagnosis), excluding more controls

2113

5411

2.21

211.70

2.1

1.9

3.76

3.69

g/l

1.00

1969

4941

Diabetic nephropathy, excluding more controls

844

2144

3.53

211.09

1.8

2.2

3.83

3.84

g/l

0.09

798

1944

L04AD Calcineurin inhibitors

587

1485

4.37

210.93

2.5

3.62

3.76

g/l

1.33

572

1385

Type 2 diabetes, wide definition

2995

10117

1.92

210.89

2.0

2.5

3.85

3.66

g/l

9.45

2769

9195

Continuous positive airway pressure

836

2148

3.45

210.40

2.3

2.4

3.81

3.70

g/l

0.72

759

1968

Headache

2036

7444

2.17

209.85

2.1

3.58

3.73

g/l

4.29

1880

6815

Viral Sepsis

1049

3805

2.95

209.68

3.2

2.1

3.64

3.70

g/l

0.44

961

3441

Hypertensive heart and/or renal disease

1236

3427

2.79

209.40

2.0

2.5

3.79

3.68

g/l

1.41

1140

3043

Implicit viral Sepsis

1046

3800

2.94

208.47

3.2

2.1

3.64

3.70

g/l

0.43

958

3436

Cerebrovascular diseases (FINNGEN)

1024

2433

3.07

207.80

2.1

2.3

3.78

3.68

g/l

1.04

941

2232

Spondylopathies

2862

8925

1.95

207.48

2.6

2.2

3.67

3.78

g/l

2.44

2652

8115

Non-Hodgkin lymphoma, all, including Hilmo

763

2341

3.59

206.62

3.0

1.4

3.67

3.77

g/l

0.38

729

2095

Symptoms and signs involving the skin and subcutaneous tissue

2681

13527

1.93

205.54

2.4

2.3

3.61

3.73

g/l

2.44

2460

12350

Asthma

2435

6189

2.08

204.74

2.1

1.9

3.78

3.69

g/l

1.37

2274

5639

Gout, idiopatic and unspecified

1335

5552

2.58

203.68

2.1

2.4

3.89

3.78

g/l

2.23

1240

5044

Asthma (mode)

2410

6239

2.08

203.67

2.1

1.9

3.77

3.69

g/l

1.35

2252

5686

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2701

12592

1.93

203.59

2.5

2.3

3.73

3.72

g/l

0.13

2489

11429

Disorders of calcium metabolism

457

987

5.33

203.42

3.9

2.4

3.72

3.71

g/l

0.05

413

905

Disorders of mineral metabolism

533

1298

4.60

202.53

3.5

2.3

3.76

3.72

g/l

0.20

483

1187

Other disorders of skin and subcutaneous tissue

2822

12951

1.90

201.39

2.3

2.4

3.70

3.72

g/l

0.38

2593

11774

Enlarged lymph nodes

715

2128

3.59

200.04

2.1

2.2

3.66

3.70

g/l

0.31

680

1944

Coagulation defects, purpura and other haemorrhagic conditions

947

3356

3.02

197.95

2.5

2.3

3.67

3.72

g/l

0.35

887

3060

Symptoms and signs involving cognition, perception, emotional state and behaviour

3362

12751

1.80

197.88

2.1

2.4

3.66

3.74

g/l

2.03

3067

11708

Rheumatoid arthritis

1323

4824

2.54

197.49

1.9

2.5

3.86

3.67

g/l

3.65

1237

4367

Exposure to unspecified factor

3502

13712

1.78

196.89

2.3

3.76

3.71

g/l

0.95

3170

12576

Syncope and collapse

1669

6315

2.28

196.26

2.3

2.2

3.73

3.75

g/l

0.22

1485

5724

Ulcer of lower limb, not elsewhere classified

864

2979

3.18

192.15

2.4

2.2

3.87

3.74

g/l

1.76

798

2681

Follow-up examination after treatment for conditions other than malignant neoplasms

1472

4149

2.44

191.55

2.4

2.1

3.70

3.84

g/l

2.63

1357

3816

Diseases of arteries, arterioles and capillaries

2741

10935

1.90

191.29

2.2

2.4

3.77

3.73

g/l

0.58

2513

9891

Disorders resulting from impaired renal tubular function

320

537

7.39

190.84

2.3

2.5

3.83

3.75

g/l

0.33

311

497

Symptoms and signs involving the urinary system

2875

11998

1.86

189.76

2.2

2.4

3.69

3.73

g/l

0.58

2606

10931

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3232

11590

1.80

187.73

2.8

2.2

3.63

3.76

g/l

3.85

2988

10645

Heart failure and bmi 25plus

1504

4370

2.42

186.87

2.2

2.5

3.87

3.78

g/l

1.28

1374

3886

Preparatory care for dialysis

364

709

6.27

185.42

2.3

2.7

3.73

3.71

g/l

0.10

348

658

Dorsalgia

3159

9358

1.83

184.88

2.4

2.2

3.68

3.76

g/l

1.91

2913

8532

Small fibre neuropathy

294

471

8.03

184.84

2.6

2.3

3.68

3.76

g/l

0.28

269

430

Disturbances of skin sensation

1071

4170

2.69

184.45

2.0

2.3

3.56

3.72

g/l

3.14

992

3846

Asthma (only as main-diagnosis)

2217

6189

2.05

183.91

2.1

1.9

3.77

3.69

g/l

1.16

2061

5639

Cardiovascular diseases

1304

2716

2.60

183.88

2.1

1.9

3.75

3.64

g/l

1.52

1235

2524

Gout, unspecified

1105

4424

2.69

183.27

2.2

2.3

3.88

3.76

g/l

2.27

1035

4008

Atrial fibrillation and flutter

1006

2310

2.92

183.11

2.6

2.3

3.80

3.69

g/l

0.99

944

2114

Disorders of thyroid, IBD co-morbidities

489

728

4.76

182.27

2.1

2.3

3.66

3.78

g/l

0.57

456

666

Glomerulonephritis

563

1555

4.02

179.42

2.9

2.4

3.82

3.74

g/l

0.51

542

1432

Certain infectious and parasitic diseases, including avohilmo

2199

5500

2.05

177.06

2.4

1.9

3.75

3.70

g/l

0.65

2052

4968

Other CVD (FINNGEN)

564

1129

4.11

176.21

2.8

2.2

3.68

3.75

g/l

0.35

506

1008

Gout, strict definition

1010

3967

2.76

174.79

2.2

2.5

3.94

3.77

g/l

3.26

941

3602

Symptoms and signs concerning food and fluid intake

548

1510

3.93

172.86

2.0

2.2

3.51

3.73

g/l

2.90

507

1368

Lower back pain or/and sciatica

3619

13485

1.70

172.52

2.5

2.3

3.64

3.74

g/l

3.27

3331

12308

Non-ischemic cardiomyopathy

1469

5312

2.31

171.52

2.3

2.4

3.79

3.73

g/l

0.53

1339

4736

Cardiac arrhythmias

1671

5045

2.17

166.99

2.4

3.75

3.64

g/l

1.60

1564

4656

Fall on same level

3566

11351

1.71

166.27

2.2

2.3

3.73

3.71

g/l

0.33

3193

10582

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1158

2922

2.56

166.22

2.4

2.2

3.76

3.65

g/l

1.22

1089

2698

Osteoporosis with pathological fracture (FG)

451

1141

4.44

163.24

2.0

2.6

3.55

g/l

0.00

379

998

Other necrotizing vasculopathies (FG)

382

853

5.10

162.89

1.6

2.9

3.85

3.62

g/l

1.95

351

766

Neurological diseases, wide definition

623

819

3.91

162.88

2.1

3.59

3.79

g/l

1.67

587

753

Extracorporeal dialysis

409

969

4.87

162.81

2.5

2.4

3.52

3.75

g/l

2.46

388

899

Other pulmonary diagnosis

2361

6243

1.94

162.72

2.6

1.9

3.71

3.69

g/l

0.15

2197

5688

Secondary hypertension

375

801

5.01

162.35

2.0

2.3

3.73

g/l

0.01

358

722

Excluding asthma or asthma-COPD overlap

2356

6243

1.93

161.36

2.6

1.9

3.72

3.69

g/l

0.36

2194

5688

Endocrine, nutritional and metabolic diseases

2085

5350

2.00

159.67

2.2

2.4

3.76

3.66

g/l

1.74

1945

4914

Benign neoplasm of colon, rectum, anus and anal canal

2548

12219

1.82

159.19

2.4

3.69

3.74

g/l

0.78

2292

11118

Hyperlipidaemia, other/unspecified

1595

7002

2.13

158.81

2.3

3.77

3.73

g/l

0.38

1457

6300

Other dorsopathies, not elsewhere classified

3099

9365

1.75

157.71

2.3

2.2

3.66

3.76

g/l

2.97

2858

8539

Bleeding

2992

12344

1.74

157.56

2.3

2.4

3.77

3.72

g/l

0.77

2730

11240

Seropositive rheumatoid arthritis

980

3929

2.60

157.19

1.9

2.6

3.82

3.68

g/l

2.28

916

3524

Other special examinations and investigations of persons without complaint or reported diagnosis

1914

4810

2.06

157.19

2.4

2.2

3.64

3.86

g/l

6.77

1770

4425

Care involving use of rehabilitation procedures

2160

10522

1.89

157.05

2.4

2.2

3.61

3.76

g/l

4.96

2073

9545

Purpura and other haemorrhagic conditions

683

2304

3.21

156.82

2.5

2.4

3.66

3.73

g/l

0.30

640

2098

Complications of medical and surgical care

2635

13630

1.78

156.82

2.5

2.3

3.73

3.71

g/l

0.19

2429

12410

Diseases of the skin and subcutaneous tissue

3044

8851

1.76

155.72

2.4

2.2

3.71

g/l

0.01

2803

8055

Malignant neoplasm, including Hilmo

2706

8927

1.80

155.57

3.6

1.4

3.65

3.75

g/l

2.23

2533

8132

COPD/asthma/ILD related infections

3144

9239

1.74

154.13

2.9

1.9

3.72

3.69

g/l

0.40

2901

8416

COPD/asthma related infections

3144

9239

1.74

154.13

2.9

1.9

3.72

3.69

g/l

0.40

2901

8416

COPD differential diagnosis

2328

6241

1.91

154.07

2.6

1.9

3.73

3.69

g/l

0.50

2170

5688

ILD differential diagnosis

2326

6239

1.91

153.65

2.6

1.9

3.73

3.69

g/l

0.49

2168

5686

Other and unspecified dermatitis

1917

10167

1.94

152.35

2.2

2.3

3.67

3.71

g/l

0.47

1774

9255

Symptoms and signs involving the nervous and musculoskeletal systems

2150

11841

1.87

151.69

2.2

2.4

3.53

3.75

g/l

11.37

1986

10765

Malignant neoplasm, wide definition

2701

8981

1.79

150.90

3.6

1.4

3.65

3.75

g/l

2.14

2532

8180

Pain (limb, back, neck, head abdominally)

2215

5886

1.93

150.56

2.3

3.72

3.80

g/l

1.52

2047

5345

Valvular heart disease excluding rheumatic fever

1739

6268

2.05

150.34

2.5

2.4

3.68

3.74

g/l

0.75

1590

5668

Asthma (diagnoses ohter than nonallergic)

2917

14025

1.72

150.27

2.0

2.4

3.77

3.70

g/l

1.13

2691

12791

Malignant neoplasm

2666

8903

1.79

150.18

3.8

1.4

3.63

3.75

g/l

2.85

2499

8105

Constipation

3106

12642

1.70

150.07

2.7

2.3

3.61

3.75

g/l

5.19

2808

11590

Dermatitis

2222

12119

1.84

149.47

2.2

2.4

3.70

3.72

g/l

0.22

2051

11042

Malignant neoplasm

2665

8917

1.79

149.17

3.8

1.4

3.64

3.75

g/l

2.65

2500

8117

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

845

1455

2.98

149.13

2.2

1.9

3.68

3.72

g/l

0.26

792

1333

Nephrotic syndrome

241

389

7.47

148.43

2.8

2.5

3.68

3.75

g/l

0.23

235

361

Dermatitis and eczema

3650

13459

1.64

148.32

2.2

2.3

3.72

g/l

0.05

3378

12265

Atrial fibrillation and flutter with reimbursement

861

1989

2.84

148.03

2.6

2.3

3.81

3.71

g/l

0.85

806

1809

Non-rheumatic valve diseases

1730

6255

2.04

147.95

2.5

2.4

3.68

3.74

g/l

0.83

1581

5656

Diabetic nephropathy

851

3299

2.77

147.53

1.8

2.1

3.83

3.87

g/l

0.43

804

3021

Symptoms and signs involving the circulatory and respiratory systems

2876

8353

1.76

146.76

2.2

3.68

3.75

g/l

1.51

2674

7641

Asthma-related infections

2065

11093

1.86

144.29

2.3

3.77

3.70

g/l

0.95

1910

10064

Asthma, hospital admission 2, infections

2065

11093

1.86

144.29

2.3

3.77

3.70

g/l

0.95

1910

10064

Other necrotizing vasculopathies

446

1233

4.08

143.00

1.7

2.6

3.79

3.72

g/l

0.40

412

1122

Hypothyroidism (congenital or acquired)

481

662

4.16

142.38

2.5

1.2

3.56

3.63

g/l

0.57

459

617

Myelodysplastic syndrome, including Hilmo

262

481

6.65

142.24

2.3

1.4

3.68

3.77

g/l

0.30

245

424

Complications of procedures, not elsewhere classified

2744

13147

1.72

142.05

2.2

2.3

3.71

3.72

g/l

0.04

2527

11987

Dizziness and giddiness

2607

11883

1.75

141.76

2.1

2.4

3.63

3.74

g/l

2.84

2373

10881

Any reimbursement code in KELA

1298

2868

2.31

141.20

2.5

1.5

3.77

3.65

g/l

1.48

1232

2590

Abnormalities of gait and mobility

675

2414

3.05

140.59

1.9

2.3

3.66

3.74

g/l

0.71

624

2201

Hypothyroidism, levothyroxine purchases

477

660

4.14

140.53

2.4

1.2

3.56

3.63

g/l

0.48

455

615

Hypothyroidism and >3 levothyroxin purchases

477

660

4.14

140.53

2.4

1.2

3.56

3.63

g/l

0.48

455

615

Spinal stenosis

1979

7897

1.91

140.24

2.3

3.65

3.79

g/l

2.91

1797

7138

Soft tissue disorders

3024

9266

1.70

138.59

2.3

2.4

3.64

3.77

g/l

4.16

2800

8431

Other disorders of urethra and urinary system

2373

9428

1.79

138.31

2.2

2.3

3.69

3.73

g/l

0.53

2182

8599

Parasetamol

1942

5136

1.95

137.22

2.4

2.0

3.77

3.73

g/l

0.39

1789

4761

Intestinal infectious diseases

3061

13996

1.66

136.89

2.9

2.2

3.72

g/l

0.05

2826

12764

Amyloidosis

219

353

7.86

136.59

7.4

2.2

3.40

3.73

g/l

0.81

212

322

Haemorrhage from respiratory passages

1365

5883

2.13

136.20

2.2

2.3

3.84

3.78

g/l

0.58

1253

5296

Amyloidosis, other/unspecified

200

296

8.94

136.15

7.8

2.2

3.37

3.71

g/l

0.79

194

269

Heart failure and coronary heart disease

1870

7033

1.94

135.92

2.1

2.5

3.74

3.76

g/l

0.18

1727

6283

Diabetes, varying definitions

3116

11075

1.66

134.21

2.0

2.5

3.83

3.65

g/l

8.47

2874

10089

Diabetes mellitus

3126

11076

1.66

134.07

2.0

2.5

3.82

3.65

g/l

8.32

2883

10091

Gastro-oesophageal reflux disease

2314

11302

1.77

133.32

2.1

2.4

3.61

3.74

g/l

3.03

2073

10359

Spondylosis

1967

8464

1.87

133.12

2.2

3.65

3.78

g/l

3.13

1808

7698

Diseases of the musculoskeletal system and connective tissue

1322

3028

2.23

132.77

2.2

3.76

3.77

g/l

0.06

1231

2770

Intestinal infectious diseases, including avohilmo, including avohilmo

3695

13162

1.59

132.61

2.8

2.2

3.71

3.72

g/l

0.24

3410

11997

Depression medications

510

675

3.87

132.36

1.7

1.2

3.69

3.62

g/l

0.51

493

630

Disorders of other endocrine glands

1529

7750

2.00

132.36

2.3

3.57

3.69

g/l

3.19

1401

7039

Persons encountering health services for examination and investigation

1839

4810

1.96

131.20

2.2

3.67

3.86

g/l

5.63

1692

4425

Speech therapy

1094

5035

2.28

130.51

2.2

2.3

3.73

3.69

g/l

0.48

1056

4558

Disorders of parathyroid gland

951

4087

2.44

130.21

2.3

3.57

3.68

g/l

1.62

863

3663

Hypertensive Heart Disease

1002

3292

2.42

129.88

2.0

2.5

3.80

3.69

g/l

1.23

912

2920

Diarrhoea and gastroenteritis of presumed infectious origin

2285

11882

1.75

129.73

2.8

2.1

3.73

3.72

g/l

0.08

2110

10829

Chronic gastritis

1163

5500

2.22

129.37

2.2

2.4

3.76

3.72

g/l

0.26

1051

4970

Type 2 diabetes

3067

10947

1.65

129.25

2.0

2.5

3.85

3.65

g/l

9.92

2827

9966

ILD medications: azathioprine

507

1597

3.34

128.92

1.8

1.6

3.71

3.66

g/l

0.42

478

1467

Rheumatoid arthritis, including avohilmo

1458

7492

2.02

128.49

1.9

2.4

3.83

3.67

g/l

3.30

1362

6756

Neoplasms

1874

5217

1.92

128.15

2.7

1.2

3.72

3.78

g/l

0.78

1761

4780

Kidney transplant status

297

656

5.10

128.10

1.7

2.4

3.55

3.73

g/l

1.13

291

615

Genitourinary diseases

1536

3800

2.07

127.71

2.1

2.3

3.78

3.82

g/l

0.35

1440

3493

Chronic lymphocytic leukaemia

250

488

6.23

127.08

2.5

1.4

3.14

3.77

g/l

2.90

236

429

Chronic lymphocytic leukaemia, helper endpoint

250

488

6.23

127.08

2.5

1.4

3.14

3.77

g/l

2.90

236

429

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

250

488

6.23

127.08

2.5

1.4

3.14

3.77

g/l

2.90

236

429

Certain disorders involving the immune mechanism

791

3205

2.61

126.65

2.7

2.2

3.68

3.70

g/l

0.11

747

2945

Hypercalcemia

324

784

4.85

126.43

4.0

2.5

3.74

3.68

g/l

0.17

298

709

Other functional intestinal disorders

1593

7654

1.94

125.41

2.6

2.3

3.54

3.75

g/l

5.17

1453

6933

Bacterial pneumoniae

1523

6975

1.98

124.81

3.6

2.0

3.83

3.70

g/l

1.24

1445

6301

Myalgia

843

3529

2.48

124.25

2.2

2.3

3.57

3.72

g/l

1.86

776

3215

Cardiomyopathy

751

3003

2.64

123.40

2.5

2.3

3.63

3.77

g/l

2.01

706

2708

Other/unspecified dorsalgia

1289

6333

2.07

123.16

2.7

2.2

3.76

3.75

g/l

0.06

1177

5746

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2179

9948

1.77

123.06

2.2

2.5

3.90

3.68

g/l

8.18

1993

8982

Bacterial pneumonia, not elsewhere classified

1459

6622

2.00

122.93

3.6

2.0

3.82

3.70

g/l

1.08

1390

5980

Acquired haemolytic anaemia

213

372

7.11

122.30

3.3

2.2

3.23

3.75

g/l

2.90

203

339

Other diseases of urinary system

3089

10857

1.63

121.58

2.3

3.70

3.75

g/l

0.87

2850

9958

Adjustment and management of implanted device

864

3721

2.46

121.46

2.6

2.1

3.75

3.81

g/l

0.58

804

3310

Diaphragmatic hernia

1457

7640

1.99

121.31

2.3

3.74

3.71

g/l

0.24

1316

6897

Non-follicular lymphoma

533

1821

3.22

121.13

2.6

2.5

3.64

3.76

g/l

0.44

509

1656

Hypertensive Renal Disease

262

550

5.48

120.80

1.9

2.7

3.68

3.77

g/l

0.28

253

493

Diseases of liver

1323

6718

2.05

120.66

1.8

2.5

4.01

3.69

g/l

9.01

1189

6183

STROKE

1801

6630

1.88

120.65

2.4

2.5

3.68

3.72

g/l

0.64

1639

6036

Fracture of lumbar spine and pelvis

1026

4742

2.27

120.58

2.3

3.69

g/l

0.02

872

4245

Asthma-related pneumonia

1427

7430

1.98

119.40

2.3

3.79

3.70

g/l

0.80

1333

6656

Neurological diseases

2333

6790

1.75

119.17

2.2

2.4

3.69

3.80

g/l

2.33

2147

6233

Asthma-related pneumonia or sepsis

1427

7442

1.98

118.81

2.3

3.79

3.70

g/l

0.80

1333

6666

Asthma, hospital admissions 3, pneumonia

1427

7442

1.98

118.81

2.3

3.79

3.70

g/l

0.80

1333

6666

Benign neoplasm: Colon

2128

11766

1.75

118.61

2.4

3.70

3.74

g/l

0.52

1907

10702

Other antidepressants

3221

10423

1.61

117.88

2.1

2.4

3.71

3.74

g/l

0.64

2919

9587

Antihypertensive medication - note that there are other indications

1249

3075

2.16

117.56

2.0

2.3

3.70

3.66

g/l

0.33

1178

2846

Nerve, nerve root and plexus disorders

3418

13317

1.57

117.37

2.2

2.3

3.67

3.73

g/l

1.35

3151

12143

Haemolytic anaemias

243

492

5.77

117.33

3.1

2.2

3.28

3.74

g/l

2.93

232

447

Arthropathies

2458

7346

1.72

117.05

2.2

2.4

3.76

3.70

g/l

0.83

2281

6733

Hypothyroidism, drug reimbursement

324

511

4.56

116.52

2.3

1.2

3.58

g/l

0.00

310

471

Insulin medication

2078

10083

1.75

115.56

2.1

2.5

3.87

3.69

g/l

5.07

1924

9139

Other disorders involving the immune mechanism, not elsewhere classified

215

396

6.34

115.12

2.3

2.4

4.19

3.77

g/l

2.43

206

371

Gastrointestinal diseases

1459

3677

2.02

115.00

2.4

1.9

3.69

3.74

g/l

0.48

1351

3394

Other disorders of kidney and ureter

641

2474

2.79

114.72

2.3

2.4

3.78

3.72

g/l

0.38

614

2262

Disorders of lens

2275

8357

1.73

114.39

2.5

2.4

3.76

3.75

g/l

0.16

2085

7738

Any event in cancer register

2673

9596

1.66

114.17

3.4

1.6

3.60

3.75

g/l

4.73

2500

8777

3568

11840

1.55

113.28

3.1

2.0

3.69

3.72

g/l

0.54

3286

10761

Abnormal findings on diagnostic imaging of lung

1901

10426

1.78

113.08

2.5

2.4

3.77

3.74

g/l

0.22

1739

9427

Lymphoid leukaemia

348

961

4.10

112.13

2.8

2.6

3.07

3.74

g/l

10.56

332

875

Use of hypnotics and sedatives

3324

12353

1.56

111.81

2.7

2.2

3.67

3.74

g/l

1.76

3042

11330

Injuries to the abdomen, lower back, lumbar spine and pelvis

1504

8041

1.90

111.58

2.4

2.2

3.68

3.71

g/l

0.24

1311

7295

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2890

10823

1.61

111.32

2.0

2.5

3.84

3.65

g/l

9.13

2661

9851

Intracranial trauma

1550

5591

1.91

110.85

2.2

2.4

3.72

3.80

g/l

0.92

1404

5153

Other arrhythmias

1906

8165

1.78

110.65

2.2

2.3

3.59

3.72

g/l

2.96

1753

7468

Dorsopathies

2939

9370

1.61

110.15

2.4

2.2

3.65

3.76

g/l

3.40

2709

8543

Thrombocytopenia, unspecified

396

1205

3.62

109.05

2.1

2.4

3.62

3.76

g/l

0.55

369

1110

Other intervertebral disc disorders

2507

9163

1.66

108.89

2.3

2.2

3.66

3.77

g/l

2.23

2306

8344

Chronic lower respiratory diseases

3600

12587

1.53

107.87

2.1

2.4

3.78

3.70

g/l

1.70

3338

11492

Disorders of choroid and retina

2803

12520

1.60

107.33

2.3

2.4

3.72

3.73

g/l

0.10

2522

11440

1423

7612

1.90

107.03

2.4

2.3

3.76

3.68

g/l

0.89

1316

6928

Other joint disorders

2346

7344

1.69

106.61

2.1

2.4

3.69

3.70

g/l

0.07

2165

6731

Other disorders of white blood cells

317

851

4.18

105.94

2.2

2.5

3.54

3.76

g/l

1.43

292

783

Azathioprine

507

1797

2.96

105.04

1.8

2.5

3.71

3.66

g/l

0.44

478

1657

Sicca syndrome [Sjögren]

414

1329

3.39

104.04

1.8

2.5

3.55

3.66

g/l

0.88

385

1210

Other and unspecified diseases of blood and blood-forming organs

205

400

6.15

103.97

5.3

2.5

3.68

3.71

g/l

0.08

197

375

All influenza

933

4412

2.19

102.91

4.6

2.0

3.56

3.69

g/l

1.84

857

3994

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2093

12497

1.68

102.77

2.3

3.72

3.71

g/l

0.02

1934

11351

Abnormal weight loss

484

1716

3.06

102.35

2.0

2.4

3.52

3.74

g/l

2.65

446

1564

Disorders of eyelid, lacrimal system and orbit

2823

13390

1.57

101.91

2.4

2.3

3.65

3.73

g/l

1.61

2564

12242

Gonarthrosis [arthrosis of knee](FG)

2247

7833

1.68

101.54

2.2

2.5

3.74

3.71

g/l

0.41

2072

7144

Weight loss

505

1837

2.97

101.54

2.1

2.4

3.51

3.72

g/l

2.69

466

1671

Chronic periodontitis, including avohilmo

3164

13335

1.54

101.50

2.5

2.3

3.73

3.72

g/l

0.24

2852

12241

Venous thromboembolism

1984

11521

1.70

101.43

2.7

2.3

3.80

3.72

g/l

1.26

1830

10402

Presence of cardiac and vascular implants and grafts

1746

7402

1.79

101.18

1.8

2.4

3.67

3.80

g/l

2.38

1551

6720

Cough

1331

6656

1.92

101.14

2.5

2.2

3.67

3.74

g/l

1.01

1224

6044

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

194

367

6.14

100.86

2.1

2.4

4.25

3.78

g/l

2.73

186

343

Periodontitis

3161

13331

1.54

100.53

2.5

2.3

3.74

3.72

g/l

0.25

2852

12235

Chronic apical periodontitis

3397

12730

1.52

100.22

2.4

2.2

3.73

3.71

g/l

0.27

3089

11663

Coxarthrosis [arthrosis of hip](FG)

1787

7114

1.77

99.73

2.2

2.6

3.74

3.71

g/l

0.23

1630

6465

Bacterial pneumonia (organism specified)

1633

8475

1.80

99.52

3.8

2.1

3.81

3.72

g/l

0.73

1547

7615

Other medical care

1719

8359

1.77

99.39

3.4

2.2

3.73

3.76

g/l

0.31

1581

7510

Unspecified haematuria

1599

7390

1.82

99.30

2.2

2.5

3.78

3.77

g/l

0.09

1466

6731

Other autoimmune haemolytic anaemias

136

187

9.90

99.30

2.6

2.3

3.16

3.82

g/l

2.11

131

170

Dialysis

221

474

5.26

98.88

2.4

2.0

3.65

3.76

g/l

0.33

214

442

Infections of the skin and subcutaneous tissue

1840

10759

1.72

98.87

2.6

2.3

3.78

3.74

g/l

0.49

1714

9886

Hyperparathyroidism

798

3581

2.32

98.82

2.4

2.2

3.57

3.68

g/l

1.48

726

3195

Sulfasalazine

905

4295

2.18

98.63

1.8

2.5

3.94

3.68

g/l

4.44

849

3903

Paroxysmal tachycardia

614

2008

2.62

98.59

2.0

2.2

3.75

3.69

g/l

0.34

567

1830

Isolated proteinuria

190

361

6.14

98.47

3.0

2.6

3.94

3.68

g/l

1.11

183

333

Other arthrosis

1703

6527

1.79

98.33

2.1

2.5

3.72

g/l

0.00

1570

5965

Injuries to the head

3377

13456

1.51

98.28

2.3

3.73

3.71

g/l

0.29

3061

12354

Injuries to the hip and thigh

1813

9629

1.73

97.99

2.2

2.3

3.70

3.72

g/l

0.23

1526

8791

Viral pneumonia

543

2087

2.75

96.98

4.0

1.9

3.57

3.67

g/l

0.84

510

1890

Type 2 diabetes, definitions combined

2859

10807

1.57

96.96

2.1

2.5

3.86

3.65

g/l

10.07

2619

9831

Type 2 diabetes, strict (exclude DM1)

2874

10885

1.56

96.65

2.1

2.5

3.86

3.65

g/l

10.27

2634

9903

General examination and investigation of persons without complaint and reported diagnosis

1654

4801

1.82

96.36

2.3

2.2

3.50

3.86

g/l

11.91

1496

4418

Senile cataract

2119

7838

1.68

96.22

2.6

2.4

3.78

3.75

g/l

0.32

1934

7246

COPD (mode)

1104

4372

2.04

95.95

1.8

2.0

3.93

3.71

g/l

2.95

996

3940

Benign neoplasms

2792

9822

1.57

95.14

2.3

2.2

3.70

3.78

g/l

1.49

2572

9030

Seronegative rheumatoid arthritis

456

1617

2.99

95.08

2.2

2.8

3.75

3.63

g/l

0.64

427

1470

Diabetes, insulin treatment (Kela reimbursement)

3112

12346

1.52

94.20

2.0

2.4

3.84

3.67

g/l

8.87

2873

11235

Hernia of abdominal wall, postoperative

619

2535

2.52

94.19

2.4

2.1

3.74

3.75

g/l

0.01

573

2333

Cerebrovascular diseases

2593

11621

1.58

94.14

2.3

2.4

3.72

3.74

g/l

0.23

2320

10620

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3039

12779

1.53

94.08

2.4

2.3

3.77

3.72

g/l

0.69

2797

11685

Bronchitis

3341

13566

1.50

93.82

3.2

2.1

3.66

3.73

g/l

1.50

3088

12356

483

1773

2.85

93.68

2.3

3.80

3.67

g/l

0.96

447

1623

Hernia

2874

12592

1.54

93.60

2.4

2.3

3.69

3.72

g/l

0.46

2622

11490

Streptococcal septicaemia, including avohilmo

429

1494

3.08

93.15

4.5

2.1

3.97

3.68

g/l

1.53

391

1342

Sciatica+with lumbago

1605

8233

1.77

93.14

2.2

3.64

3.77

g/l

2.98

1480

7517

Falls/tendency to fall

2973

9781

1.54

92.58

2.2

2.4

3.69

3.72

g/l

0.58

2689

9135

Other bacterial intestinal infections, including avohilmo

889

4309

2.15

92.37

3.5

2.1

3.62

3.72

g/l

0.98

816

3902

Hyperkalaemia

326

976

3.67

92.06

2.4

2.2

3.81

3.77

g/l

0.10

300

871

Explicit bacterial Sepsis, including avohilmo

483

1803

2.85

91.67

4.6

2.1

3.94

3.71

g/l

1.32

441

1642

Hard cardiovascular diseases

2571

9782

1.58

91.37

2.3

2.5

3.68

3.75

g/l

1.38

2382

8934

Other nutritional deficiencies

1999

11283

1.65

91.08

1.9

2.4

3.96

3.66

g/l

15.51

1847

10402

Symptoms and signs involving the digestive system and abdomen

2950

9734

1.54

91.00

2.3

3.67

3.76

g/l

2.45

2723

8857

Insulin, combination of fast acting with intermediate-acting or long-acting

2078

11788

1.63

90.54

2.1

2.4

3.87

3.72

g/l

3.53

1924

10719

Other cataract

1577

6775

1.78

90.25

2.6

2.4

3.82

3.75

g/l

0.61

1439

6243

Insulin, intermediate and long-acting

1880

11122

1.67

89.88

2.0

2.4

3.89

3.72

g/l

4.54

1739

10128

Other diseases of intestine

639

2747

2.45

89.84

2.4

2.3

3.67

3.74

g/l

0.58

605

2503

DVT of lower extremities and pulmonary embolism

1564

9136

1.76

89.50

2.8

2.3

3.80

3.72

g/l

0.98

1438

8243

Other external causes of accidental injury

2249

6998

1.64

89.04

2.3

3.68

3.74

g/l

1.00

2038

6536

Hypo-osmolality and hyponatraemia

719

3246

2.30

88.15

2.7

2.2

3.62

3.70

g/l

0.49

648

2884

Type 2 diabetes, definitions combined, including avohilmo

2808

10730

1.54

87.96

2.0

2.5

3.87

3.65

g/l

10.51

2576

9768

Viral hepatitis, IBD co-morbidity

149

243

6.42

87.88

2.0

3.93

3.70

g/l

0.51

138

231

Arthrosis

2063

6939

1.66

87.63

2.1

2.4

3.73

3.71

g/l

0.14

1909

6342

Diseases of the digestive system

1648

9777

1.72

87.58

2.3

3.72

3.73

g/l

0.09

1518

8851

Other bacterial intestinal infections

732

3366

2.28

87.54

3.6

2.1

3.64

3.73

g/l

0.63

672

3042

Other and unspecified disorders of white blood cells

241

614

4.44

86.97

2.1

2.5

3.47

3.80

g/l

2.16

226

566

Streptococcal septicaemia

411

1453

3.03

86.82

4.6

2.1

3.98

3.69

g/l

1.49

375

1302

SLE (Finngen)

191

404

5.30

86.77

1.7

2.4

3.50

3.66

g/l

0.81

180

371

Diseases of the eye and adnexa

1949

5884

1.68

86.54

2.2

2.1

3.75

3.77

g/l

0.19

1822

5479

Diabetes medication

3057

12060

1.50

86.39

1.9

2.4

3.82

3.66

g/l

7.04

2810

10978

Non-Hodgkin lymphoma, all

267

734

4.08

86.36

3.7

1.4

3.91

3.77

g/l

0.24

258

641

Diseases of the respiratory system

1799

5330

1.72

86.04

2.5

1.9

3.72

3.70

g/l

0.24

1665

4837

Peripheral artery disease

1709

8125

1.71

85.93

2.1

2.4

3.81

3.73

g/l

1.16

1564

7301

Pruritus

474

1813

2.76

85.58

2.1

2.3

3.64

3.67

g/l

0.12

441

1657

Factors influencing health status and contact with health services

783

1736

2.31

85.46

2.4

1.9

3.72

3.93

g/l

2.01

724

1585

IgA nephropathy (IgA glomerulonephritis)

161

300

6.29

85.37

1.9

2.5

4.29

3.83

g/l

2.26

153

279

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3044

13256

1.49

85.31

2.6

2.2

3.70

3.72

g/l

0.22

2808

12085

Other diseases of blood and blood-forming organs

348

1138

3.34

85.06

4.2

2.5

3.72

3.73

g/l

0.02

324

1050

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2731

14233

1.52

85.00

2.8

2.2

3.67

3.73

g/l

0.76

2510

13022

Other retinal disorders

2261

11068

1.59

84.57

2.3

2.4

3.74

3.73

g/l

0.04

2021

10060

Explicit bacterial Sepsis

463

1763

2.79

84.52

4.7

2.1

3.95

3.71

g/l

1.32

423

1607

Accidents

2217

6998

1.61

82.83

2.2

2.3

3.68

3.74

g/l

0.98

2009

6536

Concussion

1286

5560

1.82

82.58

2.1

2.4

3.72

3.80

g/l

0.82

1166

5123

Polyarthrosis

775

3329

2.18

82.50

2.3

2.6

3.58

3.64

g/l

0.68

691

2994

Other diseases of pleura

1717

9128

1.68

82.18

2.4

2.3

3.80

3.74

g/l

0.68

1571

8248

Other acute lower respiratory infections

1716

10015

1.67

81.69

3.2

2.2

3.69

3.73

g/l

0.46

1598

9092

Obesity related asthma

1155

6381

1.86

81.20

1.9

2.4

3.88

3.69

g/l

2.98

1068

5852

Fracture of rib(s), sternum and thoracic spine

1175

6546

1.86

80.87

2.6

2.3

3.68

3.75

g/l

0.74

1050

5962

Polyuria

892

4555

2.04

80.72

2.0

2.5

3.65

3.78

g/l

1.66

809

4144

Giant cell arteritis

263

753

3.97

80.70

1.7

2.6

3.83

3.73

g/l

0.53

237

676

Vocal cord dysfunction

368

1092

3.06

80.36

2.5

3.67

3.64

g/l

0.12

335

1017

Abnormalities of heart beat

1127

6003

1.87

79.81

2.2

3.60

3.74

g/l

1.56

1023

5408

Abdominal and pelvic pain

2877

9734

1.50

79.68

2.3

3.68

3.76

g/l

1.87

2660

8857

Cystitis

2495

9788

1.54

79.46

2.3

3.67

3.74

g/l

1.26

2267

8935

Acute myeloid leukaemia and myelodysplastic syndromes

171

359

5.57

79.44

1.9

1.4

3.69

3.77

g/l

0.26

160

318

Myelodysplastic syndrome

124

195

8.10

79.41

2.1

1.3

3.68

3.67

g/l

0.01

114

171

Disorders of gallbladder, biliary tract and pancreas

3053

13086

1.47

79.41

2.3

3.79

3.72

g/l

1.55

2783

11963

Seropositive rheumatoid arthritis, wide

980

5192

1.96

79.34

1.9

2.4

3.82

3.65

g/l

3.52

916

4692

Benzodiazepine use

3023

14063

1.47

79.32

2.2

2.3

3.68

3.73

g/l

0.73

2716

12912

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1907

12084

1.61

79.14

2.2

2.4

3.73

3.71

g/l

0.15

1758

10985

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

956

5034

1.97

78.88

1.9

2.4

3.82

3.65

g/l

3.49

894

4551

Obesity and other hyperalimentation

1850

10937

1.62

78.87

1.8

2.4

3.98

3.67

g/l

17.32

1714

10079

Urinary track infection

1456

4163

1.78

78.71

2.2

3.59

3.66

g/l

0.88

1338

3789

Injuries to the thorax

1607

9807

1.68

78.69

2.4

2.3

3.70

3.75

g/l

0.69

1444

8959

Obesity

1839

10880

1.62

78.65

1.8

2.4

3.98

3.67

g/l

17.41

1705

10029

Other/unspecified seropositive rheumatoid arthritis

969

5144

1.96

77.99

1.9

2.4

3.82

3.66

g/l

3.53

905

4646

Fibromyalgia

323

1053

3.23

77.94

2.1

3.62

3.68

g/l

0.29

304

978

Pulmonary heart disease, diseases of pulmonary circulation

1221

6965

1.81

77.59

2.5

2.3

3.79

3.71

g/l

0.94

1127

6274

Implicit fungal Sepsis, including avohilmo

344

1183

3.14

76.78

3.0

2.2

3.73

3.67

g/l

0.22

311

1079

Sleep apnoea

2904

12578

1.48

76.76

2.0

2.4

3.76

3.71

g/l

1.00

2684

11531

Nausea and vomiting

925

4726

1.97

76.34

2.9

2.3

3.71

3.74

g/l

0.16

858

4233

Secondary and unspecified malignant neoplasm of lymph nodes

383

1400

2.94

76.24

1.7

1.4

3.54

3.73

g/l

0.89

364

1248

Statin medication

1672

5678

1.68

76.22

2.1

2.5

3.74

3.66

g/l

1.06

1560

5186

Abnormal findings on examination of urine, without diagnosis

237

653

4.03

76.21

3.2

2.5

3.89

3.74

g/l

0.71

227

602

Bacterial intestinal infections, IBD co-morbidities

727

3521

2.16

76.19

3.7

2.1

3.64

3.73

g/l

0.64

668

3191

Irritable bowel syndrome

826

4174

2.04

75.92

2.3

2.2

3.51

3.68

g/l

2.96

752

3810

Undetermined asthma, excluding more controls

433

1672

2.70

75.88

2.1

1.7

3.85

3.69

g/l

0.54

401

1505

Idiopathic gout

455

1823

2.69

75.81

2.1

2.3

3.88

3.76

g/l

1.00

416

1658

Mood disorders, excluding more controls

2743

10953

1.49

75.51

2.1

2.4

3.72

3.71

g/l

0.10

2507

10087

Sleep disorders (combined)

3242

11846

1.45

74.85

2.0

2.4

3.74

3.71

g/l

0.56

2965

10817

Other disorders of lacrimal gland

1226

7063

1.79

74.81

2.7

2.3

3.58

3.69

g/l

1.25

1107

6433

Episodal and paroxysmal disorders

3050

10691

1.47

74.50

2.0

2.4

3.64

3.75

g/l

3.62

2793

9776

Asthma, hospital admissions , main diagnosis only

2400

14044

1.51

74.27

2.0

2.3

3.76

3.70

g/l

1.03

2215

12812

Other specified/unspecified systemic involvement of connective tissue

265

797

3.62

74.11

1.8

2.7

3.70

g/l

0.02

253

725

Dysphagia

934

4976

1.94

74.09

2.3

2.5

3.69

3.77

g/l

0.51

849

4507

Ischemic heart diseases

2540

10172

1.51

74.07

2.3

2.5

3.68

3.75

g/l

1.19

2363

9241

Gonarthrosis

1890

6712

1.62

73.74

2.1

2.5

3.74

3.72

g/l

0.28

1748

6126

Coxarthrosis

1604

6299

1.68

73.55

2.2

2.5

3.75

3.72

g/l

0.30

1459

5733

Postmenopausal osteoporosis with pathological fracture

356

1288

3.04

73.28

2.1

2.3

3.50

3.70

g/l

1.61

295

1154

Conduction disorders

1040

4553

1.89

73.06

2.2

2.3

3.64

3.74

g/l

1.52

933

4084

Percutaneous Coronary Intervention

2451

9994

1.52

73.03

2.1

2.5

3.68

3.75

g/l

1.49

2299

9072

Shoulder lesions

2227

8755

1.55

72.97

2.2

2.4

3.66

3.78

g/l

2.48

2047

7958

Fibrosis and cirrhosis of liver

371

1369

2.93

72.90

1.6

2.5

4.28

3.68

g/l

8.80

345

1264

Systemic lupus erythematosus

191

466

4.57

72.71

1.7

2.3

3.50

3.74

g/l

1.24

180

431

Asthma, including avohilmo

3425

13428

1.42

72.38

2.1

2.4

3.78

3.71

g/l

1.55

3171

12242

Fracture of femur

1092

5520

1.84

72.36

2.3

2.2

3.70

3.71

g/l

0.07

872

4966

Other symptoms and signs involving cognitive functions and awareness

1663

9234

1.64

72.24

2.2

2.4

3.72

3.76

g/l

0.43

1460

8373

Persons encountering health services for specific procedures, not carried out

327

1125

3.07

72.07

2.2

2.0

3.89

3.73

g/l

0.99

311

1037

Other disorders of veins

1360

8021

1.71

71.53

2.2

2.3

3.78

3.68

g/l

1.09

1224

7293

Depression or dysthymia

2012

7050

1.59

71.45

2.3

2.5

3.72

3.73

g/l

0.07

1817

6540

Acute bronchitis

1348

7923

1.71

70.67

3.2

2.2

3.70

3.73

g/l

0.19

1254

7150

Other gastritis (incl. Duodenitis)

814

4219

2.00

70.33

2.3

2.4

3.79

3.72

g/l

0.54

739

3837

Atherosclerosis, excluding cerebral and coronary sclerosis

1582

7723

1.66

70.20

2.0

2.4

3.80

3.73

g/l

0.81

1451

6936

Emergency coronary revascularization (for ACS)

2696

11208

1.48

70.18

2.1

2.5

3.67

3.76

g/l

1.91

2519

10140

Chronic rhinitis, nasopharyngitis and pharyngitis

995

5503

1.86

69.47

2.1

2.3

3.69

3.72

g/l

0.19

910

5044

Biological medication for rheuma

521

2285

2.36

69.28

1.6

2.3

4.05

3.68

g/l

7.07

501

2145

Pulmonary embolism

1098

6293

1.80

68.71

2.6

2.3

3.79

3.70

g/l

1.08

1013

5687

Osteonecrosis

302

1031

3.18

68.56

7.6

2.1

3.70

3.71

g/l

0.02

284

956

Diseases of oral cavity, salivary glands and jaws

1817

5907

1.61

68.49

2.3

2.1

3.68

3.77

g/l

1.29

1635

5388

Pulmonary heart disease

1098

6301

1.80

68.41

2.6

2.3

3.79

3.70

g/l

1.10

1013

5695

Soft tissue disorders related to use, overuse and pressure

918

4985

1.90

68.35

2.4

2.5

3.62

3.76

g/l

1.58

847

4535

Enterocolitis due to Clostridium difficile

468

1987

2.50

68.20

4.2

2.2

3.72

g/l

0.02

436

1797

Coronary revascularization (ANGIO or CABG)

2426

9998

1.50

68.20

2.1

2.5

3.68

3.75

g/l

1.41

2275

9075

Other diseases of anus and rectum

1015

5667

1.83

68.03

2.3

3.72

3.77

g/l

0.36

896

5120

Solid cancers, including Hilmo

2290

8931

1.52

67.78

2.3

1.4

3.71

3.75

g/l

0.61

2127

8131

Cardiomyopathy in other diseases

14.04

67.69

7.5

2.0

3.24

3.56

g/l

1.05

Diffuse large B-cell lymphoma, including Hilmo

257

807

3.51

67.64

1.7

1.4

3.46

3.75

g/l

2.66

241

720

Diffuse large B-cell lymphoma, helper endpoint

257

807

3.51

67.64

1.7

1.4

3.46

3.75

g/l

2.66

241

720

Diffuse large B-cell lymphoma

257

807

3.51

67.64

1.7

1.4

3.46

3.75

g/l

2.66

241

720

Visual disturbances and blindness

1686

10805

1.59

67.16

2.3

3.58

3.73

g/l

4.16

1522

9810

Immunodeficiency with predominantly antibody defects

153

335

5.19

67.13

4.9

2.1

2.93

3.74

g/l

5.30

145

319

Hypokalaemia

471

2017

2.45

66.93

2.6

2.2

3.75

3.72

g/l

0.14

431

1809

Other CVD

847

4533

1.95

66.93

2.5

2.3

3.76

3.74

g/l

0.09

741

4048

Retention of urine

1262

6064

1.73

66.78

2.0

2.5

3.79

g/l

0.00

1143

5511

Immunodeficiencies

222

638

3.80

66.74

4.4

2.3

3.21

3.70

g/l

2.64

209

594

Unspecified privation

421

1722

2.58

66.40

2.0

2.3

3.80

3.71

g/l

0.58

394

1580

Temporal arteritis

222

647

3.88

66.37

1.6

2.7

3.88

3.73

g/l

0.71

199

576

Obesity, other/unspecified

949

5245

1.85

66.32

1.7

2.3

4.00

3.64

g/l

11.80

888

4855

Obesity due to excess calories

1325

8045

1.68

66.05

1.8

2.4

3.96

3.67

g/l

12.32

1228

7431

Other diseases of pericardium

219

628

3.81

66.05

1.7

2.4

3.81

g/l

0.00

200

560

Disorders of lacrimal system

1419

8630

1.66

65.97

2.6

2.3

3.59

3.69

g/l

1.41

1276

7843

Insulin, fast-acting

1149

6729

1.75

65.93

1.9

2.4

3.81

3.72

g/l

0.91

1073

6147

Major coronary heart disease event

2592

10730

1.47

65.67

2.2

2.5

3.68

3.75

g/l

1.42

2415

9737

Type 1 diabetes

720

3649

2.02

65.42

1.7

2.4

3.71

3.67

g/l

0.22

682

3356

Chronic nephritic syndrome

200

546

4.06

65.24

2.6

3.93

3.72

g/l

0.99

193

507

Lumbar disc prolapse

1816

8725

1.57

65.20

2.4

2.2

3.67

3.77

g/l

1.45

1685

7980

Asthma/COPD (KELA code 203)

2692

12585

1.45

65.13

2.1

2.4

3.75

3.70

g/l

0.78

2464

11491

Hypotension

757

3948

2.01

64.86

2.6

2.3

3.76

3.73

g/l

0.12

655

3526

Undetermined asthma

433

1805

2.49

64.67

2.1

1.7

3.85

3.68

g/l

0.61

401

1631

Zoster [herpes zoster], including avohilmo

1742

10953

1.57

64.55

3.0

2.3

3.68

3.71

g/l

0.29

1578

9920

ILD, hospital admission 2, with pulmonary infections

426

1781

2.54

64.33

2.4

1.9

3.88

3.72

g/l

1.21

401

1602

Other diseases of liver

638

3144

2.11

63.70

2.0

2.4

3.94

3.67

g/l

4.17

583

2903

Other (not insulin) diabetes medications

2850

11834

1.43

63.47

1.9

2.5

3.86

3.67

g/l

9.49

2610

10764

GI-bleeding

1177

7026

1.72

63.41

2.3

3.79

3.75

g/l

0.41

1084

6338

Primary hyperparathyroidism

478

2121

2.40

63.28

2.6

2.4

3.53

3.69

g/l

1.82

432

1915

Any mental disorder

3123

11191

1.41

63.09

2.1

2.4

3.72

3.71

g/l

0.12

2839

10300

Cutaneous abscess, furuncle and carbuncle

811

4345

1.92

62.94

2.2

2.3

3.73

3.70

g/l

0.21

760

4009

Other (seronegative) rheumatoid arthritis, wide

695

3552

2.04

62.88

2.0

2.3

3.75

3.67

g/l

0.53

645

3207

Visual disturbances

1548

9891

1.60

62.87

2.3

3.57

3.73

g/l

4.87

1417

9017

Other diseases of the digestive system

1173

7016

1.72

62.78

2.3

3.79

3.74

g/l

0.48

1075

6336

External causes of morbidity and mortality

1715

5449

1.60

62.61

2.3

3.74

g/l

0.04

1565

5078

SLE, ICD10

179

466

4.28

62.53

1.7

2.0

3.46

3.72

g/l

1.53

169

433

SLE, strict definition

179

466

4.28

62.53

1.7

2.0

3.46

3.72

g/l

1.53

169

433

Sleep apnoea, including avohilmo

2937

12683

1.42

62.42

2.0

2.4

3.76

3.70

g/l

1.04

2713

11626

Viral infections characterized by skin and mucous membrane lesions

1282

7838

1.67

62.22

3.4

2.2

3.65

3.71

g/l

0.54

1192

7164

Other diseases of hard tissues of teeth

1761

5851

1.59

62.12

2.3

2.1

3.67

3.76

g/l

1.52

1579

5341

Endocarditis

180

476

4.16

61.23

2.2

2.4

4.23

3.83

g/l

0.81

170

429

Cardiomyopathy, other and unspecified

319

1188

2.86

61.17

2.3

3.65

3.78

g/l

0.80

301

1068

Other dialysis

170

438

4.38

60.53

2.5

2.7

3.72

3.79

g/l

0.16

165

408

Urticaria and erythema

1017

5894

1.76

60.44

2.2

3.72

3.66

g/l

0.53

942

5406

Idiopathic thrombocytopenic purpura

164

411

4.46

60.41

2.4

3.39

3.71

g/l

1.71

155

375

Malignant neoplasm of skin, including Hilmo

1658

7166

1.58

60.34

2.6

1.4

3.67

3.75

g/l

0.94

1509

6461

AV-block

686

2997

2.03

60.00

2.3

3.74

3.78

g/l

0.30

614

2650

Other abnormal findings of blood chemistry

221

679

3.53

59.85

3.0

2.4

3.88

3.64

g/l

1.01

214

628

Systemic lupus erythematosus, unspecified

158

393

4.50

58.82

1.8

2.0

3.49

3.73

g/l

1.16

150

367

Giant cell arteritis with polymyalgia rheumatica

222

701

3.57

58.60

1.6

2.5

3.88

3.73

g/l

0.73

199

629

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

574

2816

2.14

58.55

1.5

2.4

4.35

3.72

g/l

14.98

517

2604

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1554

6724

1.59

58.38

2.6

1.4

3.71

3.75

g/l

0.36

1409

6034

Anaemia in chronic diseases classified elsewhere

148

355

4.75

58.14

1.8

2.5

3.50

3.73

g/l

0.96

139

325

Noninfective enteritis and colitis

1336

8382

1.62

58.10

2.4

2.3

3.69

3.71

g/l

0.17

1230

7669

Early onset COPD, excluding more controls

617

3096

2.05

58.05

2.0

1.9

3.92

3.74

g/l

1.11

571

2827

Cirrhosis of liver, NAS

273

970

3.07

58.00

1.6

2.6

4.44

3.68

g/l

9.28

257

895

Anxiety disorders, excluding more controls

2249

9926

1.47

57.90

2.3

2.4

3.66

3.70

g/l

0.61

2072

9163

Chronic periodontitis, complicated

1814

11894

1.52

57.84

2.5

2.4

3.80

3.72

g/l

1.25

1652

10930

Insulin, fast-acting or short human

1153

7017

1.68

57.28

1.9

2.3

3.81

3.73

g/l

0.70

1077

6406

Other headache syndromes

1160

7047

1.67

56.93

1.9

2.5

3.51

3.70

g/l

5.41

1062

6459

Solid cancers

2194

8846

1.47

56.90

2.2

1.4

3.70

3.75

g/l

0.80

2034

8047

Ischaemic heart disease, wide definition

2407

10415

1.45

56.60

2.4

2.5

3.72

3.74

g/l

0.34

2240

9450

Agranulocytosis

423

1864

2.39

56.57

4.1

2.3

3.76

3.73

g/l

0.09

410

1709

Convulsions, not elsewhere classified

596

2939

2.05

56.44

1.8

2.2

3.83

3.72

g/l

0.85

550

2696

Biguanides

2792

12148

1.41

56.31

1.9

2.4

3.87

3.67

g/l

10.09

2566

11058

Iron deficiency anaemia secondary to blood loss (chronic)

600

3036

2.06

55.89

2.1

2.3

3.65

3.68

g/l

0.19

536

2738

Unspecified fall

1599

10366

1.54

55.61

2.2

2.3

3.70

3.74

g/l

0.51

1395

9455

Calcific aortic valvular stenosis, including rheumatic fever

1159

6867

1.68

55.31

2.3

3.77

3.74

g/l

0.26

1053

6129

Methotrexate

444

2009

2.30

55.16

1.9

2.5

3.77

3.62

g/l

1.41

419

1820

Later onset COPD, excluding more controls

785

3272

1.90

55.14

1.6

2.0

3.86

3.68

g/l

3.26

703

2893

Calcific aortic valvular stenosis, operated

1155

6851

1.68

55.14

2.4

2.3

3.77

3.74

g/l

0.25

1049

6115

Calcific aortic valvular stenosis

1155

6851

1.68

55.14

2.4

2.3

3.77

3.74

g/l

0.25

1049

6115

Operations 2 for CAVS

1154

6847

1.67

55.02

2.4

2.3

3.77

3.74

g/l

0.26

1048

6111

Calcific aortic valvular stenosis, diagnosis (helper)

1154

6847

1.67

55.02

2.4

2.3

3.77

3.74

g/l

0.26

1048

6111

Abnormal findings on diagnostic imaging of other body structures

540

2649

2.13

54.94

2.8

2.4

3.71

3.72

g/l

0.04

506

2408

Arthropathies in other diseases classified elsewhere

166

448

4.04

54.78

2.4

2.6

3.92

3.62

g/l

1.17

153

411

Volume depletion

379

1613

2.47

54.76

1.9

2.2

3.78

3.73

g/l

0.18

333

1434

Gingivitis and periodontal diseases

2854

10658

1.40

54.70

2.4

2.2

3.72

3.71

g/l

0.12

2572

9750

Mood disorders

2848

13252

1.39

54.60

2.1

2.4

3.72

g/l

0.00

2609

12135

Mood [affective] disorders

2840

13243

1.39

54.33

2.1

2.4

3.72

g/l

0.01

2601

12127

Chronic ulcer of skin, not elsewhere classified

309

1207

2.74

54.21

2.1

2.2

3.71

3.74

g/l

0.14

286

1091

Other and unspecified coagulation defects

205

639

3.44

54.00

2.6

2.5

3.65

3.67

g/l

0.09

195

592

Malignant neoplasm of skin

1571

6962

1.56

53.77

2.6

1.4

3.66

3.75

g/l

1.06

1425

6262

Type 1 diabetes, wide definition, subgroup 1

559

2780

2.06

53.74

1.7

2.3

3.71

3.66

g/l

0.21

525

2579

COPD

1555

8329

1.55

53.45

1.9

2.5

3.88

3.73

g/l

2.44

1413

7540

Cardiomyopathies, Primary/intrinsic

438

2002

2.29

53.44

1.9

2.3

3.71

3.79

g/l

0.64

408

1799

Secondary uncertain malignant neoplasm

493

2370

2.17

52.90

1.9

1.4

3.59

3.75

g/l

0.86

461

2114

Other neurological diseases

2295

12652

1.43

52.69

2.2

2.4

3.57

3.75

g/l

7.78

2061

11518

Symptoms and signs involving speech and voice

1085

6655

1.67

52.65

2.5

2.3

3.62

3.69

g/l

1.02

986

6047

Anxiety (asthma-related co-morbidities)

1460

7197

1.56

52.61

1.9

2.3

3.64

3.69

g/l

0.54

1353

6694

Non-allergic asthma (mode), excluding more controls

511

2457

2.12

52.55

2.0

1.8

3.81

3.68

g/l

0.67

474

2220

Other respiratory diseases principally affecting the interstitium

710

3886

1.90

52.47

2.4

2.3

3.87

3.73

g/l

1.44

668

3501

Motor neuron disease ALS

117

253

5.23

52.14

1.4

2.2

3.40

3.88

g/l

1.91

110

235

Injuries to the shoulder and upper arm

2531

14124

1.40

52.12

2.5

2.3

3.69

3.74

g/l

0.79

2267

12942

Prurigo nodularis

145

372

4.41

52.07

1.7

2.8

3.78

3.65

g/l

0.65

133

340

Other anxiety disorders

1084

5614

1.67

51.94

1.9

2.2

3.65

3.69

g/l

0.41

1004

5216

Benign neoplasm: Colon, unspecified

935

5554

1.74

51.86

2.4

3.66

3.73

g/l

0.75

819

5041

Isolated proteinuria with specified morphological lesion

150

7.12

51.72

4.3

2.6

3.82

3.71

g/l

0.17

138

Cardiomyopathy (excluding other)

448

2095

2.23

51.62

1.9

2.3

3.71

3.79

g/l

0.58

418

1886

Diseases of pulp and periapical tissues and dental caries

2005

7056

1.48

51.47

2.2

2.3

3.70

3.74

g/l

0.38

1811

6419

Rotator cuff syndrome

1804

8449

1.49

51.36

2.3

2.4

3.67

3.78

g/l

1.74

1652

7686

Motor neuron disease (with DMD)

117

256

5.14

51.33

1.4

2.1

3.40

3.87

g/l

1.87

110

237

Diabetic retinopathy, excluding more controls

846

2653

1.84

51.25

1.8

2.1

3.83

3.82

g/l

0.04

780

2413

Amputation

431

1998

2.28

51.19

2.3

4.03

3.75

g/l

1.47

396

1789

Basal cell carcinoma, including Hilmo

1485

6587

1.56

50.87

2.6

1.4

3.67

3.75

g/l

0.95

1335

5907

ILD, hospital admissions 3, with pneumonia sepsis

365

1585

2.44

50.82

2.3

1.9

3.80

3.65

g/l

1.20

343

1429

Mycoses, including avohilmo

2588

14360

1.39

50.67

2.3

3.71

3.72

g/l

0.13

2348

13175

Dental caries, including avohilmo

2204

7908

1.45

50.62

2.2

2.3

3.70

3.73

g/l

0.37

1991

7212

Persons with potential health hazards related to communicable diseases

813

4610

1.78

50.23

2.3

2.1

3.66

3.68

g/l

0.16

786

4303

Seropositive rheumatoid arthritis, strict definition

528

2659

2.07

49.98

1.7

2.3

3.98

3.67

g/l

5.82

493

2428

Other coagulation defects

275

1055

2.75

49.64

2.5

2.4

3.66

3.70

g/l

0.20

258

966

Nonalcoholic fatty liver disease

352

1515

2.44

49.59

1.9

2.5

4.09

3.73

g/l

4.15

326

1412

Selective serotonin reuptake inhibitors

2745

10424

1.38

49.51

2.2

2.4

3.71

3.74

g/l

0.52

2514

9588

Amputation of toe

322

1349

2.55

48.91

2.2

2.4

4.06

3.76

g/l

1.09

296

1227

Other diseases of arteries and capillaries

354

1542

2.42

48.75

2.3

2.4

3.77

3.73

g/l

0.17

323

1408

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1463

6547

1.55

48.68

2.6

1.4

3.69

3.75

g/l

0.52

1323

5871

Other disorders of skin and subcutaneous tissue, not elsewhere classified

514

2591

2.06

48.48

2.1

2.2

3.59

3.72

g/l

1.34

463

2348

Other reaction to severe stress, and adjustment disorders

840

4900

1.74

48.47

2.5

2.2

3.62

3.69

g/l

0.64

793

4555

Other and unspecified immunodeficiencies with predominantly antibody defects

145

6.85

48.46

5.2

2.3

2.91

3.82

g/l

3.46

137

Exposure to other specified factors

2200

13544

1.41

48.39

2.1

2.3

3.80

3.71

g/l

1.43

1988

12478

Depression

2572

12571

1.38

48.38

2.1

2.4

3.70

3.71

g/l

0.14

2356

11542

Candidiasis, including avohilmo

887

5274

1.72

48.35

2.5

2.2

3.72

3.67

g/l

0.34

798

4805

All anxiety disorders

1473

7573

1.53

48.31

1.9

2.3

3.64

3.70

g/l

0.77

1366

7016

Other noninfective gastroenteritis and colitis

754

4291

1.80

48.08

2.7

2.3

3.61

3.69

g/l

0.97

694

3896

Tumor necrosis factor alpha inhibitors

426

2000

2.19

48.08

1.5

2.3

4.06

3.69

g/l

6.06

407

1878

Open wound of head

1666

10722

1.48

48.03

2.2

2.3

3.78

3.75

g/l

0.32

1488

9809

Fungal Sepsis

202

674

3.25

47.90

3.5

2.2

3.55

3.65

g/l

0.35

187

620

Diseases of pulp and periapical tissues, including avohilmo

2906

11140

1.36

47.78

2.2

2.3

3.72

3.71

g/l

0.16

2640

10171

Pericarditis

161

467

3.74

47.75

1.9

2.2

4.20

3.79

g/l

0.72

148

421

Zoster [herpes zoster]

677

3760

1.87

47.52

4.0

2.3

3.63

3.72

g/l

0.50

612

3383

Functional dyspepsia

791

4581

1.77

47.50

2.4

2.3

3.53

3.70

g/l

2.88

735

4198

Subjective visual disturbances

802

4671

1.76

47.39

2.4

2.3

3.54

3.69

g/l

3.17

737

4265

Sequelae of external causes of morbidity and mortality

855

5075

1.73

47.28

2.3

2.4

3.77

3.69

g/l

0.69

807

4624

Abnormal involuntary movements

471

2323

2.11

47.20

2.2

2.3

3.56

3.75

g/l

2.41

426

2129

Other diseases of upper respiratory tract

3124

12223

1.35

47.19

2.3

3.68

3.74

g/l

1.02

2866

11134

Covid-19 suspected case

560

2921

1.97

47.14

2.5

2.2

3.69

g/l

0.00

532

2708

Trochanteric bursitis

485

2417

2.08

47.04

2.2

2.4

3.54

3.70

g/l

1.77

442

2190

Pleural effusion

610

3305

1.92

46.65

2.6

2.3

3.89

3.74

g/l

1.50

572

2984

Peripheral artery operations in Hilmo

504

2560

2.05

46.65

2.4

2.3

3.92

3.73

g/l

0.98

460

2302

Disorder of lipoprotein metabolism, unspecified

475

2363

2.10

46.58

1.9

2.3

3.89

3.76

g/l

0.60

438

2122

Coronary atherosclerosis

2010

8957

1.44

46.38

2.4

2.5

3.73

3.76

g/l

0.37

1865

8086

Stroke, including SAH

2063

10555

1.43

46.32

2.3

2.4

3.75

g/l

0.03

1850

9612

Osteomyelitis

266

1043

2.72

46.29

2.4

2.2

4.01

3.75

g/l

0.68

247

969

Conjunctivitis

1982

11308

1.43

46.23

2.3

3.67

3.68

g/l

0.07

1808

10362

Type 1 diabetes, wide definition

574

3035

1.94

46.21

1.7

2.3

3.68

3.66

g/l

0.09

539

2801

Deforming dorsopathies

780

4533

1.76

46.09

2.4

2.2

3.53

3.71

g/l

3.39

711

4119

Urticaria

775

4497

1.76

46.01

2.2

3.74

3.65

g/l

0.54

715

4137

Non-invasive ventilation

581

2644

1.93

45.90

3.1

2.4

3.35

3.65

g/l

2.19

541

2427

Psychiatric diseases

2701

9975

1.37

45.71

2.2

2.4

3.71

g/l

0.03

2453

9212

Caries of dentine, including avohilmo

2306

8481

1.41

45.67

2.2

2.3

3.69

3.73

g/l

0.47

2084

7742

Other and unspecified types of non-Hodgkin lymphoma, hilmo

206

717

3.14

45.63

3.0

2.6

3.55

3.77

g/l

0.81

193

652

Neurotic, stress-related and somatoform disorders

2313

11573

1.39

45.53

2.2

2.3

3.64

3.71

g/l

1.53

2134

10642

ILD, hospital admissions

601

3273

1.92

45.37

2.4

2.3

3.90

3.73

g/l

1.70

568

2963

Stroke, excluding SAH

1991

10230

1.43

45.20

2.3

2.4

3.75

g/l

0.01

1781

9306

Injury, poisoning and certain other consequences of external causes

1337

4337

1.57

44.90

2.3

3.73

3.76

g/l

0.21

1225

4021

Lichen simplex chronicus and prurigo

256

1000

2.72

44.86

1.9

2.6

3.74

3.63

g/l

0.72

236

912

Anxiety disorders

2337

11696

1.39

44.76

2.2

2.3

3.65

3.71

g/l

1.09

2154

10749

Substance abuse, excluding more controls

1518

8622

1.49

44.73

1.6

2.4

3.87

3.74

g/l

3.12

1358

8004

Acute upper respiratory infections of multiple and unspecified sites

2071

10829

1.41

44.60

3.4

2.1

3.61

3.73

g/l

2.68

1921

9910

Disorders of continuity of bone

318

1370

2.42

44.57

3.9

2.1

3.50

3.71

g/l

2.25

294

1274

Disorders of conjunctiva

2238

12614

1.39

44.51

2.3

3.68

3.70

g/l

0.19

2044

11553

Other interstitial pulmonary diseases

605

3322

1.90

44.46

2.4

2.3

3.91

3.73

g/l

1.78

572

3003

Presence of other functional implants

1885

9107

1.44

44.44

2.3

3.68

3.77

g/l

1.82

1696

8281

Other inflammation of eyelid, including avohilmo

1136

7321

1.58

44.26

2.6

2.3

3.69

g/l

0.00

1030

6749

Implicit fungal Sepsis

186

620

3.26

44.24

3.7

2.2

3.49

3.63

g/l

0.57

171

570

Spondylopathies (FG)

347

1552

2.30

44.17

1.8

2.6

3.92

3.65

g/l

2.48

332

1431

Interstitial lung disease

605

3330

1.90

44.13

2.4

2.3

3.91

3.73

g/l

1.75

572

3011

Interstitial lung disease endpoints

605

3330

1.90

44.13

2.4

2.3

3.91

3.73

g/l

1.75

572

3011

Acute upper respiratory infections

2963

13419

1.34

44.07

3.1

2.1

3.66

3.73

g/l

1.38

2729

12215

Other chronic obstructive pulmonary disease

1461

8112

1.51

43.97

1.8

2.5

3.87

3.73

g/l

2.08

1327

7346

Major coronary heart disease event excluding revascularizations

1928

9031

1.43

43.79

2.2

2.5

3.72

3.76

g/l

0.57

1767

8142

Injuries to the knee and lower leg

3272

13535

1.32

43.62

2.0

2.4

3.70

3.72

g/l

0.20

2981

12400

Rare circulating lymphoid malignancy, including Hilmo

138

385

3.93

43.59

4.6

1.4

3.66

3.72

g/l

0.10

132

343

Fitting and adjustment of other devices

1211

6984

1.56

43.58

2.4

2.2

3.42

3.77

g/l

12.29

1072

6238

L01XX Other antineoplastic agents

273

1123

2.62

43.45

3.4

2.5

3.33

3.77

g/l

4.53

254

1028

Basal cell carcinoma

1406

6424

1.52

43.44

2.6

1.4

3.67

3.75

g/l

0.81

1267

5755

Dental operations

1878

6769

1.45

43.35

2.3

2.1

3.71

3.79

g/l

1.37

1697

6168

Secondary right heart disease

207

743

3.04

43.32

1.9

2.4

3.76

g/l

0.01

193

677

Diabetic neuropathy

466

2364

2.07

43.26

2.0

2.1

3.99

3.87

g/l

0.50

435

2165

Pacemaker

1311

8159

1.53

43.13

2.1

2.3

3.65

3.75

g/l

1.14

1167

7320

Ischaemic Stroke, excluding all haemorrhages

1891

9915

1.43

42.99

2.3

2.4

3.76

3.75

g/l

0.09

1689

8998

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1362

8777

1.51

42.99

2.1

2.2

3.66

3.65

g/l

0.06

1234

8045

Chronic sinusitis

1173

7661

1.56

42.93

2.5

2.3

3.69

3.72

g/l

0.16

1091

7031

Meniscus derangement

1474

6616

1.50

42.91

2.2

2.5

3.65

3.72

g/l

0.92

1354

6052

Drug-induced osteoporosis with pathological fracture

115

290

4.65

42.88

1.7

2.6

3.63

3.74

g/l

0.28

264

Gastroduodenal ulcer

876

5350

1.68

42.86

2.1

2.4

3.73

3.76

g/l

0.19

803

4840

Psoriatic and enteropathic arthropathies

325

1435

2.34

42.84

1.8

2.6

3.92

3.66

g/l

2.41

307

1325

Artrosis, including avohilmo

2234

8868

1.40

42.78

2.1

2.5

3.71

3.75

g/l

0.56

2046

8161

Fracture of shoulder and upper arm

1115

7228

1.57

42.46

2.7

2.3

3.74

3.71

g/l

0.32

977

6569

L04AC Interleukin inhibitors

211

765

2.90

42.43

1.6

2.3

4.17

3.72

g/l

3.29

203

718

Spondyloarthritis

519

2742

1.95

42.26

2.2

2.3

3.97

3.71

g/l

3.38

494

2501

Cholelithiasis, broad definition with cholecystitis

2517

12486

1.36

42.05

2.4

3.76

3.70

g/l

0.89

2295

11388

Rash and other nonspecific skin eruption

335

1517

2.31

41.98

2.4

2.3

3.64

3.70

g/l

0.31

316

1386

Cellulitis

686

3959

1.78

41.95

3.0

2.3

3.82

3.71

g/l

0.68

643

3631

Asthma and allergy, excluding more controls

257

1012

2.56

41.90

2.0

1.5

3.67

3.65

g/l

0.12

235

935

Missing teeth due to accident, extraction or parodontitis

1951

12589

1.41

41.87

2.3

2.4

3.70

3.73

g/l

0.34

1695

11575

Other symptoms and signs involving the nervous and musculoskeletal systems

1175

7733

1.55

41.86

2.2

2.4

3.40

3.73

g/l

13.69

1094

7063

Special screening examination for infectious and parasitic diseases

456

1645

2.05

41.67

2.4

2.2

3.72

3.85

g/l

1.05

415

1569

Voice disturbances

827

5043

1.68

41.24

2.7

2.3

3.62

3.69

g/l

0.77

761

4602

Adverse effects, not elsewhere classified

532

2860

1.91

41.04

2.3

3.77

3.69

g/l

0.51

505

2646

Eosinophilic disease (BM)

149

5.94

41.04

2.5

1.6

3.72

3.55

g/l

0.38

138

Overexertion and strenuous or repetitive movements

324

1461

2.31

40.95

2.6

2.4

3.86

3.72

g/l

0.86

296

1358

Non-allergic asthma (mode)

511

2686

1.93

40.89

2.0

1.9

3.81

3.67

g/l

0.78

474

2427

Open wound of lower leg

494

2604

1.96

40.78

2.0

2.3

3.72

3.71

g/l

0.01

446

2370

Allergic conjunctivitis

1406

9261

1.48

40.70

2.0

2.3

3.66

g/l

0.03

1275

8503

Viral pneumonia (unknown virus, not influenza)

243

969

2.64

40.63

3.4

2.4

3.61

3.72

g/l

0.68

231

893

Allergic asthma (mode), excluding more controls

471

2371

1.97

40.53

1.9

1.7

3.72

3.66

g/l

0.52

439

2177

Superficial injury of head

757

4526

1.71

40.43

2.1

2.3

3.69

g/l

0.01

676

4108

Other infectious diseases, including avohilmo

334

1540

2.27

40.18

2.5

2.3

3.77

3.73

g/l

0.18

317

1411

Complications of internal orthopaedic prosthetic devices, implants and grafts

796

4850

1.69

40.12

2.1

2.3

3.82

3.69

g/l

0.95

717

4343

Other abnormalities of plasma proteins

230

4.89

39.81

5.1

2.7

3.94

3.56

g/l

1.01

208

Need for immunization against other single viral diseases

100

238

4.71

39.60

3.1

2.4

3.52

3.84

g/l

1.06

221

Reactive arthropathies, FINNGEN

212

798

2.78

39.60

2.3

2.7

3.98

3.60

g/l

2.34

192

731

Other disorders of bone

524

2838

1.89

39.52

3.7

2.0

3.66

3.73

g/l

0.40

484

2647

ILD, hospital admissions 1, main diag only

534

2933

1.90

39.36

2.4

3.94

3.71

g/l

2.24

503

2656

Rheumatism, unspecified

406

2035

2.06

38.83

2.2

2.5

3.56

3.68

g/l

1.20

381

1834

Diseases of the myoneural junction and muscle

439

2271

2.01

38.68

1.7

2.3

3.60

3.73

g/l

1.01

382

2063

Myeloproliferative diseases

328

1530

2.26

38.62

2.7

2.4

3.49

3.73

g/l

1.50

299

1393

Cholelithiasis

2405

12334

1.35

38.28

2.4

2.3

3.76

3.70

g/l

0.83

2190

11239

Somatoform disorder

461

2426

1.96

38.12

2.4

2.3

3.54

3.70

g/l

1.87

421

2243

Other pulmonary heart/vessel disease

214

836

2.76

37.95

1.9

2.4

3.77

3.78

g/l

0.03

198

762

All influenza (not pneumonia)

414

2104

2.02

37.88

4.6

1.9

3.64

3.68

g/l

0.23

380

1929

Hypoparathyroidism

172

601

3.12

37.85

1.7

2.3

3.64

3.76

g/l

0.49

152

548

Paralytic ileus and intestinal obstruction

795

4899

1.66

37.82

2.9

2.3

3.75

3.77

g/l

0.11

731

4435

Injuries to the elbow and forearm

1933

12128

1.38

37.73

2.1

2.3

3.70

g/l

0.03

1727

11113

Hypothyroidism, strict autoimmune

1817

8578

1.41

37.72

2.1

2.5

3.60

3.72

g/l

3.19

1658

7763

Migraine without aura

400

2008

2.03

37.48

2.2

3.57

3.62

g/l

0.25

378

1879

Phlebitis and thrombophlebitis (not including DVT)

697

4174

1.71

37.36

2.9

2.3

3.75

3.70

g/l

0.34

643

3802

Acute sinusitis

1287

7996

1.48

37.36

3.4

2.1

3.63

3.72

g/l

0.90

1188

7360

Asthma and allergy

257

1070

2.42

37.18

2.0

1.5

3.67

3.64

g/l

0.15

235

982

In situ neoplasms

1251

8563

1.49

37.10

2.4

2.3

3.61

3.73

g/l

1.88

1134

7723

Papulosquamous disorders

1147

7717

1.51

37.01

2.2

2.4

3.93

3.70

g/l

3.01

1062

7076

DVT of lower extremities

625

3648

1.77

36.99

3.1

2.3

3.79

3.73

g/l

0.34

570

3312

Myocardial infarction

1556

7679

1.44

36.94

2.1

2.5

3.75

3.76

g/l

0.11

1416

6909

Pain in thoracic spine

422

2178

1.99

36.92

2.8

2.2

3.49

3.72

g/l

2.82

397

1980

Other degenerative diseases of the nervous system

844

3828

1.64

36.74

1.9

2.4

3.74

3.82

g/l

0.55

742

3479

Hypocalcemia

123

359

3.81

36.67

4.6

2.6

3.75

3.69

g/l

0.16

108

336

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

501

2752

1.88

36.54

1.9

1.4

3.55

3.75

g/l

1.19

474

2483

Other chronic obstructive pulmonary disease, including avohilmo

1753

10442

1.40

36.52

1.8

2.5

3.84

3.73

g/l

1.63

1590

9506

Haemorrhage, not elsewhere classified

162

556

3.12

36.45

2.8

2.4

3.71

3.74

g/l

0.10

151

502

Gastric ulcer

600

3480

1.78

36.32

2.1

2.4

3.72

g/l

0.01

544

3142

Nonorganic sleeping disorders, excluding more controls

496

2708

1.87

36.31

1.7

2.3

3.70

3.68

g/l

0.11

461

2529

Coxibs

765

2396

1.70

36.25

2.1

2.3

3.72

3.73

g/l

0.05

701

2195

Other inflammation of eyelid

468

2523

1.92

36.21

3.0

2.3

3.60

3.71

g/l

0.89

410

2311

Benign neoplasm of other and ill-defined parts of digestive system

609

3557

1.77

36.14

2.2

2.4

3.64

3.71

g/l

0.53

559

3234

Diseases of spleen

243

4.47

35.99

2.0

2.1

3.32

3.74

g/l

1.67

224

Abnormal serum enzyme levels

985

6235

1.56

35.96

2.2

2.4

3.81

3.74

g/l

0.61

923

5716

Myeloproliferative diseases (CML excluded)

299

1387

2.28

35.78

2.8

2.4

3.52

3.72

g/l

1.11

272

1265

Charcot foot

231

4.54

35.72

2.3

2.9

4.13

3.77

g/l

0.72

209

Personality disorders, excluding more controls

530

2960

1.82

35.58

1.7

2.3

3.73

3.67

g/l

0.39

494

2786

Other diseases of lip and oral mucosa

1196

8177

1.49

35.56

2.6

2.4

3.64

3.69

g/l

0.55

1083

7498

Disorders of synovium and tendon

1355

8015

1.45

35.09

1.9

2.4

3.56

3.76

g/l

7.29

1240

7318

Other symptoms and signs involving the urinary system

366

1842

2.07

34.93

2.5

2.4

3.43

3.77

g/l

5.50

350

1674

Adalimumab

264

1166

2.34

34.89

1.4

2.4

4.04

3.72

g/l

3.00

253

1096

Other viral diseases, including avohilmo

840

5289

1.60

34.73

3.3

2.1

3.58

3.69

g/l

1.24

808

4913

Other general symptoms and signs

147

482

3.15

34.66

1.4

2.4

3.44

3.73

g/l

2.06

138

445

Systemic atrophies primarily affecting the central nervous system

186

709

2.82

34.64

1.6

2.6

3.48

3.67

g/l

1.05

174

648

Budesonide

374

1896

2.03

34.50

2.0

2.4

3.61

3.65

g/l

0.23

342

1737

Superficial injury of lower leg

706

4323

1.67

34.48

1.9

2.3

3.65

3.70

g/l

0.45

634

3950

Peripheral arterial reconstruction

634

3800

1.73

34.34

2.1

2.4

3.81

3.75

g/l

0.30

583

3410

Atopic dermatitis

1323

7327

1.45

34.31

1.8

2.3

3.76

3.67

g/l

1.55

1214

6768

Intracranial injury

1632

11030

1.40

34.26

2.2

2.3

3.75

3.73

g/l

0.18

1462

10065

Allergic asthma (mode)

471

2510

1.86

34.15

1.9

1.7

3.72

3.66

g/l

0.47

439

2305

Disorders of sclera, cornea, iris and ciliary body

1507

10824

1.41

34.03

2.3

3.81

3.72

g/l

0.99

1397

9895

Acetic acid derivatives and related substances

761

2384

1.68

34.02

2.1

2.3

3.77

3.73

g/l

0.25

697

2183

Other extrapyramidal and movement disorders in other diseases

785

4966

1.62

33.89

2.2

2.3

3.57

3.70

g/l

2.08

712

4526

Phobic anxiety disorders

262

1160

2.30

33.87

2.1

3.66

3.71

g/l

0.25

250

1094

Polyarthritis, unspecified

141

468

3.22

33.63

2.6

2.5

3.85

3.65

g/l

0.87

135

428

Reactive arthropathies

252

1110

2.35

33.63

2.1

2.5

3.92

3.63

g/l

2.11

227

1025

Other peripheral vascular diseases

280

1295

2.26

33.46

1.9

2.3

3.40

3.70

g/l

3.60

258

1191

Recurrent or chronic depression

932

4194

1.56

33.36

2.1

2.4

3.69

3.70

g/l

0.06

858

3944

Stomatitis and related lesions

566

3304

1.76

33.32

2.6

2.2

3.61

3.70

g/l

1.05

527

3029

Bipolar affective disorders

420

2237

1.92

33.30

1.9

2.3

3.66

3.69

g/l

0.18

394

2095

Other disorders of eye and adnexa

415

2211

1.93

33.22

1.9

2.3

3.60

3.68

g/l

0.68

390

2037

Valvular operations

447

2443

1.89

33.11

1.7

2.3

3.75

3.80

g/l

0.31

409

2188

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

291

1372

2.21

33.03

3.5

2.3

3.83

3.69

g/l

0.54

272

1259

Etanercept

199

796

2.61

33.02

1.5

2.3

4.06

3.64

g/l

3.71

193

746

1575

10205

1.40

32.86

1.6

2.4

3.96

3.75

g/l

6.93

1419

9449

Other viral diseases

665

4046

1.67

32.69

3.6

2.1

3.58

3.70

g/l

1.12

641

3755

Mycoses

809

5193

1.59

32.62

2.9

2.4

3.61

3.70

g/l

1.09

746

4746

Other and unspecified effects of external causes

667

4083

1.66

32.56

2.2

3.73

3.68

g/l

0.30

626

3773

Alcohol use disorder, Swedish definition

1500

9849

1.40

32.27

1.7

2.4

3.96

3.75

g/l

6.24

1352

9123

Cervicalgia

578

3423

1.73

32.23

2.2

2.3

3.57

3.71

g/l

1.52

524

3113

Other enthesopathies

766

4861

1.60

32.22

2.0

2.4

3.58

3.73

g/l

2.32

702

4455

Any death

1989

10463

1.35

32.10

3.0

2.3

3.75

3.72

g/l

0.35

1795

9550

Persons encountering health services in other circumstances

1021

6825

1.50

32.00

2.3

3.64

3.71

g/l

0.65

957

6164

1632

10405

1.38

31.85

1.6

2.4

3.94

3.75

g/l

5.80

1473

9639

Degeneration of macula and posterior pole

1635

9253

1.39

31.73

2.3

2.4

3.71

3.73

g/l

0.18

1438

8343

Localized swelling, mass and lump of skin and subcutaneous tissue

893

5894

1.54

31.67

2.3

2.4

3.73

3.70

g/l

0.13

819

5376

Extrapyramidal and movement disorders

1213

8512

1.45

31.65

2.1

2.4

3.55

3.74

g/l

5.22

1091

7728

Psoriasis

800

5158

1.58

31.64

1.9

2.4

4.05

3.68

g/l

4.24

745

4744

Pyogenic arthritis

222

957

2.42

31.36

2.9

2.5

3.80

3.64

g/l

0.71

209

873

Other metabolic disorders

346

1771

2.01

31.13

3.5

2.2

3.67

3.64

g/l

0.13

332

1622

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

916

6104

1.53

31.04

2.3

3.61

3.68

g/l

0.62

844

5580

Disease of hard tissues of teeth, NOS

1507

5653

1.41

31.02

2.2

2.1

3.71

3.76

g/l

0.52

1366

5172

Metatarsalgia

282

1345

2.17

30.95

2.3

3.67

3.71

g/l

0.15

259

1237

Viral pneumonia (known virus, not influenza)

129

431

3.25

30.74

6.6

2.6

3.53

3.66

g/l

0.32

120

390

Sequelae with surgical and medical care as external cause

654

4061

1.65

30.66

2.1

2.3

3.73

3.71

g/l

0.13

615

3688

Fracture of lower leg, including ankle

1503

10776

1.39

30.57

2.0

2.4

3.79

3.72

g/l

0.90

1359

9857

Sub-endpoint used in defining T1D endpoints

760

4797

1.59

30.49

1.7

2.2

3.72

3.74

g/l

0.09

716

4382

Noninfectious colitis NAS

404

2195

1.90

30.49

2.6

2.2

3.68

3.71

g/l

0.23

378

2009

Raynaud syndrome

268

1263

2.20

30.46

1.6

2.5

3.33

3.72

g/l

5.83

248

1166

Superficial injury of hip and thigh

491

2830

1.78

30.41

2.0

2.3

3.67

3.72

g/l

0.25

428

2576

Hypertrophic cardiomyopathy

174

686

2.72

30.31

2.6

2.7

3.49

3.79

g/l

2.22

165

633

Sequelae of cerebrovascular disease

1222

7368

1.44

30.28

2.1

2.3

3.79

3.73

g/l

0.57

1056

6677

Systemic sclerosis (FG)

279

3.81

30.08

1.9

3.0

3.23

3.50

g/l

1.44

255

Myocardial infarction, strict

1434

7339

1.41

29.92

2.1

2.5

3.75

3.76

g/l

0.14

1308

6602

Non-selective monoamine reuptake inhibitors

1042

6883

1.48

29.79

2.3

2.5

3.66

3.70

g/l

0.40

951

6273

Decubitus ulcer and pressure area

246

1138

2.28

29.66

1.8

2.3

3.85

3.77

g/l

0.37

217

1023

Elevated blood glucose level

266

1266

2.19

29.54

2.0

2.2

3.73

3.63

g/l

0.71

238

1162

Postprocedural endocrine and metabolic disorders, not elsewhere classified

320

1625

2.02

29.50

3.5

2.2

3.68

3.63

g/l

0.18

306

1486

Gonarthrosis,primary

2652

12589

1.28

29.48

2.1

2.4

3.72

3.74

g/l

0.16

2410

11478

Disorders of muscles

296

1465

2.09

29.43

1.7

2.2

3.75

g/l

0.00

278

1351

Other pleural conditions

384

2088

1.92

29.33

2.9

2.3

3.76

3.75

g/l

0.04

351

1874

Other complications of surgical and medical care, not elsewhere classified

304

1524

2.07

29.30

2.4

2.3

3.67

3.70

g/l

0.16

280

1398

Essential (haemorrhagic) thrombocythaemia

153

576

2.84

29.19

2.5

1.4

3.47

3.69

g/l

1.35

137

513

Nonischemic cardiomyopathy

344

1807

1.98

29.03

2.3

3.73

g/l

0.01

322

1632

Myocardial infarction, without ST-elevation

1353

8849

1.41

28.98

2.1

2.4

3.74

3.75

g/l

0.14

1221

7969

Other enthesopathy of foot (+metatarsalgia)

293

1455

2.08

28.85

2.3

3.67

3.71

g/l

0.13

268

1338

Carpal tunnel syndrome

1679

10882

1.35

28.81

2.3

2.4

3.63

3.71

g/l

1.34

1562

9916

Other infectious diseases

268

1296

2.16

28.72

2.6

2.3

3.75

3.77

g/l

0.09

254

1185

Mental and behavioural disorders due to psychoactive substance use

1563

10607

1.37

28.72

1.7

2.4

3.87

3.75

g/l

2.78

1399

9805

Vascular disorders of the intestines

260

1244

2.19

28.67

2.4

2.1

3.72

3.80

g/l

0.37

244

1109

COPD, early/later onset

1477

9116

1.38

28.59

1.8

2.4

3.86

3.74

g/l

1.80

1340

8270

Progressive vascular leukoencephalopathy

191

813

2.53

28.45

2.2

2.4

3.93

3.80

g/l

0.43

165

730

Enthesopathies of lower limb, excluding foot

579

3544

1.67

28.43

2.4

2.2

3.61

3.72

g/l

1.50

530

3242

Other skin changes

627

3925

1.64

28.43

3.2

2.3

3.49

3.72

g/l

3.44

562

3565

Other and unspecified acquired haemolytic anaemias

142

5.26

28.12

3.0

1.7

3.35

3.83

g/l

0.78

132

Substance abuse

1518

10441

1.37

28.11

1.6

2.4

3.87

3.76

g/l

2.58

1358

9658

Generalized anxiety disorder

318

1632

1.98

28.05

1.8

2.2

3.71

g/l

0.02

296

1527

Migraine with aura

506

2995

1.71

28.01

1.7

2.4

3.56

3.65

g/l

1.00

469

2779

Other or unspecified ileus, impaction or obstruction

559

3411

1.68

27.96

2.8

2.2

3.78

3.76

g/l

0.05

517

3083

Psoriatic arthropathies

273

1337

2.11

27.94

1.9

2.5

3.97

3.64

g/l

3.04

255

1237

COPD related to multimorbidity

1318

8080

1.40

27.90

1.8

2.4

3.82

3.74

g/l

1.37

1189

7320

Migraine

1069

5781

1.45

27.87

2.0

2.4

3.56

3.68

g/l

2.01

992

5350

Conjunctivitis (acute, non atopic), including avohilmo

2664

12748

1.27

27.83

2.3

3.72

g/l

0.01

2456

11673

Disorders of the thyroid gland

2506

12808

1.28

27.81

2.2

2.4

3.63

3.74

g/l

2.23

2294

11714

Diseases of external ear

1012

7033

1.46

27.81

2.3

3.60

3.72

g/l

1.65

866

6447

Recurrent aphthous stomatitis , including avohilmo

421

2384

1.82

27.79

2.6

2.3

3.60

3.70

g/l

0.93

392

2181

Neuromuscular dysfunction of bladder

296

1501

2.05

27.74

2.1

2.5

3.54

3.72

g/l

1.62

276

1373

Cervical disc disorders

966

6663

1.47

27.56

2.4

2.2

3.58

3.77

g/l

4.60

878

6092

Oxicams

653

2300

1.64

27.49

2.4

3.66

3.74

g/l

0.56

587

2102

5-aminosalicylic acid

464

2701

1.75

27.47

1.9

2.4

3.82

3.68

g/l

1.14

433

2486

Special screening examination for other diseases and disorders

298

1512

2.02

27.40

2.6

2.3

3.49

3.83

g/l

4.08

285

1397

Panic disorder

299

1519

2.01

27.35

1.7

2.3

3.56

3.71

g/l

1.38

278

1425

Pneumonia due to other infectious organisms, not elsewhere classified

128

454

3.01

27.27

6.0

1.9

3.35

3.59

g/l

1.04

123

413

Other hammer toe(s) (acquired)

506

2746

1.72

27.27

2.0

2.6

3.59

3.65

g/l

0.43

441

2454

COPD, hospital admissions

1453

9049

1.38

27.23

1.8

2.4

3.86

3.74

g/l

1.70

1319

8211

Substance use, excluding alcohol

478

2817

1.73

27.16

1.6

2.3

3.68

3.73

g/l

0.29

417

2646

Angina pectoris

1687

8413

1.35

27.13

2.4

2.5

3.70

3.76

g/l

0.79

1570

7585

Inflammatory bowel disease

780

5173

1.53

27.04

2.1

2.3

3.80

3.70

g/l

0.88

721

4780

Injuries to unspecified part of trunk, limb or body region

321

1689

1.97

26.95

2.1

2.4

3.78

3.72

g/l

0.28

290

1547

Diabetic maculopathy, excluding more controls

321

1689

1.96

26.88

1.5

2.4

3.87

3.71

g/l

1.28

298

1544

Injuries to the ankle and foot

1726

11174

1.33

26.80

2.2

2.3

3.75

3.71

g/l

0.39

1595

10326

Protozoal diseases

130

473

2.97

26.66

6.3

2.6

3.46

3.71

g/l

0.98

124

436

Diseases of salivary glands

871

5931

1.49

26.62

2.3

3.60

3.68

g/l

1.09

792

5433

Hydronephrosis

338

1815

1.92

26.59

1.9

2.1

3.83

3.76

g/l

0.42

315

1645

Spondylolisthesis/Spondylolysis

498

2990

1.70

26.55

2.6

2.3

3.55

3.73

g/l

2.27

459

2722

Oter anti-inflammatory and antirheumatic agents, non-steroids

650

2231

1.63

26.49

2.4

3.77

3.74

g/l

0.16

586

2033

Fracture of forearm

1472

9833

1.36

26.43

2.1

2.4

3.69

3.68

g/l

0.05

1304

8953

Other disorders of ear

2529

12975

1.27

26.43

2.3

3.61

3.76

g/l

4.40

2282

11914

Mixed connective tissue disease

223

3.98

26.30

1.9

2.5

3.51

3.80

g/l

0.82

206

Paracetamol or NSAID medication

340

876

1.98

26.28

2.4

1.9

3.77

3.76

g/l

0.01

314

821

Sequelae of other external causes

195

861

2.37

26.24

2.8

2.6

3.86

3.79

g/l

0.22

187

791

Cerebral palsy and other paralytic syndromes

328

1754

1.93

26.16

2.2

2.3

3.67

3.74

g/l

0.36

303

1613

Heart failure and hypertrophic cardiomyopathy

304

3.55

26.08

3.0

2.6

3.66

3.69

g/l

0.08

276

Unspecified acute lower respiratory infection

431

2507

1.76

25.87

3.2

2.2

3.64

3.75

g/l

0.69

407

2301

Disorders of skin appendages

1177

8449

1.40

25.85

2.2

2.3

3.74

3.69

g/l

0.48

1102

7781

Restless leg syndrome

435

2545

1.76

25.74

2.0

2.3

3.49

3.68

g/l

2.24

393

2336

Collagenous colitis

297

1549

1.99

25.71

2.9

2.4

3.55

3.70

g/l

1.17

272

1418

Use of pramipexole

684

4474

1.57

25.71

1.9

2.3

3.56

3.69

g/l

1.67

602

4051

Fissure and fistula of anal and rectal regions

613

3906

1.60

25.56

2.3

3.64

3.75

g/l

1.23

556

3579

Disorders of adult personality and behaviour

571

3575

1.62

25.48

1.8

2.2

3.71

3.68

g/l

0.15

534

3356

Conjunctivitis (acute, non atopic)

680

4421

1.56

25.34

2.8

2.2

3.69

3.68

g/l

0.04

629

4070

Caries of enamel

2441

12695

1.27

25.24

2.7

2.3

3.71

g/l

0.05

2234

11706

Eosinophilia

221

3.95

25.18

2.5

2.3

3.72

3.80

g/l

0.12

206

Protozoal diseases, including avohilmo

131

494

2.85

25.08

6.2

2.7

3.47

3.68

g/l

0.76

125

456

Cardiodefibrillation

1155

8380

1.40

24.71

2.3

2.4

3.84

3.74

g/l

1.22

1066

7594

Malignant neoplasm of urinary organs, including Hilmo

370

2096

1.82

24.64

2.0

1.4

3.86

3.78

g/l

0.30

343

1868

Benign neoplasm: Transverse colon

385

2212

1.81

24.61

2.7

2.4

3.69

3.73

g/l

0.20

345

2020

Atopic dermatitis, strict definition with reimbursement

553

3321

1.62

24.61

1.9

2.1

3.77

3.65

g/l

1.16

510

3092

Other encephalitis

106

359

3.16

24.60

1.9

2.6

3.70

g/l

0.00

335

Crystal arthropathies, rheuma endpoint

289

3.48

24.47

1.6

3.1

3.70

3.53

g/l

0.67

257

Hallux valgus (acquired)

820

3972

1.50

24.39

2.2

2.5

3.66

3.63

g/l

0.15

732

3597

Other disorders of glucose regulation and pancreatic internal secretion

248

1238

2.07

24.27

1.9

2.3

3.80

3.74

g/l

0.31

225

1134

Ankylosing spondylitis

232

1130

2.12

24.19

1.7

2.2

3.97

3.83

g/l

0.71

223

1045

Other symptoms and signs involving the circulatory and respiratory systems

199

915

2.25

24.14

2.5

2.3

3.52

3.74

g/l

1.56

179

827

Amputation of foot

121

448

2.93

24.14

2.4

2.6

4.31

3.67

g/l

1.01

112

408

Other embolism and thrombosis

390

2255

1.78

24.11

2.8

2.2

3.70

3.72

g/l

0.11

366

2043

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

327

1798

1.88

24.09

1.9

1.4

3.85

3.76

g/l

0.35

303

1602

Other and unspecified urticaria

472

2866

1.68

24.06

2.2

3.59

3.67

g/l

0.58

432

2645

Other and unspecified drugs and medicaments

264

1356

2.02

23.92

3.4

2.4

3.84

3.69

g/l

0.58

247

1241

Coxarthrosis, primary

1862

12048

1.30

23.88

2.2

2.4

3.71

3.73

g/l

0.20

1677

10905

Other disorders of eyelid

1362

9621

1.36

23.83

2.1

2.4

3.66

3.73

g/l

0.84

1232

8703

Bullous disorders

215

1032

2.19

23.74

1.9

2.4

3.62

3.77

g/l

0.88

204

941

Benign neoplasm: Sigmoid colon

620

4046

1.57

23.70

2.5

2.3

3.73

3.72

g/l

0.05

564

3679

Other/unspecified reactive arthropathies

197

911

2.25

23.68

2.3

2.4

3.90

3.70

g/l

0.92

179

849

Other respiratory disorders and diseases

656

4330

1.55

23.68

2.0

2.3

3.68

3.73

g/l

0.35

587

3907

Other diseases of the respiratory system

656

4330

1.55

23.68

2.0

2.3

3.68

3.73

g/l

0.35

587

3907

Mixed and other personality disorders

185

832

2.29

23.58

1.7

2.1

3.96

3.69

g/l

0.98

178

787

Benign neoplasm of other and unspecified endocrine glands

402

2361

1.75

23.55

2.5

2.3

3.61

3.71

g/l

0.75

365

2177

KRA_PSY_EATING, excluding more controls

119

429

2.80

23.52

1.7

1.8

3.42

3.72

g/l

1.62

113

405

Migraine without aura and triptan purchases

303

1629

1.89

23.45

1.6

2.0

3.55

3.63

g/l

0.33

287

1517

Encephalitis

109

386

3.01

23.35

1.9

2.5

3.68

3.70

g/l

0.02

360

Sarcoidosis

385

2239

1.77

23.35

1.9

2.3

3.62

3.72

g/l

0.80

361

2066

Open wound of ankle and foot

291

1554

1.93

23.34

2.4

2.3

4.00

3.73

g/l

1.59

267

1442

Other specified and unspecified disorders of eye and adnexa

139

558

2.64

23.30

2.3

2.4

3.72

3.78

g/l

0.18

131

515

Chronic pancreatitis

388

2266

1.77

23.24

1.8

2.4

3.85

3.69

g/l

1.41

355

2087

Herpesviral [herpes simplex] infections, including avohilmo

590

3810

1.57

23.20

2.8

2.2

3.66

3.68

g/l

0.05

548

3502

Thyroiditis, ILD-related definition

285

1514

1.93

23.14

2.3

2.4

3.53

3.64

g/l

0.88

259

1387

Nonorganic sleeping disorders

496

3079

1.64

23.11

1.7

2.2

3.70

3.68

g/l

0.09

461

2859

Diabetic retinopathy

1090

4877

1.42

23.03

1.8

2.1

3.85

3.86

g/l

0.08

995

4490

Cramp and spasm

152

638

2.50

23.02

2.6

2.3

3.52

3.77

g/l

1.52

140

594

Fracture of foot, except ankle

594

3850

1.57

23.01

2.5

2.2

3.74

3.69

g/l

0.22

547

3569

Pneumonia derived septicemia

128

497

2.73

22.98

6.3

2.4

4.18

3.63

g/l

0.92

112

455

Faecal incontinence

301

1637

1.90

22.97

1.7

2.4

3.60

3.73

g/l

0.82

275

1461

Exclusions for E4_PCOS_BROAD

427

2559

1.70

22.88

2.9

2.3

3.55

3.71

g/l

1.63

400

2372

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1444

9965

1.33

22.82

2.0

2.3

3.65

3.70

g/l

0.52

1341

9197

Hyperplasia of prostate

1058

4259

1.42

22.82

2.5

3.67

3.87

g/l

3.54

978

3951

Ulcerative colitis

601

3915

1.56

22.80

2.2

2.3

3.84

3.71

g/l

1.06

554

3619

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

530

3306

1.60

22.74

1.9

2.2

3.69

3.67

g/l

0.10

484

3100

Pneumococcal septicemia

123

471

2.77

22.72

6.2

2.5

4.17

3.65

g/l

0.80

108

432

Radiculopathy

461

2833

1.67

22.60

2.5

2.2

3.61

3.75

g/l

1.53

422

2558

Transient ischemic attack

1612

9889

1.32

22.57

2.2

2.4

3.57

3.74

g/l

5.67

1444

8969

Diseases of inner ear

1565

11522

1.32

22.50

2.0

2.4

3.62

3.73

g/l

1.88

1410

10464

Vitamin B12 deficiency anaemia

334

1890

1.82

22.35

2.1

2.4

3.60

3.70

g/l

0.71

303

1710

Ascites

253

1314

2.00

22.31

1.5

2.4

3.98

3.78

g/l

0.95

234

1198

Haemorrhoids and perianal venous thrombosis

913

6438

1.43

22.26

2.4

2.3

3.52

3.77

g/l

6.23

829

5828

Idiopathic urticaria

238

3.54

22.22

1.3

2.0

3.77

3.82

g/l

0.08

227

Primary biliary cholangitis, wide definition

300

3.26

22.21

1.5

2.3

3.89

3.66

g/l

0.82

275

Disorders of vestibular function (Vertigo)

1362

10048

1.34

22.09

2.1

2.4

3.62

3.72

g/l

1.49

1223

9097

Chronic tubulo-interstitial nephritis

127

500

2.67

22.08

2.2

2.1

3.56

3.75

g/l

0.70

116

455

Diagnoses used for exclusion with ILD

747

5132

1.48

22.06

2.3

3.73

3.72

g/l

0.07

679

4667

Scoliosis

213

1041

2.10

22.01

2.4

2.2

3.44

3.68

g/l

1.84

190

943

Amiodarone users

350

2023

1.80

22.00

2.1

2.4

3.70

3.75

g/l

0.34

331

1842

Retinal detachments and breaks

1074

7873

1.39

21.90

2.6

2.4

3.69

3.73

g/l

0.40

977

7172

Abnormality of white blood cells, not elsewhere classified

115

5.04

21.86

2.2

2.1

3.69

3.56

g/l

0.18

108

Respiratory insufficiency

252

1310

1.98

21.82

1.7

3.70

3.69

g/l

0.01

222

1169

Carcinoma in situ of skin of other and unspecified parts of face

340

1958

1.81

21.77

2.2

2.4

3.63

3.71

g/l

0.47

314

1747

Systemic sclerosis

342

3.08

21.72

1.9

2.2

3.23

3.73

g/l

3.25

315

Disorders of vitreous body and globe

1527

11140

1.31

21.60

2.4

3.62

3.72

g/l

1.28

1389

10148

COPD, hospital admission 2, with asthma infections

1029

6447

1.40

21.55

1.9

2.4

3.88

3.75

g/l

1.15

930

5845

Psoriasis vulgaris

506

3219

1.61

21.51

1.8

2.3

4.14

3.70

g/l

2.97

470

2982

Other crystal arthropathies

313

3.20

21.46

1.6

2.4

3.70

3.58

g/l

0.46

278

Cyst of kidney

255

1351

1.97

21.35

2.4

2.5

3.82

3.74

g/l

0.24

241

1237

Barrett oesophagus

180

841

2.25

21.34

2.3

2.7

3.72

3.74

g/l

0.05

164

776

Vitreous haemorrhage

319

1810

1.82

21.23

2.1

2.4

3.72

3.76

g/l

0.15

300

1660

Autoimmune hepatitis, wide definition

138

575

2.50

21.21

1.7

2.6

3.74

3.75

g/l

0.02

128

519

Other diseases of pancreas

283

1552

1.89

21.18

2.2

2.4

3.70

3.68

g/l

0.09

258

1425

Persistent mood disorders

482

3044

1.61

21.04

2.1

2.3

3.78

3.70

g/l

0.47

447

2791

Vasomotor and allergic rhinitis

800

5474

1.44

20.94

2.3

2.2

3.74

3.71

g/l

0.17

731

5046

Congenital malformations, deformations and chromosomal abnormalities

1262

9015

1.34

20.86

2.0

2.3

3.64

3.69

g/l

0.57

1178

8322

Other and unspecified myopathies

294

1639

1.86

20.84

1.8

2.3

3.69

3.76

g/l

0.29

248

1487

Suppurative and necrotic conditions of lower respiratory tract

195

948

2.15

20.83

2.7

2.4

4.07

3.75

g/l

1.24

183

867

1358

9330

1.33

20.76

2.8

2.3

3.67

3.73

g/l

0.62

1211

8372

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1309

9586

1.33

20.65

2.3

3.64

3.75

g/l

2.08

1207

8818

Personality disorders

530

3430

1.57

20.64

1.7

2.1

3.73

3.68

g/l

0.30

494

3215

Iridocyclitis

599

3990

1.53

20.63

2.4

2.3

4.00

3.70

g/l

1.83

556

3650

COPD, hospital admissions 3, with asthma pneumonia sepsis

893

5485

1.42

20.56

1.9

2.4

3.91

3.76

g/l

1.19

809

4946

Misadventures to patients during surgical and medical care

419

2583

1.66

20.41

2.1

2.2

3.75

3.70

g/l

0.22

384

2349

Problems related to lifestyle

242

1271

1.95

20.35

1.5

2.4

3.97

3.74

g/l

0.48

226

1168

Disorders of vitreous body

1481

10917

1.31

20.32

2.4

3.60

3.73

g/l

2.03

1347

9951

Agoraphobia

215

3.47

20.30

1.8

3.48

3.74

g/l

1.06

206

Folate deficiency anaemia

167

4.12

20.29

2.7

1.9

4.21

3.77

g/l

0.81

152

Candidiasis

387

2341

1.69

20.25

3.1

2.2

3.59

3.69

g/l

0.65

352

2143

Fall on and from stairs and steps

715

4952

1.47

20.23

2.2

2.3

3.74

3.70

g/l

0.37

639

4528

Pyothorax

154

692

2.34

20.13

3.0

2.6

4.11

3.74

g/l

1.15

143

634

Cutaneous lupus erythematosus

357

2.95

20.11

2.1

3.59

3.87

g/l

0.93

328

Special screening examination for neoplasms

184

883

2.15

20.08

2.8

2.2

3.44

3.89

g/l

5.00

166

819

Abnormal results of function studies

252

1352

1.92

20.06

2.4

2.5

3.59

3.72

g/l

0.59

234

1253

Other viral diseases, not elsewhere classified, including avohilmo

561

3676

1.54

20.05

3.1

2.2

3.63

3.69

g/l

0.46

537

3405

Other and unspecified local infections of skin and subcutaneous tissue

281

1561

1.85

20.01

3.2

2.4

3.75

3.71

g/l

0.10

258

1436

Dilated cardiomyopathy

380

2303

1.70

20.00

1.9

2.4

3.73

3.76

g/l

0.16

354

2109

Demyelinating diseases of the central nervous system

199

984

2.08

19.98

1.6

2.1

3.37

3.69

g/l

3.56

187

920

Intestinal stricture

923

6705

1.40

19.97

2.8

2.3

3.74

3.73

g/l

0.08

844

6068

Other local infections of skin and subcutaneous tissue

295

1665

1.82

19.91

3.1

2.4

3.76

3.72

g/l

0.13

267

1528

Traumatic subdural haemorrhage

416

2404

1.66

19.86

2.3

3.76

3.82

g/l

0.30

360

2178

Skin changes due to chronic exposure to nonionizing radiation

1301

9005

1.33

19.82

2.9

2.3

3.66

3.73

g/l

0.74

1162

8070

Actinic keratosis

1276

8854

1.33

19.79

2.9

2.3

3.65

3.73

g/l

0.79

1138

7932

Lesion of ulnar nerve

381

2311

1.69

19.76

2.1

2.2

3.68

3.76

g/l

0.55

362

2145

Heartburn

305

1743

1.79

19.65

2.2

2.3

3.57

3.76

g/l

1.16

271

1585

Other diseases of stomach and duodenum

214

1098

2.03

19.63

2.2

2.5

3.85

3.77

g/l

0.30

201

1001

Allergic urticaria

205

1032

2.04

19.62

2.2

2.4

3.82

3.66

g/l

0.73

191

953

Mixed hyperlipidaemia

135

579

2.45

19.61

1.5

2.2

3.77

3.79

g/l

0.04

124

531

Other shoulder lesions

240

1275

1.93

19.59

1.5

2.3

3.53

3.75

g/l

2.23

223

1179

Fibroblastic disorders

636

4336

1.49

19.55

2.3

2.4

3.71

3.78

g/l

0.48

580

3936

Benign neoplasm: Stomach

319

1860

1.78

19.45

2.5

2.4

3.67

3.70

g/l

0.11

292

1698

Memory loss

317

1848

1.78

19.40

2.1

2.4

3.67

3.69

g/l

0.13

277

1684

Intestinal malabsorption

150

676

2.32

19.38

2.0

2.5

3.78

3.72

g/l

0.19

141

621

Primary biliary cholangitis (PBC)

292

3.12

19.37

1.7

2.0

3.80

3.72

g/l

0.20

268

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

297

1696

1.81

19.37

2.9

2.5

3.62

3.72

g/l

0.70

280

1562

Acute pancreatitis

554

3683

1.54

19.37

2.0

2.3

3.81

3.71

g/l

1.06

509

3369

Bronchiectasis

274

1532

1.86

19.36

2.8

2.5

3.72

3.68

g/l

0.19

255

1375

Herpesviral [herpes simplex] infections

311

1796

1.78

19.35

3.2

2.3

3.74

3.70

g/l

0.10

295

1650

Diseases of the ear and mastoid process

2826

11718

1.22

19.30

2.3

3.59

3.76

g/l

6.85

2586

10789

Congenital malformations of the urinary system, including avohilmo

165

774

2.21

19.18

2.0

2.5

3.57

3.73

g/l

0.82

157

721

Congenital malformations of the urinary system

156

716

2.26

19.16

2.0

2.5

3.56

3.71

g/l

0.85

149

665

Delirium, not induced by alcohol and other psychoactive substances

430

2709

1.63

19.13

2.1

2.3

3.69

3.67

g/l

0.10

379

2435

Mucosal proctocolitis

296

1689

1.79

19.12

2.2

2.4

4.10

3.72

g/l

3.00

285

1580

Primary gonarthrosis, bilateral

1556

10230

1.29

18.96

2.0

2.5

3.72

3.73

g/l

0.15

1403

9270

Thoracic aortic aneurysm

457

2936

1.60

18.90

2.4

2.5

3.82

3.78

g/l

0.18

411

2709

Juvenile arthritis (FINNGEN)

304

2.94

18.81

1.9

2.2

3.91

3.45

g/l

1.74

286

Diseases of male genital organs

1248

4737

1.34

18.80

2.2

2.4

3.71

3.88

g/l

2.97

1166

4411

Migraine with aura and triptan purchases

288

1638

1.79

18.67

1.6

2.0

3.55

3.65

g/l

0.74

273

1516

Internal derangement of knee

844

6035

1.40

18.64

2.2

2.5

3.63

3.71

g/l

0.92

751

5539

Fracture of skull and facial bones

542

3619

1.52

18.46

2.9

2.3

3.69

3.72

g/l

0.18

487

3353

Transport accidents

1014

6258

1.36

18.46

1.9

2.3

3.66

3.74

g/l

0.83

935

5859

Thyrotoxicosis, other and/or unspecified

504

3317

1.55

18.42

2.0

2.3

3.64

3.68

g/l

0.25

464

3032

Injury of unspecified body region

230

1235

1.93

18.37

1.8

2.5

3.82

3.74

g/l

0.28

204

1129

Hypoglycaemia, other or unspecified

191

963

2.05

18.33

1.7

2.3

3.76

3.74

g/l

0.07

175

882

Oesophageal varices

144

655

2.31

18.33

1.6

2.4

4.38

3.72

g/l

4.61

132

601

Other/unspecified rheumatoid arthritis

380

2356

1.66

18.27

1.9

2.3

3.78

3.68

g/l

0.50

346

2119

Mental and behavioural disorders due to alcohol

1286

9447

1.31

18.19

1.6

2.4

3.92

3.76

g/l

3.86

1161

8759

Adhesive capsulitis of shoulder

437

2797

1.59

18.17

2.0

2.4

3.74

g/l

0.03

403

2550

Viral hepatitis, including avohilmo

174

849

2.11

18.17

2.3

2.1

3.90

3.73

g/l

0.48

161

799

Carcinoma in situ of skin of scalp and neck

130

573

2.45

18.17

2.1

2.6

3.86

3.66

g/l

0.49

119

516

Other inflammatory liver diseases

196

1002

2.03

18.16

1.8

2.6

3.73

3.70

g/l

0.11

176

920

Alcoholic liver disease

304

1781

1.76

18.16

1.3

2.4

4.45

3.73

g/l

10.22

257

1654

Dermatitis due to substances taken internally

155

726

2.21

18.13

4.2

2.6

3.51

3.65

g/l

0.67

145

668

Guillain-Barre syndrome

214

3.45

18.08

3.1

2.1

3.37

3.67

g/l

1.27

199

Familial hypercholesterolemia

437

2804

1.60

18.08

2.5

2.3

3.63

3.75

g/l

0.66

392

2501

Personal history of malignant neoplasm

242

1328

1.88

18.01

2.5

2.0

3.75

3.71

g/l

0.13

222

1217

Other viral diseases, not elsewhere classified

411

2588

1.61

17.95

3.4

2.2

3.64

3.72

g/l

0.38

395

2394

Other viral hepatitis, including avohilmo

147

675

2.24

17.95

2.4

2.1

3.92

3.74

g/l

0.42

138

643

Thyrotoxicosis

644

4477

1.46

17.92

1.9

2.3

3.64

3.66

g/l

0.08

587

4075

Epilepsy

763

5444

1.42

17.91

2.0

2.5

3.63

3.76

g/l

1.68

684

4981

Chronic laryngitis and laryngotracheitis

394

2477

1.63

17.77

1.9

2.2

3.58

3.76

g/l

1.55

347

2259

Fenamates

377

1570

1.66

17.67

2.2

2.3

3.73

3.67

g/l

0.31

345

1425

Artificial joint operation, meniscal resection

2521

13376

1.21

17.67

2.2

2.4

3.71

3.74

g/l

0.41

2297

12215

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

407

2557

1.62

17.66

2.4

1.4

3.72

3.75

g/l

0.10

369

2250

therapeutic use

124

540

2.44

17.64

2.0

2.5

4.02

3.76

g/l

0.30

103

491

Systemic sclerosis, icd10

377

2.76

17.63

2.0

2.1

3.23

3.72

g/l

3.53

350

Benign neoplasm: Ascending colon

462

3026

1.57

17.61

2.3

2.4

3.72

3.73

g/l

0.04

418

2746

Hypothyroidism, other/unspecified

2228

12013

1.23

17.54

2.2

2.4

3.60

3.73

g/l

4.23

2039

10972

Pain associated with micturition

333

2015

1.69

17.52

2.5

2.3

3.52

3.71

g/l

1.17

299

1839

Hypermobility syndrome

108

438

2.54

17.50

2.1

1.9

3.58

3.71

g/l

0.45

103

421

Other viral hepatitis

141

644

2.25

17.47

2.3

2.0

3.92

3.74

g/l

0.41

132

612

Viral hepatitis

167

817

2.10

17.35

2.2

2.1

3.90

3.73

g/l

0.45

154

768

Insulin, fast-acting (human)

307

1819

1.72

17.34

1.7

2.1

3.47

3.71

g/l

3.04

289

1693

Atopic dermatitis, strict definition

513

3346

1.51

17.33

1.9

2.1

3.78

3.64

g/l

1.32

479

3138

Acute posthaemorrhagic anaemia

116

492

2.47

17.32

3.1

2.6

3.93

3.85

g/l

0.13

101

442

Hernia of abdominal wall

1241

9611

1.31

17.32

2.4

3.75

3.74

g/l

0.11

1154

8794

Early onset COPD

617

4290

1.47

17.29

2.0

2.5

3.92

3.72

g/l

1.37

571

3937

Diplopia

376

2357

1.63

17.22

2.1

2.3

3.52

3.72

g/l

2.50

346

2167

Exclusions for E4_PCOS_CONSORTIUM

1566

7720

1.28

17.19

2.2

3.62

3.66

g/l

0.46

1418

7045

Alcohol induced polyneuropathy

143

4.05

17.16

1.4

2.0

3.82

3.68

g/l

0.35

130

Poisoning by drugs, medicaments and biological substances

480

3172

1.53

17.12

2.0

2.2

3.85

3.70

g/l

1.05

440

2960

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

364

2190

1.64

17.11

1.8

2.4

3.58

3.73

g/l

1.70

340

2030

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

392

2405

1.61

17.11

1.8

2.3

3.60

3.72

g/l

1.32

365

2224

Ankylosing spondylitis, ICD10

221

1198

1.90

17.08

1.7

2.4

3.99

3.73

g/l

1.67

212

1120

Other and unspecified visual disturbances

301

1787

1.73

17.08

2.4

2.3

3.67

3.70

g/l

0.20

279

1646

COPD-related respiratory insufficiency

393

2500

1.62

17.07

2.0

2.5

3.87

3.73

g/l

0.45

351

2244

Ocular pain

220

1191

1.90

17.07

1.6

2.5

3.53

3.73

g/l

1.51

206

1094

Neuralgia and neuritis, unspecified

148

698

2.20

17.05

2.4

3.40

3.80

g/l

3.64

133

646

Other lack of coordination

228

3.26

16.92

2.0

2.7

3.44

3.81

g/l

1.25

208

Malignant neoplasm of kidney, except renal pelvis

273

1586

1.78

16.85

1.9

1.4

3.86

3.76

g/l

0.36

253

1413

Sequelae of injuries, of poisoning and of other consequences of external causes

582

4017

1.47

16.85

2.6

2.3

3.88

3.72

g/l

0.84

529

3722

Other specified/unspecified bacterial intestinal infections

204

1086

1.95

16.84

3.1

2.4

3.47

3.71

g/l

1.58

184

999

Other disorders of the musculoskeletal system and connective tissue

432

2813

1.57

16.81

2.5

2.3

3.87

3.70

g/l

1.02

407

2576

Biomechanical lesions, not elsewhere classified

168

840

2.09

16.72

2.3

2.5

3.84

3.70

g/l

0.61

159

772

Social phobias

137

628

2.22

16.66

1.9

3.70

3.75

g/l

0.16

132

598

Intestinal adhesions without obstruction

252

1435

1.81

16.65

3.8

2.2

3.96

3.76

g/l

0.40

227

1304

Allergic rhinitis

570

3869

1.47

16.62

2.4

2.1

3.74

3.66

g/l

0.58

525

3600

Poisoning by medicine

434

2826

1.56

16.61

2.0

2.2

3.86

3.69

g/l

1.14

399

2646

Inflammatory diseases of the central nervous system

225

1239

1.87

16.59

2.8

2.5

3.79

3.70

g/l

0.22

201

1142

Dermatophytosis, including avohilmo

1644

12958

1.25

16.50

2.3

3.68

3.73

g/l

0.82

1485

11907

Other disorders of bladder

359

2251

1.64

16.50

2.2

2.4

3.58

3.77

g/l

1.99

323

2045

Hypothyreosis and Thyroxine purchase for inclusion criteria

2323

12609

1.21

16.49

2.2

2.3

3.60

3.73

g/l

4.15

2123

11508

Keratitis

882

6555

1.36

16.47

2.2

2.3

3.69

3.68

g/l

0.01

813

6004

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1120

8536

1.31

16.43

1.6

2.4

3.95

3.76

g/l

4.62

1009

7914

Malignant neoplasm of urinary organs

295

1763

1.72

16.42

1.8

1.4

3.90

3.76

g/l

0.55

275

1565

Vitamin deficiency, wide

144

684

2.19

16.35

2.3

2.4

3.94

3.68

g/l

0.65

127

627

Vitamin deficiency

144

684

2.19

16.35

2.3

2.4

3.94

3.68

g/l

0.65

127

627

Other/unspecified enthesopathies of lower limb, excluding foot

180

925

2.00

16.34

2.3

2.1

3.55

3.77

g/l

1.83

168

855

Acute nephritic syndrome

276

2.98

16.31

2.3

2.5

3.67

3.80

g/l

0.30

254

Spirochaetal infections, other/unspecified

265

1543

1.77

16.26

2.4

3.44

3.71

g/l

2.05

226

1421

Cervicobrachial syndrome

502

3392

1.50

16.17

2.2

3.49

3.72

g/l

5.10

476

3091

Nummular dermatitis

246

1404

1.81

16.16

2.4

2.5

3.67

3.69

g/l

0.09

224

1284

Other and unspecified mood [affective] disorders

135

625

2.21

16.11

1.8

2.1

3.73

3.67

g/l

0.23

127

586

Cystic kidney disease

102

423

2.54

16.07

2.0

2.5

3.49

3.72

g/l

1.01

391

Benign neoplasm: Rectum, anus and anal canal

612

4313

1.45

16.06

2.3

2.4

3.66

3.71

g/l

0.40

557

3920

Olecranon bursitis

184

962

1.98

16.03

2.6

2.3

3.83

3.80

g/l

0.06

168

892

Benign neoplasm: Caecum

355

2246

1.63

15.88

2.8

2.4

3.53

3.70

g/l

1.43

327

2049

Other diseases of oesophagus

280

1665

1.73

15.86

2.3

2.5

3.66

3.73

g/l

0.17

262

1520

Drug-induced polyneuropathy

123

4.19

15.84

15.1

1.5

3.64

3.99

g/l

0.25

116

Speech disturbances, not elsewhere classified

281

1675

1.73

15.84

1.9

2.4

3.58

3.71

g/l

0.70

246

1527

Other and unspecified nerve root and plexus disorders, also in other diseases

516

3524

1.49

15.83

2.5

2.4

3.49

3.71

g/l

3.14

470

3258

Invasive ventilation

221

1232

1.85

15.78

2.5

2.4

4.02

3.73

g/l

1.22

205

1129

Other specified/unspecified hearing loss

284

1706

1.71

15.56

2.5

2.3

3.69

3.75

g/l

0.17

271

1556

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

732

5254

1.39

15.56

2.1

2.2

3.70

3.68

g/l

0.20

678

4906

Fentanyl

290

1744

1.70

15.55

5.5

1.8

3.52

3.76

g/l

1.78

255

1550

Cholecystectomy

1894

13199

1.23

15.54

2.3

3.67

3.71

g/l

0.51

1733

11997

Microscopic polyangiitis

4.73

15.51

1.4

2.0

3.76

3.99

g/l

0.25

Sequelae of injuries of lower limb

238

1360

1.80

15.50

2.3

2.4

3.76

3.70

g/l

0.29

223

1264

Impingement syndrome of shoulder

588

4134

1.44

15.48

2.4

2.5

3.53

3.77

g/l

4.25

525

3793

Aortic aneurysm

705

5019

1.40

15.45

2.3

2.4

3.83

3.77

g/l

0.40

633

4568

Dementia in Alzheimer disease

290

3920

0.61

15.40

1.6

2.3

3.75

3.67

g/l

0.30

223

3492

Crohn disease

291

1758

1.69

15.38

1.7

2.3

3.78

3.70

g/l

0.42

274

1630

Emotionally unstable personality disorder

203

1104

1.87

15.37

1.7

1.9

3.71

3.66

g/l

0.15

189

1046

Myocarditis

105

447

2.41

15.36

2.6

2.1

3.49

3.68

g/l

0.48

100

404

Other bursopathies

350

2220

1.61

15.27

2.2

2.3

3.62

3.76

g/l

1.11

325

2015

Alcohol-induced chronic pancreatitis

182

965

1.95

15.25

1.8

2.4

3.97

3.76

g/l

1.05

161

903

Pemphigoid

113

506

2.38

15.17

1.5

2.4

3.69

3.66

g/l

0.07

106

456

Cystic kidney disease, including avohilmo

105

453

2.43

15.15

2.0

2.5

3.49

3.73

g/l

1.11

100

418

Ventral hernia

656

4723

1.41

15.13

2.7

2.3

3.73

3.68

g/l

0.39

608

4288

Drug-induced cataract

334

2.71

15.11

2.4

2.5

3.24

3.75

g/l

2.98

309

Benign thyroid growths and nodules

879

6146

1.35

15.08

2.2

2.4

3.64

3.68

g/l

0.19

795

5535

Acute pancreatitis (for exclusion)

554

3876

1.46

15.08

2.0

2.3

3.81

3.73

g/l

0.67

509

3548

Coeliac disease

296

1808

1.67

15.06

2.4

2.2

3.47

3.70

g/l

2.58

275

1660

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

403

2646

1.55

15.04

2.7

2.3

3.78

3.71

g/l

0.32

380

2438

Pollen allergy

298

1791

1.66

15.01

2.6

2.1

3.76

3.69

g/l

0.35

270

1698

Speech and linguistic disorders, excluding more controls

130

569

2.18

15.01

2.1

2.3

3.56

3.74

g/l

0.82

121

521

Benign neoplasm: Adrenal gland

244

1423

1.77

15.00

2.2

2.6

3.58

3.73

g/l

0.99

221

1308

Lesion of lateral popliteal nerve

143

701

2.12

15.00

2.5

2.3

3.68

3.73

g/l

0.14

131

651

Striking against or struck by other objects

741

5434

1.38

14.93

1.9

2.3

3.76

3.73

g/l

0.21

665

5053

Cardiac arrest

166

720

2.01

14.91

2.1

2.3

3.82

3.76

g/l

0.14

150

640

Glucagon-like peptide-1 (GLP-1) analogues

757

5591

1.37

14.84

1.7

2.6

4.06

3.66

g/l

14.77

710

5180

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

757

5591

1.37

14.84

1.7

2.6

4.06

3.66

g/l

14.77

710

5180

Benign paroxysmal vertigo

821

6145

1.36

14.83

2.1

2.4

3.62

3.70

g/l

0.68

739

5570

Tubulo-interstitial nephritis, not specified as acute or chronic

181

965

1.93

14.82

2.7

2.1

3.70

3.74

g/l

0.13

168

880

Arthropathic psoriasis

291

1779

1.67

14.81

1.8

2.4

3.98

3.69

g/l

2.71

272

1654

Open wound of forearm

251

1476

1.74

14.78

2.2

2.3

3.81

3.74

g/l

0.24

228

1361

Anosmia

143

3.53

14.73

3.5

1.3

3.53

3.69

g/l

0.45

127

Macular pucker

510

3540

1.48

14.69

2.0

2.5

3.72

3.70

g/l

0.08

449

3208

Chronic viral hepatitis

111

495

2.31

14.65

2.0

1.9

3.90

3.74

g/l

0.29

103

476

Ptosis of eyelid

346

2217

1.60

14.62

2.5

2.4

3.64

3.71

g/l

0.46

324

2020

Cervicocranial syndrome

264

1580

1.71

14.53

1.9

2.2

3.53

3.73

g/l

1.93

246

1430

Temporomandibular joint disorders, including avohilmo

888

6509

1.33

14.52

2.2

3.48

3.67

g/l

4.44

820

6009

Other demyelinating diseases of the central nervous system

380

2.51

14.52

1.7

2.0

3.44

3.73

g/l

1.30

361

Viral and other specified intestinal infections, including avohilmo

502

3327

1.47

14.51

2.2

2.1

3.80

3.72

g/l

0.39

479

3070

Other localized connective tissue disorders

272

2.86

14.44

2.7

2.0

3.56

3.77

g/l

0.55

251

Trigger finger

351

2259

1.58

14.35

1.6

2.4

3.53

3.74

g/l

2.90

327

2077

Acute generalized exanthematous pustulosis

134

653

2.13

14.33

4.4

2.6

3.52

3.76

g/l

1.23

126

601

Hyperhidrosis

294

2.71

14.26

2.2

2.3

3.46

3.78

g/l

1.70

269

Postviral fatigue syndrome

5.77

14.24

1.2

2.3

3.77

3.48

g/l

0.26

Synovial cyst of popliteal space [Baker]

207

1167

1.83

14.23

2.5

2.2

3.69

3.75

g/l

0.24

192

1061

Autoimmune hepatitis

4.36

14.20

1.6

2.6

3.74

3.65

g/l

0.18

Squamous cell neoplasms and carcinomas of the skin

320

2026

1.62

14.19

2.5

1.4

3.62

3.76

g/l

0.77

290

1772

Anterior Iridocyclitis

506

3521

1.46

14.17

2.5

2.3

3.94

3.69

g/l

1.11

469

3234

Superficial injury of abdomen, lower back and pelvis

375

2456

1.55

14.15

2.1

2.2

3.69

3.72

g/l

0.12

340

2258

Injuries to the neck

519

3625

1.45

14.15

2.6

2.2

3.65

3.72

g/l

0.47

474

3357

Ulcerative colitis, NAS

318

2007

1.61

14.14

2.0

2.3

3.74

3.71

g/l

0.10

298

1858

Otitis externa

557

3947

1.43

14.07

2.3

2.2

3.58

3.72

g/l

1.38

492

3650

Hallux rigidus

353

2289

1.57

14.02

2.2

2.6

3.61

3.65

g/l

0.21

307

2082

Specific personality disorders

432

2916

1.50

14.00

1.8

2.2

3.67

3.68

g/l

0.04

401

2733

Mouth breathing

961

7401

1.31

13.93

2.4

3.66

3.75

g/l

1.45

904

6862

Fall on same level involving ice and snow

1479

11996

1.24

13.90

2.1

2.4

3.69

3.71

g/l

0.15

1325

10970

Benign neoplasm: Rectum

543

3851

1.44

13.86

2.3

2.4

3.68

3.71

g/l

0.17

493

3502

Alcohol use disorder, ICD-based

1019

7925

1.30

13.85

1.7

2.4

3.93

3.75

g/l

4.09

924

7351

Other disorders of adrenal gland

125

601

2.16

13.82

2.6

2.5

3.38

3.74

g/l

1.99

118

564

Cluster headache, strict

365

2.49

13.76

1.7

2.8

3.37

3.77

g/l

2.02

339

Other hearing loss

892

6616

1.32

13.72

2.4

2.3

3.71

3.78

g/l

0.48

794

5974

Acute and subacute iridocyclitis

472

3263

1.47

13.71

2.5

2.2

3.98

3.70

g/l

1.23

436

2997

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

366

2.49

13.69

1.6

1.9

3.31

3.68

g/l

2.71

354

Other and unspecified injuries of head

210

1204

1.79

13.64

1.8

2.3

3.71

3.76

g/l

0.17

184

1097

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

125

601

2.12

13.63

1.6

1.9

3.61

3.76

g/l

0.64

111

576

Acute peritonitis

189

1055

1.85

13.52

2.4

2.5

3.56

3.75

g/l

1.13

184

966

Personal history of other diseases and conditions

193

1072

1.82

13.50

4.1

2.0

3.58

3.73

g/l

0.78

172

996

Fall involving bed

125

610

2.15

13.49

2.4

2.5

3.55

3.77

g/l

1.09

107

548

Infections with a predominantly sexual mode of transmission

525

3701

1.43

13.34

2.1

3.58

3.65

g/l

0.56

485

3460

Erosion of teeth , including avohilmo

549

3914

1.42

13.33

2.3

2.2

3.72

3.69

g/l

0.12

512

3641

Cluster headache, wide

408

2.38

13.30

1.8

2.7

3.43

3.76

g/l

1.51

377

Supplementary factors related to causes of morbidity and mortality classified elsewhere

761

5721

1.35

13.30

2.0

2.3

3.59

3.70

g/l

1.19

662

5241

Umbilical hernia

684

5066

1.37

13.26

2.0

2.3

3.74

3.76

g/l

0.10

641

4695

Benign neoplasm of mouth and pharynx

299

1895

1.62

13.25

3.3

2.4

3.80

3.72

g/l

0.26

271

1741

Additional codes for the location of defect, injury or illness

164

882

1.92

13.21

1.5

2.5

3.57

3.73

g/l

0.86

158

816

Gingival hyperplasia

107

494

2.26

13.19

3.4

2.5

3.77

3.76

g/l

0.02

458

Benign neoplasm: Rectosigmoid junction

142

732

2.03

13.16

2.1

2.7

3.70

3.73

g/l

0.09

127

671

Eating disorder

119

567

2.13

13.16

1.7

3.42

3.66

g/l

1.32

113

542

Left bundle-branch block

211

1225

1.77

13.15

1.7

2.3

3.43

3.76

g/l

3.68

181

1097

Unstable angina pectoris

1087

6723

1.29

13.12

2.4

3.74

3.77

g/l

0.19

1006

6003

Psoriatic arthropathies, ICD10

267

1650

1.66

13.10

1.9

2.4

3.98

3.73

g/l

1.84

249

1533

Acute gastritis

211

1227

1.77

13.08

2.0

2.5

3.72

3.75

g/l

0.14

187

1119

Adrenocortical insufficiency

107

497

2.24

13.00

2.7

2.6

3.32

3.76

g/l

2.36

101

463

Hepatic failure, not elsewhere classified

118

571

2.16

12.95

1.8

2.7

4.22

3.69

g/l

0.96

108

523

Polycythaemia vera

111

526

2.21

12.90

2.5

1.4

3.43

3.71

g/l

1.36

102

464

Pneumonia due to Streptococcus pneumoniae

113

537

2.18

12.89

5.2

1.9

3.94

3.63

g/l

0.54

100

485

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

444

3073

1.47

12.84

2.8

2.3

3.77

3.72

g/l

0.26

421

2823

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

120

587

2.14

12.82

2.5

2.4

3.67

3.71

g/l

0.12

111

543

Diseases of peritoneum

282

1779

1.62

12.77

2.2

2.4

3.57

3.73

g/l

1.19

263

1619

Enteropathic arthropathies

237

2.82

12.71

1.4

2.4

3.85

3.43

g/l

1.56

223

Mental disorders, not otherwise specified

166

904

1.87

12.71

1.8

2.2

3.63

3.68

g/l

0.20

160

847

Other disorders of patella

317

2049

1.57

12.68

2.2

2.5

3.56

3.65

g/l

0.76

292

1917

Other spirochaetal diseases, including avohilmo

849

6529

1.32

12.68

2.5

2.4

3.56

3.69

g/l

1.89

762

5997

Malignant melanoma, including Hilmo

462

3235

1.45

12.62

2.6

1.4

3.50

3.76

g/l

3.27

412

2911

Malignant melanoma

417

2867

1.48

12.58

2.6

1.4

3.52

3.76

g/l

2.61

372

2581

Bacterial, viral and other infectious agents, including avohilmo

200

1156

1.77

12.58

3.3

2.3

3.79

3.75

g/l

0.15

189

1085

Background retinopathy and retinal vascular changes

316

2.58

12.58

1.8

2.8

3.78

3.59

g/l

0.62

293

Sacroiliitis, not elsewhere classified

411

2.32

12.57

2.1

1.9

3.89

3.69

g/l

0.71

386

Artificial joint re-operation

228

1374

1.72

12.57

2.0

2.5

3.83

3.71

g/l

0.57

210

1242

Generalized skin eruption due to drugs and medicaments

116

564

2.14

12.55

4.7

2.6

3.48

3.76

g/l

1.37

108

522

Unspecified urinary incontinence

257

1594

1.66

12.51

1.5

2.4

3.51

3.68

g/l

1.11

202

1432

Follicular lymphoma, hilmo

146

774

1.97

12.50

1.6

2.7

3.30

3.73

g/l

3.88

136

707

Other symptoms and signs involving the digestive system and abdomen

409

2801

1.48

12.50

2.3

2.4

3.40

3.72

g/l

5.52

355

2537

Eating disorders

160

863

1.88

12.47

2.2

1.9

3.49

3.64

g/l

0.88

151

811

Right bundle-branch block

114

552

2.15

12.46

2.7

2.3

3.53

3.79

g/l

1.27

108

494

IBD patients in KELA-register

475

3344

1.44

12.46

2.2

3.85

3.71

g/l

1.43

448

3117

Other spirochaetal diseases

838

6452

1.31

12.42

2.5

2.4

3.56

3.70

g/l

1.94

752

5925

Parkinson's disease, strict definition, excluding more controls

356

2213

1.53

12.41

1.8

2.5

3.59

3.84

g/l

2.74

315

2008

Retinal vascular occlusion

373

2522

1.51

12.37

2.5

2.4

3.86

3.69

g/l

1.08

339

2262

Mental and behavioural disorders due to sedatives or hypnotics

149

792

1.93

12.36

1.4

2.1

3.68

3.70

g/l

0.07

133

743

Disorders of orbit

126

636

2.05

12.30

3.4

2.5

4.00

3.73

g/l

0.58

120

588

Total colectomy operation

113

548

2.14

12.29

2.6

2.5

3.95

3.71

g/l

0.81

107

509

Total colectomy

113

548

2.14

12.29

2.6

2.5

3.95

3.71

g/l

0.81

107

509

Colonic or urogenital fistula

658

4905

1.36

12.27

2.5

2.4

3.65

3.72

g/l

0.68

594

4504

Clear cell adenocarcinoma of kidney

143

756

1.97

12.25

1.5

1.4

4.04

3.75

g/l

0.63

132

676

Spirochaetal infections, other/unspecified, including avohilmo

836

6449

1.31

12.22

2.5

2.4

3.56

3.70

g/l

1.87

750

5921

Exposure to other and unspecified inanimate mechanical forces

180

1019

1.81

12.21

2.7

2.4

3.98

3.70

g/l

0.85

175

946

Inguinal hernia

1485

8082

1.23

12.16

2.7

2.2

3.72

3.78

g/l

0.57

1376

7397

Other abnormal uterine and vaginal bleeding

530

2724

1.42

12.13

2.1

2.2

3.52

3.69

g/l

1.13

440

2455

Type of accident

709

5351

1.34

12.13

2.0

2.3

3.59

3.70

g/l

1.38

612

4913

Other congenital malformations, including avohilmo

252

1561

1.64

12.13

2.0

2.4

3.69

3.70

g/l

0.02

239

1451

Gonarthrosis, primary, with knee surgery

1682

10890

1.21

12.12

2.2

2.5

3.73

g/l

0.07

1520

9891

Superficial injury of thorax

386

2638

1.49

11.99

1.6

2.3

3.77

3.73

g/l

0.19

343

2426

Lyme disease, including avohilmo

828

6397

1.31

11.98

2.5

2.4

3.56

3.70

g/l

1.96

742

5878

Lyme disease

828

6397

1.31

11.98

2.5

2.4

3.56

3.70

g/l

1.96

742

5878

Malignant neoplasm of other connective and soft tissue

354

2.44

11.96

4.0

1.4

3.68

3.72

g/l

0.04

319

Ovarian cyst

698

2972

1.36

11.94

2.1

2.2

3.54

3.68

g/l

1.80

642

2703

Parkinson's disease, excluding more controls

375

2343

1.50

11.90

1.8

2.5

3.58

3.83

g/l

2.97

331

2128

Carbimazole or st.post thyroidectomy, condition for graves disease

481

3428

1.42

11.87

2.4

2.2

3.65

3.66

g/l

0.06

442

3141

Polycystic ovarian syndrome, consortium definition

1494

7020

1.23

11.87

2.0

2.2

3.53

3.63

g/l

1.60

1320

6412

Retinal vascular disorders

375

2560

1.50

11.86

2.5

2.4

3.86

3.69

g/l

1.06

341

2296

Other psoriatic arthropathies

255

1600

1.63

11.81

1.9

2.4

3.97

3.74

g/l

1.66

238

1485

Menorrhagia

705

2936

1.35

11.78

2.0

2.2

3.62

3.68

g/l

0.22

606

2659

Otalgia

205

1217

1.72

11.77

2.0

2.3

3.43

3.71

g/l

2.67

180

1117

Excessive, frequent and irregular menstruation

751

3018

1.34

11.76

2.0

2.2

3.52

3.67

g/l

1.62

671

2739

Emphysema

229

1404

1.68

11.75

2.6

2.5

4.13

3.72

g/l

0.98

211

1269

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

304

1984

1.55

11.70

1.9

2.3

3.85

3.72

g/l

0.61

278

1873

Secondary thrombocytopenia

177

3.11

11.64

4.0

1.7

3.87

3.66

g/l

0.13

166

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

530

3848

1.39

11.60

1.9

2.2

3.69

3.67

g/l

0.09

484

3599

Pain and other conditions associated with female genital organs and menstrual cycle

361

2034

1.50

11.55

2.0

2.2

3.43

3.65

g/l

1.68

325

1870

Speech and linguistic disorders

131

651

1.96

11.52

2.1

2.0

3.55

3.71

g/l

0.74

122

603

Viral and other specified intestinal infections

350

2301

1.50

11.48

2.2

2.0

3.78

3.72

g/l

0.18

331

2125

Symptoms and signs involving emotional state

322

2.44

11.44

1.7

2.1

3.72

3.62

g/l

0.33

296

979

6668

1.28

11.44

2.3

3.74

3.72

g/l

0.09

845

5955

Other and unspecified injuries of lower leg

175

1002

1.78

11.43

2.3

2.4

3.60

3.76

g/l

0.87

165

921

Suggestive for eosinophilic asthma

250

1576

1.63

11.41

2.3

4.07

3.69

g/l

1.08

238

1450

Colectomy operation

478

3434

1.42

11.41

2.7

2.4

3.98

3.72

g/l

1.81

441

3100

Crohn's disease NAS

144

778

1.90

11.41

1.9

2.4

3.92

3.75

g/l

0.58

134

724

Other or ill-defined heart diseases

128

665

1.97

11.41

2.2

3.73

3.76

g/l

0.09

112

602

Lung cancer and mesothelioma

504

3084

1.41

11.37

2.1

2.0

3.98

3.68

g/l

2.58

459

2764

Carcinoma in situ of other and unspecified digestive organs

145

792

1.91

11.33

1.8

2.6

3.76

g/l

0.00

137

725

Cardiomyopathy, Hypertrophic obstructive

236

2.73

11.26

1.8

2.7

3.53

3.70

g/l

0.48

213

Deviated nasal septum

797

6174

1.30

11.20

2.7

2.4

3.68

3.79

g/l

1.35

738

5724

Acute pharyngitis

262

1653

1.59

11.18

2.8

2.0

3.79

3.75

g/l

0.19

248

1552

Mental and behavioural disorders due to opioids

294

2.48

11.17

1.8

3.43

3.64

g/l

0.79

283

Artificial opening status

164

932

1.82

11.17

3.2

2.2

4.11

3.83

g/l

0.42

154

853

Alcohol-induced acute pancreatitis

101

488

2.15

11.16

2.1

2.6

4.05

3.79

g/l

1.09

458

Disorders of psychological development

162

841

1.81

11.14

1.9

3.57

3.69

g/l

0.62

152

785

Superficial injury of wrist and hand

430

3041

1.43

11.06

1.9

2.2

3.63

3.70

g/l

0.54

395

2815

Allergic contact dermatitis

281

1829

1.56

11.03

1.7

2.3

3.79

3.62

g/l

1.07

258

1682

Carcinoma in situ of skin of upper limb, including shoulder

107

538

2.11

10.87

2.6

3.80

3.73

g/l

0.14

102

479

Inflammatory bowel disease, strict (require KELA)

475

3430

1.40

10.84

2.2

2.3

3.85

3.71

g/l

1.47

448

3202

Other disorders of nervous system

194

1166

1.71

10.80

2.8

2.5

3.44

3.77

g/l

2.10

175

1073

Alcohol abuse, main dg, excluding more controls

323

2176

1.51

10.79

1.3

2.5

3.94

3.75

g/l

1.75

291

2044

Other specified and unspecified personality disorders

173

1004

1.76

10.77

1.9

2.2

3.59

3.69

g/l

0.52

161

942

Calculus of kidney and ureter

796

6212

1.30

10.76

2.1

2.4

3.78

3.77

g/l

0.12

728

5703

Diseases of tongue

161

918

1.80

10.75

2.6

2.0

3.51

3.80

g/l

1.56

147

827

Bacterial, viral and other infectious agents

181

1068

1.73

10.66

3.2

2.3

3.79

3.75

g/l

0.12

170

1004

Hypothyroidism, strict autoimmune, 3 medication purchases required

2033

11655

1.18

10.64

2.1

2.3

3.61

3.72

g/l

2.86

1850

10626

Anti-inflammatory and antirheumatic products, non-steroids

641

2405

1.35

10.62

2.6

2.3

3.73

g/l

0.00

589

2204

Malignant neoplasm of digestive organs, including Hilmo

1092

6478

1.25

10.59

2.1

1.4

3.78

3.76

g/l

0.26

985

5819

Blepharochalasis

803

6290

1.29

10.58

2.0

2.4

3.63

3.72

g/l

0.63

726

5695

Bullous pemphigoid

395

2.28

10.58

1.4

2.6

3.75

3.64

g/l

0.33

357

Impacted cerumen

334

2282

1.50

10.57

2.4

3.48

3.72

g/l

2.83

250

2087

Follow-up examination after treatment for malignant neoplasms

243

1548

1.60

10.56

2.5

2.2

3.84

3.81

g/l

0.09

222

1399

Infections with a predominantly sexual mode of transmission, including avohilmo

639

4421

1.33

10.56

2.1

2.0

3.57

3.65

g/l

0.90

593

4135

Fracture of neck

185

1106

1.73

10.54

3.1

2.3

3.77

3.76

g/l

0.01

170

1013

Diabetic retinopathy, strict definition

466

2995

1.41

10.53

1.7

2.1

3.84

3.87

g/l

0.09

426

2753

Other nonthrombocytopenic purpura

139

3.29

10.47

2.2

2.1

3.89

3.51

g/l

0.90

126

Respiratory disorders in diseases classified elsewhere

205

2.82

10.46

1.7

2.1

3.59

3.75

g/l

0.29

191

Paraplegia, diplegia of upper limbs

300

2.45

10.44

2.1

2.4

3.76

3.73

g/l

0.06

277

Cryoglobulinemia

13.74

10.43

4.2

1.3

3.79

3.57

g/l

0.15

D07AA Corticosteroids, weak (group I)

295

1962

1.52

10.39

1.8

2.3

3.96

3.69

g/l

2.41

267

1818

Propionic acid derivatives

639

2405

1.35

10.39

2.4

2.3

3.76

3.73

g/l

0.14

581

2204

Traumatic subarachnoid haemorrhage

105

530

2.05

10.30

2.4

2.5

3.91

3.79

g/l

0.23

491

Suicide or other Intentional self-harm

475

3461

1.39

10.28

1.9

2.3

3.76

3.70

g/l

0.34

435

3230

Hyperkinetic disorders, excluding more controls

117

565

1.95

10.28

1.4

1.8

3.42

3.70

g/l

2.47

111

545

Disorders of myoneural junction and muscle in diseases classified elsewhere

115

3.53

10.25

1.6

2.3

3.35

3.97

g/l

1.11

107

Melanocytic naevi of trunk

287

1911

1.53

10.23

2.4

3.64

3.71

g/l

0.21

272

1774

Xerosis cutis

279

2.51

10.23

1.7

2.6

3.52

3.70

g/l

0.40

256

Ganglion

420

3004

1.41

10.17

2.1

2.3

3.58

3.73

g/l

1.35

380

2753

Type 1 diabetes, definitions combined

140

775

1.83

10.09

2.0

2.1

3.26

3.63

g/l

3.57

130

735

Carcinoma in situ of skin

271

1796

1.55

10.08

2.1

2.5

3.72

3.73

g/l

0.02

250

1624

MS-disease / Multiple Sclerosis

142

795

1.82

10.06

1.7

2.1

3.26

3.70

g/l

4.93

137

742

Type 1 diabetes, strict (exclude DM2)

139

770

1.82

10.01

2.0

2.1

3.26

3.64

g/l

3.64

129

730

Other/unspecified synovitis and tenosynovitis

255

1664

1.56

9.97

1.9

2.3

3.48

3.73

g/l

2.99

236

1523

Carcinoma in situ of colon

100

505

2.08

9.97

1.8

2.5

3.71

3.75

g/l

0.08

460

Other orthopaedic follow-up care

148

844

1.80

9.94

1.7

2.0

4.18

3.76

g/l

0.58

137

766

Abscess of anal and rectal regions

181

1090

1.69

9.90

1.4

2.2

3.90

3.79

g/l

0.52

168

1015

Disorders of oesophagus in diseases classified elsewhere

327

2.35

9.88

4.1

2.9

3.39

3.60

g/l

0.82

296

Behavioural syndromes associated with physiological disturbances and physical factors

2234

13070

1.16

9.86

2.1

2.3

3.72

3.71

g/l

0.13

2032

11985

Pediculosis, acariasis and other infestations, including avohilmo

326

2240

1.47

9.85

1.7

2.2

3.63

3.72

g/l

0.82

310

2091

Exfoliative dermatitis

139

3.16

9.76

1.6

2.4

3.89

3.64

g/l

0.84

124

Sulfonylureas

1013

6520

1.25

9.73

1.8

2.5

3.90

3.69

g/l

5.13

914

5821

Benign neoplasm: Small intestine

133

744

1.86

9.72

2.3

2.5

3.60

3.80

g/l

0.70

123

682

Vascular diseases of the intestine

127

699

1.88

9.71

2.9

2.3

3.76

3.70

g/l

0.20

119

630

Duodenal ulcer

304

2074

1.49

9.70

1.9

2.4

3.74

3.75

g/l

0.06

284

1884

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

190

1156

1.66

9.69

1.7

2.2

3.85

3.69

g/l

0.73

180

1080

Crohn's disease of small intestine

145

827

1.79

9.68

1.8

2.4

3.62

3.77

g/l

0.65

135

768

Unspecified misadventure during surgical and medical care

163

965

1.74

9.67

2.1

2.5

3.73

g/l

0.02

148

892

Other/unspecified disorders of vestibular function

129

715

1.87

9.65

1.8

2.6

3.72

3.71

g/l

0.02

116

660

Other and unspecified glaucoma

224

1438

1.60

9.63

2.1

2.4

3.92

3.72

g/l

1.11

197

1287

Superficial injury of shoulder and upper arm

285

1920

1.51

9.63

2.3

2.2

3.66

3.72

g/l

0.39

258

1778

Superficial injury of ankle and foot

235

1517

1.57

9.62

1.8

2.3

3.55

3.70

g/l

1.24

218

1423

Allergic bronchopulmonary aspergillosis (ABPA)

8.19

9.60

2.3

2.4

4.39

3.33

g/l

1.06

malignant neoplasm of male genital organs, including Hilmo

732

3413

1.30

9.60

2.2

1.4

3.77

3.88

g/l

0.97

672

3118

Arterial embolism and thrombosis

169

1011

1.72

9.60

1.4

2.4

3.66

3.76

g/l

0.42

152

917

Monoplegia

208

2.70

9.59

2.2

2.5

3.73

3.78

g/l

0.09

192

Malignant neoplasm of bladder, including Hilmo

323

2205

1.47

9.58

2.3

1.4

3.77

3.81

g/l

0.18

287

1971

Event of undetermined intent

138

779

1.81

9.56

2.3

3.69

3.72

g/l

0.07

130

728

Visual impairment including blindness (binocular or monocular)

197

1228

1.64

9.53

2.1

2.2

3.65

3.72

g/l

0.21

160

1107

Dermatographic urticaria

144

824

1.79

9.52

2.0

2.5

3.85

3.65

g/l

0.76

137

771

Other and unspecified disorders of vitreous body

1146

9237

1.22

9.51

2.4

3.54

3.72

g/l

2.92

1035

8432

Other infective otitis externa

156

917

1.75

9.45

2.6

2.3

3.55

3.73

g/l

1.11

142

850

Cholecystitis

388

2782

1.42

9.43

2.2

2.3

3.68

3.69

g/l

0.04

351

2510

Psychotic depression

134

753

1.82

9.42

2.3

2.7

3.85

3.70

g/l

0.30

119

695

Melanocytic naevi of lower limb, including hip

113

604

1.93

9.41

2.9

2.3

3.67

3.72

g/l

0.10

108

562

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

243

1595

1.56

9.41

2.3

2.4

3.70

3.68

g/l

0.08

215

1457

Attention to artificial openings

122

670

1.88

9.39

2.6

2.0

3.98

3.78

g/l

0.46

106

611

Other Crohn's disease

137

776

1.80

9.37

1.5

2.2

3.85

3.70

g/l

0.67

128

724

Scabies, including avohilmo

259

1720

1.52

9.30

1.7

2.3

3.59

3.71

g/l

0.92

248

1618

Disorders of optic nerve and visual pathways

210

1335

1.60

9.29

2.2

2.5

3.53

3.72

g/l

1.21

195

1236

Urolithiasis

851

6821

1.26

9.28

2.1

2.4

3.78

3.77

g/l

0.04

775

6251

Inflammatory diseases of female pelvic organs

1283

7291

1.21

9.27

1.8

2.3

3.62

3.61

g/l

0.14

1145

6642

Other superficial mycoses, including avohilmo

208

1319

1.60

9.24

1.9

2.3

3.75

3.72

g/l

0.08

192

1222

Cerebral cysts

129

722

1.83

9.23

1.6

2.4

3.59

3.72

g/l

0.35

117

668

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

323

2248

1.46

9.20

2.3

3.90

3.72

g/l

1.47

305

2096

Disorders of breast

1034

7431

1.23

9.20

2.1

2.3

3.54

3.62

g/l

0.74

930

6743

Other/unspecified enthesopathies, not elsewhere classified

204

1292

1.61

9.19

1.8

2.2

3.49

3.76

g/l

2.72

188

1182

Malignant neoplasm of other connective and soft tissue, including Hilmo

116

632

1.90

9.15

4.4

1.4

3.65

3.70

g/l

0.08

107

567

Ulcerative colitis (strict definition, require KELA)

333

2336

1.44

9.09

2.4

2.3

3.91

3.72

g/l

1.52

314

2181

Plantar fascial fibromatosis

218

1405

1.58

9.08

2.5

2.2

3.72

g/l

0.01

202

1297

Wet age-related macular degeneration

560

4123

1.33

9.06

2.4

2.2

3.82

3.68

g/l

0.84

484

3630

Other follicular disorders

156

926

1.72

9.06

2.4

2.3

3.86

3.70

g/l

0.68

147

866

Asthma and opportunity respiratory infection

149

879

1.76

9.06

2.6

2.7

3.71

3.67

g/l

0.12

142

787

Childhood asthma (age<16), excluding more controls

117

490

1.88

9.02

1.4

3.87

3.71

g/l

0.48

110

471

Psoriasis (vulgaris), strict definition

440

2.07

8.93

1.4

2.6

4.25

3.70

g/l

2.33

413

Entropion and trichiasis of eyelid

268

1818

1.51

8.93

2.3

2.5

3.70

3.73

g/l

0.15

238

1642

Idiopathic pulmonary fibrosis

239

1585

1.55

8.91

2.0

2.4

4.08

3.71

g/l

2.51

221

1427

Other renal tubulo-interstitial diseases

264

2.40

8.88

1.8

2.0

3.80

3.64

g/l

0.38

248

Cluster headache, strict, including avohilmo

104

552

1.93

8.82

1.6

2.3

3.42

3.75

g/l

1.95

518

Fibrosis of liver

3.55

8.78

1.5

1.8

4.01

3.39

g/l

2.19

Conductive and sensorineural hearing loss

2105

12148

1.16

8.76

2.4

3.59

3.77

g/l

4.44

1879

11130

Cluster headache, wide,, including avohilmo

110

596

1.89

8.75

1.7

2.3

3.46

3.74

g/l

1.42

102

556

Acute bronchiolitis

305

2.19

8.73

5.3

1.8

3.44

3.64

g/l

0.50

280

Coronary artery bypass grafting

746

4383

1.28

8.70

1.7

2.5

3.82

3.81

g/l

0.06

679

3908

Dissociative [conversion] disorders

349

2.17

8.69

1.3

2.0

4.12

3.74

g/l

0.47

327

Other specified and unspecified retinal disorders

106

572

1.92

8.68

2.6

2.5

3.61

3.70

g/l

0.27

524

Other sleep disorders

260

1758

1.50

8.68

1.8

2.4

3.92

3.76

g/l

0.58

227

1625

Thiazolidinediones

320

2257

1.45

8.67

1.7

2.5

3.98

3.67

g/l

4.38

294

2048

Redundant prepuce, phimosis and paraphimosis

442

3226

1.36

8.64

1.9

2.4

3.89

3.88

g/l

0.03

416

3007

Hypopituitarism

144

848

1.73

8.62

2.6

2.4

3.54

3.77

g/l

1.22

135

802

Childhood asthma (age<16)

117

498

1.85

8.60

1.4

3.87

3.70

g/l

0.51

110

478

Other and unspecified tonsillitis

522

3284

1.33

8.58

1.8

2.0

3.85

3.77

g/l

0.64

501

3100

Palmar fascial fibromatosis [Dupuytren]

403

2957

1.38

8.57

2.2

2.4

3.71

3.80

g/l

0.65

364

2680

Carcinoma in situ of skin of trunk

119

671

1.85

8.56

3.1

2.4

3.56

3.71

g/l

0.48

112

602

COPD, hospital admissions 1, only main diagnosis

990

6984

1.23

8.53

1.9

2.4

3.88

3.75

g/l

1.06

891

6327

Benign neoplasm: Parathyroid gland

174

2.78

8.51

2.8

2.0

3.47

3.75

g/l

0.52

164

Other keratitis

246

1652

1.51

8.49

2.2

3.79

3.71

g/l

0.43

229

1526

Scleritis and episcleritis

141

831

1.74

8.48

2.1

2.2

4.01

3.71

g/l

0.66

131

777

Primary coxarthrosis, bilateral

831

6720

1.25

8.48

2.2

2.4

3.70

3.72

g/l

0.08

751

6038

Unspecified/other endometriosis

150

877

1.70

8.47

1.9

2.0

3.53

3.63

g/l

0.47

136

804

Exposure to other and unspecified animate mechanical forces

314

2.23

8.46

2.8

2.1

3.45

3.70

g/l

1.32

302

Bronchitis, not specified as acute or chronic

205

1326

1.58

8.46

2.2

2.4

3.64

3.72

g/l

0.38

185

1197

Acidosis

310

2.26

8.43

1.7

2.4

3.73

3.83

g/l

0.25

284

Anogenital herpesviral [herpes simplex] infection, including avohilmo

170

1050

1.64

8.42

2.3

2.1

3.46

3.68

g/l

1.72

158

993

Chondropathies

319

2255

1.43

8.41

2.1

2.2

3.85

3.71

g/l

0.64

286

2094

Carrier of infectious disease

303

2.26

8.40

1.3

2.4

3.55

3.77

g/l

0.69

281

Iridocyclitis in diseases classified elsewhere

254

2.39

8.31

2.0

2.3

4.22

3.59

g/l

0.57

237

Complications of cardiac and vascular prosthetic devices, implants and grafts

346

2.19

8.27

2.3

2.8

3.95

3.66

g/l

0.80

315

Deficiency of other B group vitamins

306

2.25

8.25

3.3

2.0

3.78

3.66

g/l

0.25

279

Coxarthrosis, primary, with hip surgery

1346

10582

1.19

8.24

2.2

2.4

3.76

3.73

g/l

0.25

1210

9552

Monoamine oxidase A inhibitors

271

1869

1.47

8.22

2.1

2.5

3.97

3.69

g/l

1.56

249

1717

Cachexia

4.17

8.21

2.4

1.7

3.72

3.53

g/l

0.27

Malignant neoplasm of prostate, including Hilmo

717

3345

1.28

8.21

2.2

1.4

3.77

3.88

g/l

1.08

658

3052

Spontaneous rupture of synovium and tendon

204

1329

1.57

8.19

1.9

2.2

3.67

3.77

g/l

0.46

183

1215

Disorders of magnesium metabolism

110

3.25

8.18

1.3

2.5

3.99

3.98

g/l

0.01

104

Specific development disorders of speech and language

482

1.93

8.17

1.8

2.1

3.50

3.72

g/l

0.98

441

Other and unspecified psoriasis

176

1111

1.62

8.16

2.0

2.5

3.96

3.71

g/l

1.82

166

1026

Bursitis of shoulder

320

2.20

8.15

3.1

2.3

3.90

3.91

g/l

0.01

297

Lactose intolerance

353

2.13

8.12

1.6

1.7

3.60

3.78

g/l

0.37

324

Congenital malformations and deformations of the musculoskeletal system

139

819

1.71

8.11

1.6

2.0

3.85

3.67

g/l

0.69

133

768

Endometriosis

651

2960

1.29

8.03

1.8

2.2

3.53

3.68

g/l

2.04

597

2687

Superficial injury of forearm

208

1365

1.55

8.03

2.2

2.3

3.66

3.72

g/l

0.27

187

1272

Crushed, pushed or stepped on by crowd or human stampede

129

752

1.74

8.02

2.6

2.1

3.76

3.69

g/l

0.25

121

706

Golimumab

375

2.08

8.00

1.3

1.9

4.05

3.76

g/l

0.91

360

Other specified/unspecified spondylopathies

384

2.09

7.98

2.9

2.0

3.37

3.78

g/l

2.02

344

Autoimmune hyperthyroidism

128

748

1.75

7.94

2.2

2.5

3.80

3.70

g/l

0.17

123

687

Viral warts

204

1337

1.55

7.94

1.9

2.4

3.40

3.72

g/l

3.07

194

1234

Anogenital herpesviral [herpes simplex] infection

104

572

1.85

7.88

2.3

2.0

3.57

3.71

g/l

0.53

538

Postzoster neuralgia

248

2.38

7.88

3.8

2.0

3.43

3.81

g/l

1.05

222

Melanocytic naevi

668

5309

1.27

7.87

2.6

2.3

3.67

3.69

g/l

0.07

637

4875

Oesophagitis

142

858

1.70

7.86

2.3

2.6

3.68

3.74

g/l

0.19

135

795

Chronic hepatitis, not elsewhere classified

483

1.95

7.85

1.9

2.6

3.84

3.62

g/l

0.93

453

Adenomyosis (Endometriosis of uterus)

302

2141

1.43

7.82

2.2

2.3

3.56

3.67

g/l

0.87

280

1934

Tobacco use

124

723

1.76

7.80

1.5

2.4

4.14

3.74

g/l

0.46

119

679

Benign neoplasm: Duodenum

451

2.00

7.80

2.6

3.63

3.70

g/l

0.15

414

Hemiplegia

126

739

1.75

7.78

2.0

2.3

3.77

3.81

g/l

0.09

112

677

Obsessive-compulsive disorder

488

1.91

7.77

1.9

2.1

3.48

3.74

g/l

1.43

466

Benign neoplasm: Descending colon

204

1350

1.55

7.75

2.0

2.5

3.61

3.72

g/l

0.66

177

1244

Other condition

316

2266

1.41

7.73

2.3

2.2

3.69

3.73

g/l

0.21

295

2093

Other benign neoplasms of skin

942

7789

1.22

7.71

3.0

2.4

3.62

3.71

g/l

1.01

841

7079

Dislocation, sprain and strain of joint and ligaments of hip

110

624

1.82

7.70

1.9

2.5

4.00

3.70

g/l

0.69

575

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

354

2587

1.38

7.70

2.3

3.89

3.73

g/l

1.29

335

2411

Dermatophytosis

346

2524

1.39

7.69

2.7

2.3

3.60

3.74

g/l

1.41

320

2312

Astigmatism

129

762

1.72

7.67

2.3

2.4

3.54

3.74

g/l

0.81

121

700

Other and unspecified rosacea

215

1441

1.52

7.60

2.2

2.4

3.76

3.69

g/l

0.26

201

1333

Sleep disorders

2110

12768

1.14

7.56

2.0

2.3

3.74

3.71

g/l

0.36

1920

11710

Mental and behavioural disorders due to tobacco

202

1338

1.54

7.55

1.8

2.5

3.73

3.71

g/l

0.08

171

1250

Use of anticholinesterases

782

7389

0.81

7.54

2.0

2.3

3.86

3.72

g/l

1.02

649

6605

N06DA Anticholinesterases

782

7389

0.81

7.54

2.0

2.3

3.86

3.72

g/l

1.02

649

6605

Nasal polyp

467

3572

1.32

7.54

2.9

2.4

3.95

3.76

g/l

0.79

436

3282

Cardiac murmurs and other cardiac sounds

178

1132

1.58

7.50

2.7

2.1

3.68

3.71

g/l

0.10

166

1024

Viral warts, including avohilmo

425

3208

1.34

7.47

2.1

2.2

3.65

3.71

g/l

0.25

396

2968

Periapical abscess

1057

8861

1.20

7.44

2.2

2.4

3.76

3.74

g/l

0.16

976

8194

Tinnitus

573

4512

1.28

7.39

2.3

2.4

3.55

3.74

g/l

2.78

531

4151

Other ulcerative colitis

120

704

1.74

7.39

1.4

2.4

3.95

3.71

g/l

0.80

113

654

Atypical facial pain

127

759

1.71

7.35

2.0

2.4

3.95

3.73

g/l

0.34

116

695

Rosacea

288

2053

1.42

7.34

2.1

2.3

3.78

3.67

g/l

0.54

270

1896

Disorders of speech understanding and production

393

1.99

7.31

1.8

2.3

3.51

3.72

g/l

0.80

355

Other obstructive and reflux uropathy

466

1.91

7.25

1.9

2.1

3.63

3.64

g/l

0.02

432

Panniculitis affecting regions of neck and back

460

1.92

7.24

2.0

2.2

3.87

3.83

g/l

0.09

427

malignant neoplasm of male genital organs

700

3377

1.26

7.24

2.2

1.4

3.76

3.88

g/l

1.17

643

3084

Thrombotic microangiopathy

3.57

7.20

3.8

1.5

3.16

3.53

g/l

0.96

Smoking dependency

202

1353

1.52

7.19

1.8

2.5

3.73

3.71

g/l

0.09

171

1264

Other disorders of iris and ciliary body

420

1.97

7.19

2.1

2.6

3.93

3.62

g/l

0.86

385

Nontoxic goitre/thyroid nodule

723

5867

1.24

7.19

2.2

2.4

3.63

3.66

g/l

0.15

656

5294

Presence of other devices

672

5322

1.26

7.19

2.8

2.3

3.34

3.78

g/l

9.73

600

4791

Necrosis of pulp, including avohilmo

1235

10394

1.18

7.16

2.3

3.71

3.72

g/l

0.09

1157

9622

Visual field defects

219

1494

1.50

7.16

2.2

3.67

3.74

g/l

0.28

198

1366

Somnolence, stupor and coma

106

608

1.79

7.12

1.6

2.7

3.61

3.74

g/l

0.48

552

Congenital malformations of the circulatory system

275

1898

1.42

7.08

1.8

2.3

3.61

3.71

g/l

0.80

254

1762

Malignant melanoma of skin, including Hilmo

353

2621

1.37

7.05

2.5

1.4

3.53

3.76

g/l

2.03

318

2364

Malignant melanoma of skin

296

2138

1.41

7.04

2.6

1.4

3.54

3.75

g/l

1.43

265

1932

Paget disease

3.49

7.03

2.5

1.3

3.48

4.07

g/l

0.78

Organic, including symptomatic, mental disorders

1540

9382

1.16

7.02

2.2

2.4

3.75

3.72

g/l

0.33

1332

8500

Other secondary coxarthrosis

524

1.85

7.01

1.6

2.4

3.68

3.69

g/l

0.02

484

Open wound of abdomen, lower back and pelvis

346

2.05

7.01

1.9

2.5

3.95

3.72

g/l

0.47

327

Malignant neoplasm of mesothelium and soft tissue

107

620

1.78

6.99

3.5

1.4

3.72

g/l

0.01

553

Arthropathy in hypersensitivity reactions classified elsewhere

15.21

6.97

1.6

1.2

3.90

3.67

g/l

—

Alzheimer’s disease (Late onset), excluding more controls

425

2093

1.34

6.94

2.0

2.5

3.91

3.82

g/l

0.33

365

1881

Other and unspecified vascular occlusions

268

1911

1.43

6.94

2.4

3.78

3.67

g/l

0.55

243

1720

Extreme obesity with alveolar hypoventilation

107

622

1.77

6.91

2.1

2.7

4.14

3.68

g/l

2.13

570

Thyrotoxicosis with diffuse goitre

285

2049

1.41

6.91

2.2

2.3

3.74

3.68

g/l

0.25

265

1885

Portal vein thrombosis

217

2.36

6.91

2.1

2.5

3.78

3.72

g/l

0.10

204

Melanoma in situ

138

860

1.66

6.91

2.3

2.6

3.50

3.73

g/l

1.28

117

781

Complications of genitourinary prosthetic devices, implants and grafts

370

2.02

6.90

1.8

2.1

3.65

3.71

g/l

0.14

335

Bell's palsy

269

1918

1.42

6.89

2.3

3.66

3.73

g/l

0.31

243

1753

Unspecified lump in breast

349

2596

1.36

6.88

1.9

2.3

3.47

3.64

g/l

2.30

317

2347

Thyrotoxicosis with toxic multinodular goitre

170

1112

1.57

6.87

1.8

2.3

3.61

3.67

g/l

0.24

152

999

Abnormal blood-pressure reading, without diagnosis

108

630

1.75

6.84

2.2

2.3

3.85

3.66

g/l

0.52

101

569

Ulcerative colitis (strict definition, all Crohn cases excluded)

277

1986

1.41

6.83

2.6

2.3

3.91

3.71

g/l

1.47

260

1854

Follicular cysts of skin and subcutaneous tissue

424

3247

1.32

6.83

2.5

2.3

3.65

3.71

g/l

0.28

396

2995

Arthropathy in ulcerative colitis

157

2.61

6.78

1.5

1.9

4.01

3.66

g/l

0.70

150

Testicular dysfunction

456

1.89

6.76

1.6

2.5

3.55

3.83

g/l

1.14

429

Varicose veins

1551

10181

1.16

6.74

2.4

2.3

3.76

3.71

g/l

0.44

1404

9235

Hepatocellular carcinoma, including Hilmo

451

1.90

6.74

2.5

1.4

4.17

3.76

g/l

1.86

399

Degenerative macular diseases

335

2489

1.37

6.74

2.1

2.4

3.55

3.66

g/l

0.72

304

2232

Hyperaldosteronism

430

1.93

6.74

3.2

2.6

3.83

3.78

g/l

0.13

398

Drug-induced hypoglycaemia without coma

213

2.35

6.74

2.2

2.4

4.12

3.76

g/l

0.81

196

Lactose intolerance, other/unspecified

318

2.07

6.70

1.6

1.7

3.67

3.79

g/l

0.21

293

Other symptoms and signs involving general sensations and perceptions

107

628

1.75

6.67

2.2

2.6

3.60

3.70

g/l

0.31

574

Malignant neoplasm of prostate

692

3309

1.25

6.67

2.2

1.4

3.74

3.88

g/l

1.38

635

3018

Procreative management

576

3769

1.27

6.66

1.9

2.2

3.67

3.71

g/l

0.27

548

3516

Pure hyperglyceridaemia

306

2.10

6.65

1.7

2.3

3.88

3.80

g/l

0.15

285

Combinations of oral blood glucose lowering drugs

728

5967

1.23

6.63

1.8

2.6

3.97

3.70

g/l

5.57

681

5460

Fracture at wrist and hand level

730

5959

1.23

6.61

2.4

2.3

3.71

3.73

g/l

0.10

660

5492

severe traumatic brain injury, does not include concussion

596

4785

1.26

6.59

2.3

3.76

3.75

g/l

0.02

521

4323

Postprocedural disorders of digestive system, not elsewhere classified

505

1.84

6.59

1.8

2.6

3.85

3.60

g/l

1.16

466

Postmenopausal bleeding

640

2681

1.26

6.58

2.2

2.3

3.64

3.69

g/l

0.45

571

2417

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

130

807

1.65

6.56

2.0

1.4

4.13

3.79

g/l

1.81

115

710

Autonomic disorders

329

2.04

6.51

1.9

2.4

3.67

3.78

g/l

0.22

302

Other aneurysm

150

966

1.59

6.51

2.2

2.5

3.85

3.75

g/l

0.33

143

887

Crohn's disease of large intestine

104

609

1.74

6.50

1.6

2.3

3.95

3.67

g/l

1.28

567

Hydrocele

291

2125

1.39

6.50

2.3

2.5

3.66

3.88

g/l

1.28

268

1952

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

163

1070

1.56

6.46

3.6

1.4

3.72

g/l

0.01

150

950

Other and specified injuries of hip and thigh

345

2.01

6.42

1.6

2.3

3.59

3.71

g/l

0.20

316

Orchitis and epididymitis

220

1534

1.46

6.42

2.0

2.4

3.74

3.86

g/l

0.45

204

1409

Chondrocostal junction syndrome [Tietze]

546

1.79

6.41

2.3

2.2

3.60

3.76

g/l

0.42

499

Later onset COPD

868

5821

1.21

6.39

1.7

2.4

3.81

3.75

g/l

0.71

776

5218

Alzheimer disease, excluding more controls

477

2404

1.30

6.39

2.0

2.5

3.86

3.83

g/l

0.13

408

2171

Alcohol abuse, main dg

323

2403

1.36

6.38

1.3

2.3

3.94

3.73

g/l

2.08

291

2248

Orthopaedic devices associated with adverse incidents

341

2.04

6.37

1.4

2.2

4.16

3.73

g/l

0.23

310

Open wound of hip and thigh

394

1.93

6.36

1.3

2.4

3.72

g/l

0.00

375

Sensorineural hearing loss

2002

11832

1.13

6.35

2.4

3.58

3.77

g/l

4.70

1783

10824

Assault

209

1443

1.46

6.35

1.9

2.1

3.72

3.75

g/l

0.08

192

1375

Other and unspecified parapsoriasis

3.43

6.34

1.4

1.8

3.47

3.69

g/l

0.37

Urethral stricture

155

1012

1.57

6.33

2.1

2.5

3.95

3.75

g/l

0.52

140

925

Sudden idiopathic hearing loss

258

1858

1.41

6.32

2.1

2.3

3.63

3.76

g/l

0.52

227

1709

Other and/or unspecified nontoxic goitre

205

1417

1.47

6.32

2.3

3.50

3.71

g/l

2.07

190

1289

Benign neoplasm: Other and unspecified parts of mouth

535

1.80

6.30

3.1

2.6

3.58

3.70

g/l

0.42

493

Other noninflammatory disorders of vulva and perineum

193

1317

1.49

6.28

2.0

2.3

3.48

3.69

g/l

1.76

174

1199

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

189

1288

1.50

6.27

2.1

2.4

3.68

3.73

g/l

0.15

172

1180

Ulcerative enterocolitis

354

1.97

6.26

1.9

2.3

3.95

3.68

g/l

0.95

329

Alzheimer’s disease (Early onset)

848

0.44

6.26

1.2

2.1

4.00

3.71

g/l

0.76

755

Other and unspecified bullous disorders

164

2.52

6.26

3.1

2.2

3.53

3.84

g/l

0.54

150

Injury of eye and orbit

283

2070

1.38

6.23

1.9

2.2

3.61

3.74

g/l

0.36

257

1939

Disorders of ocular muscles, binocular movement, accommodation and refraction

981

8230

1.19

6.23

2.1

2.3

3.62

3.70

g/l

0.78

910

7567

Other epidermal thickening

115

703

1.68

6.19

1.9

2.5

3.56

3.79

g/l

0.89

105

646

Lichen simplex chronicus

478

1.83

6.19

2.5

2.8

3.83

3.71

g/l

0.37

441

Use of donepezil

415

5070

0.77

6.18

1.7

2.2

3.94

3.68

g/l

1.09

340

4477

Achilles tendinitis

220

1545

1.44

6.18

2.6

2.2

3.69

3.77

g/l

0.42

201

1437

Use of antiglaucoma preparations and miotics

227

1608

1.44

6.17

2.2

2.4

3.95

3.72

g/l

0.89

198

1430

Other otitis externa (chronic)

157

1033

1.55

6.16

2.5

3.46

3.71

g/l

1.70

131

955

Insomnia

2030

12556

1.13

6.15

2.0

2.3

3.72

3.70

g/l

0.28

1849

11520

Thyroiditis

155

1018

1.55

6.13

2.2

2.4

3.61

3.67

g/l

0.26

138

940

Malignant neoplasm of breast, ER-positive, including Hilmo

682

4147

1.23

6.10

2.1

1.4

3.77

3.65

g/l

0.88

597

3714

Other disorders of optic [2nd] nerve and visual pathways

146

949

1.57

6.07

2.3

2.5

3.56

3.69

g/l

0.44

134

875

Malignant neoplasm of breast, HER-positive

680

4141

1.23

6.07

2.1

1.4

3.76

3.65

g/l

0.83

595

3709

Amenorrhoea

567

1.73

6.07

1.9

2.1

3.47

3.67

g/l

0.98

532

Injury of muscle and tendon at hip and thigh level

222

1569

1.44

6.04

2.0

2.4

3.45

3.73

g/l

3.18

206

1472

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

127

799

1.62

6.03

1.7

2.2

3.51

3.72

g/l

1.24

121

742

Complications of other internal prosthetic devices, implants and grafts

114

703

1.66

5.97

2.7

2.3

3.76

3.71

g/l

0.14

108

637

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

229

2.18

5.96

1.6

1.8

3.53

3.64

g/l

0.30

218

Diabetic maculopathy

318

2256

1.35

5.95

1.5

2.1

3.88

3.83

g/l

0.32

295

2066

Retinal detachment with retinal break

336

2547

1.34

5.95

2.9

2.4

3.64

3.68

g/l

0.25

304

2326

Leisure time condition

412

3206

1.30

5.94

1.7

2.2

3.53

3.72

g/l

2.17

337

2937

Bicipital tendinitis

114

703

1.66

5.94

2.0

2.4

3.53

3.80

g/l

1.31

108

660

Paralytic ileus

100

597

1.72

5.93

3.8

2.3

3.80

3.84

g/l

0.10

541

Type 1 diabetes, strict definition

488

1.78

5.90

1.5

1.7

3.22

3.62

g/l

2.98

471

Other misadventures during surgical and medical care

363

1.94

5.90

1.8

2.8

3.98

3.66

g/l

1.04

335

Other salmonella infections

515

1.77

5.89

2.8

2.2

3.76

3.71

g/l

0.09

473

Nonsuppurative otitis media, including avohilmo

537

3721

1.25

5.86

2.2

2.1

3.61

3.69

g/l

0.89

509

3449

Injuries to the wrist and hand

2396

14302

1.11

5.79

2.2

2.3

3.68

3.72

g/l

0.58

2201

13110

Pulmonary oedema

296

2.04

5.76

2.8

2.5

4.04

3.71

g/l

0.75

265

Glucosamine medication

1307

9081

1.16

5.76

2.3

2.4

3.66

3.72

g/l

0.53

1177

8148

UC patients in KELA-register (code 208), prior to 1994

106

648

1.68

5.76

2.4

2.6

3.70

3.76

g/l

0.18

100

602

Left ventricular outflow tract obstruction (LVOTO), broad definition

200

1400

1.45

5.76

1.8

2.4

3.94

3.74

g/l

1.42

187

1312

Episcleritis

111

685

1.65

5.75

2.1

2.2

4.02

3.64

g/l

0.67

104

644

Disorders of parathyroid gland, other and/or unspecified

117

2.77

5.70

1.5

1.8

3.53

3.89

g/l

0.60

109

Alcohol dependence

613

5019

1.23

5.69

1.6

2.5

3.95

3.75

g/l

3.46

550

4677

Other disorders of penis

220

1569

1.42

5.68

1.7

2.5

3.96

3.85

g/l

0.19

199

1447

Excessive earwax

1634

13095

1.14

5.68

2.5

2.4

3.68

3.73

g/l

0.44

1446

11963

Infective dermatitis

254

1860

1.38

5.64

1.7

2.4

4.02

3.69

g/l

1.24

230

1712

Seborrhoeic dermatitis

230

1658

1.41

5.63

2.4

3.76

3.72

g/l

0.16

209

1520

Aortic valve malfunction, age under 60 years

191

1332

1.46

5.63

1.9

2.3

3.97

3.73

g/l

1.74

178

1250

Other disorders of pigmentation

114

714

1.63

5.62

3.0

2.2

3.75

3.78

g/l

0.06

108

651

Otitis externa, unspecified

231

1666

1.40

5.61

2.1

2.3

3.58

3.72

g/l

1.11

212

1541

Irregular menses

808

5084

1.20

5.60

2.1

2.2

3.51

3.62

g/l

1.68

743

4713

Malignant neoplasm, without specification of site, including Hilmo

120

762

1.61

5.55

2.9

1.4

3.75

3.74

g/l

0.04

110

666

Other deformities of toe(s)

502

1.76

5.55

2.4

2.3

3.49

3.56

g/l

0.19

454

Hordeolum and other deep inflammation of eyelid

131

849

1.57

5.54

2.5

2.6

3.53

3.76

g/l

1.35

115

792

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

644

5312

1.22

5.54

2.5

2.3

3.66

3.73

g/l

0.72

590

4910

Burns and corrosions

265

1958

1.37

5.53

2.0

2.2

3.76

3.73

g/l

0.12

244

1828

Chronic iridocyclitis

112

701

1.63

5.52

2.1

2.4

3.76

3.68

g/l

0.25

106

644

665

5144

1.22

5.49

2.2

3.63

3.71

g/l

0.65

572

4556

Malignant neoplasm of breast, including Hilmo

835

4497

1.20

5.48

2.1

1.4

3.77

3.64

g/l

1.17

741

4049

Malignant neoplasm of breast, HER2-negative, including Hilmo

835

4498

1.20

5.48

2.1

1.4

3.76

3.64

g/l

1.15

741

4050

Premature rupture of membranes

134

1445

0.66

5.46

1.9

2.0

3.50

3.58

g/l

0.29

126

1374

Gluteal tendinitis

101

618

1.67

5.46

2.0

2.3

3.66

3.72

g/l

0.18

572

Seborrhoeic keratosis

644

5327

1.22

5.45

2.5

2.3

3.57

3.70

g/l

1.15

591

4812

Impotence

142

942

1.54

5.45

1.9

2.4

3.49

3.84

g/l

2.93

129

862

Malignant neoplasm of colon, including Hilmo

457

3629

1.27

5.45

2.6

1.4

3.81

3.75

g/l

0.33

410

3242

Benign neoplasm of urinary organs

127

823

1.58

5.44

1.9

2.6

3.50

3.76

g/l

1.64

119

754

Pustulosis palmaris et plantaris

103

635

1.66

5.43

2.2

2.4

4.04

3.61

g/l

2.89

593

Brachial plexus disorders

157

1062

1.50

5.40

2.4

3.61

3.71

g/l

0.14

151

1008

Cholangitis (primary sclerosing, PSC)

153

1033

1.51

5.38

1.9

2.4

3.84

3.66

g/l

0.91

141

945

Benign neoplasm of major salivary glands

238

1741

1.39

5.38

1.9

2.4

3.86

3.73

g/l

0.63

219

1591

Other and unspecified nonorganic psychotic disorders

317

2415

1.32

5.36

1.7

2.3

3.63

3.71

g/l

0.61

289

2268

Other congenital malformations of skin, including avohilmo

153

1033

1.50

5.34

1.9

2.3

3.67

3.74

g/l

0.32

142

955

Excessive attrition of teeth

1275

11036

1.15

5.32

2.4

2.3

3.60

3.71

g/l

2.18

1176

10213

Postprocedural musculoskeletal disorders, not elsewhere classified

189

1334

1.45

5.31

2.8

2.4

3.79

3.69

g/l

0.38

179

1217

Other other unspecified disorders of the circulatory system

570

1.69

5.31

2.1

2.5

3.81

3.72

g/l

0.14

521

Pneumothorax

169

1167

1.47

5.31

2.5

2.3

4.05

3.76

g/l

0.42

157

1077

Other, unspecified and serous retinal detachments

502

1.74

5.30

2.2

2.7

3.74

3.69

g/l

0.14

463

Moderate visual impairment, binocular

503

1.74

5.27

1.7

2.1

3.59

3.71

g/l

0.21

453

!Aliquae complicationes praecoces traumatis

102

632

1.65

5.26

2.7

2.4

3.68

3.75

g/l

0.24

590

Early complications of trauma

102

632

1.65

5.26

2.7

2.4

3.68

3.75

g/l

0.24

590

Other salmonella infections, including avohilmo

586

1.67

5.25

2.7

2.3

3.74

g/l

0.00

541

Acute laryngitis and tracheitis

158

1058

1.48

5.24

1.6

1.9

3.89

3.73

g/l

0.63

146

989

Postprocedural disorders of nervous system

112

709

1.60

5.22

2.3

2.0

3.56

3.72

g/l

0.51

104

669

Recurrent dislocation and subluxation of joint

102

631

1.64

5.22

1.9

2.3

3.55

3.56

g/l

0.01

600

Other and unspecified trigeminal disorders

184

2.26

5.21

1.9

2.0

3.82

g/l

0.00

170

Ulcer of oesophagus

172

1198

1.46

5.19

2.3

2.6

3.57

3.75

g/l

0.96

154

1096

Malignant neoplasm of breast, HER2-negative

819

4462

1.19

5.14

2.1

1.4

3.77

3.64

g/l

1.24

725

4014

Other specified/unspecified disorders of bone/cartilage

358

1.87

5.14

2.8

2.1

3.44

3.74

g/l

0.96

338

Tongue abnormality

153

1045

1.49

5.13

2.7

2.4

3.53

3.73

g/l

0.92

139

952

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

408

3192

1.27

5.11

2.1

3.51

3.67

g/l

1.88

380

2973

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

120

776

1.56

5.10

1.9

2.3

3.54

3.59

g/l

0.15

105

730

Familial hypercholesterolemia, with ischemic heart disease

260

1948

1.36

5.10

2.0

2.4

3.61

3.77

g/l

1.18

232

1738

Retinal breaks without detachment

391

3090

1.28

5.09

2.4

3.54

3.71

g/l

2.00

351

2837

Use of memantine

633

6107

0.83

5.07

1.9

2.3

3.71

3.72

g/l

0.07

506

5428

Use of other anti-dementia drugs

633

6107

0.83

5.07

1.9

2.3

3.71

3.72

g/l

0.07

506

5428

Postpartum haemorrhage

184

2131

0.71

5.06

1.9

2.1

3.51

3.59

g/l

0.33

170

2011

Malignant neoplasm of breast

819

4468

1.19

5.06

2.1

1.4

3.78

3.64

g/l

1.27

725

4020

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

204

1273

1.40

5.03

1.4

1.6

3.48

3.67

g/l

1.69

192

1215

Disorders of tooth development and eruption

282

1729

1.34

5.03

1.9

2.1

3.73

g/l

0.00

258

1593

Injury of muscle and tendon at lower leg level

333

2583

1.30

5.02

2.5

3.72

3.77

g/l

0.15

314

2410

Ulcerative proctitis

118

765

1.57

5.01

1.4

2.3

3.78

3.72

g/l

0.15

109

709

Colitis, primary sclerosing, strict definition

100

2.71

4.99

2.7

2.4

3.86

3.61

g/l

0.72

Monocytic leukaemia

3.52

4.99

3.6

1.4

3.63

4.18

g/l

0.41

Malignant neoplasm, without specification of site

503

1.71

4.98

2.8

1.4

3.76

3.71

g/l

0.11

437

Diffuse brain injury

398

1.79

4.95

2.5

2.0

3.91

3.75

g/l

0.41

372

Other retinal artery occlusion

401

1.81

4.93

2.1

2.8

4.04

3.62

g/l

1.12

366

Post-traumatic wound infection, not elsewhere classified

363

1.84

4.92

2.4

2.5

3.61

3.70

g/l

0.23

338

Colitis, primary sclerosing

131

2.45

4.90

2.5

2.1

3.82

3.66

g/l

0.46

125

Benign neoplasm: salivary glands, exclude unknown (D119)

212

1548

1.39

4.90

2.0

2.4

3.89

3.72

g/l

0.80

195

1419

Colorectal cancer, including Hilmo

652

5082

1.21

4.89

2.5

1.4

3.80

3.75

g/l

0.36

585

4535

Spontaneous abortion

583

4716

0.82

4.89

2.0

2.3

3.54

3.63

g/l

0.90

547

4326

Pustular psoriasis

110

709

1.59

4.86

2.1

2.3

3.97

3.66

g/l

1.70

103

656

Benign neoplasm: Pituitary gland, craniopharyngeal duct

113

733

1.57

4.83

2.8

2.5

3.71

3.68

g/l

0.05

106

678

Inflammatory disease of uterus

225

1659

1.37

4.81

1.8

2.2

3.41

3.61

g/l

1.83

201

1537

Drug-induced neutropenia

173

1225

1.44

4.81

3.5

2.5

3.56

3.71

g/l

0.54

168

1129

Oesophageal obstruction

586

1.65

4.81

3.1

2.7

3.64

3.81

g/l

0.61

534

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

139

2.37

4.76

5.0

1.9

3.30

3.61

g/l

0.50

130

Nail disorders

176

1251

1.43

4.75

1.9

2.3

3.74

3.71

g/l

0.06

164

1159

Central retinal artery occlusion

391

1.80

4.74

3.6

2.5

3.99

3.58

g/l

0.79

353

Asthma mixed form (mode), excluding more controls

547

1.65

4.73

2.0

1.6

3.55

3.71

g/l

0.53

487

Type 1 diabetes, strict definition, subgroup 1

446

1.72

4.72

1.4

1.6

3.25

3.61

g/l

2.47

430

Dystonia

121

802

1.54

4.71

1.3

2.5

3.34

3.70

g/l

2.60

112

745

Dislocation, sprain and strain of joints and ligaments at neck level

264

2002

1.33

4.69

2.2

2.3

3.64

3.71

g/l

0.36

245

1874

Nonsuppurative otitis media

353

2405

1.28

4.69

2.0

2.1

3.57

3.69

g/l

1.08

333

2222

Crohn disease (strict definition, require KELA, min 2 HDR)

110

714

1.56

4.67

1.9

2.2

3.72

3.71

g/l

0.01

102

666

Other blood glucose lowering drugs, excl. Insulins

404

3243

1.26

4.66

1.8

2.4

3.92

3.68

g/l

3.03

374

2911

Other obstetric conditions, not elsewhere classified

318

1546

1.30

4.64

1.7

1.8

3.45

3.54

g/l

0.83

301

1482

Crohn disease (strict definition, require KELA)

112

731

1.55

4.64

1.9

2.2

3.71

g/l

0.00

104

683

Other arterial embolism and thrombosis

461

1.72

4.63

1.4

2.5

3.68

3.69

g/l

0.01

419

Salpingitis and oophoritis

345

2718

1.28

4.62

1.8

2.5

3.69

3.65

g/l

0.26

315

2494

Nontoxic multinodular goitre

463

3776

1.24

4.60

2.1

2.4

3.67

3.68

g/l

0.02

412

3405

Benign neoplasm of middle ear and respiratory system

187

1353

1.40

4.59

2.5

2.4

3.59

3.76

g/l

1.05

175

1242

Complications of labour and delivery

893

5758

0.86

4.59

2.5

2.2

3.69

3.61

g/l

0.68

834

5253

Lagophthalmos

202

2.13

4.58

2.0

2.2

3.62

3.83

g/l

0.37

186

Corneal scars and opacities

402

1.76

4.57

2.8

2.6

3.57

3.66

g/l

0.32

370

Disorders of optic nerve, not elsewhere classified

329

1.86

4.57

2.5

2.7

3.30

3.68

g/l

1.53

303

Burns and corrosions of external body surface, specified by site

205

1507

1.38

4.52

2.1

2.3

3.80

3.71

g/l

0.36

186

1410

Atrophic disorders of skin

333

2621

1.28

4.51

2.1

2.2

3.63

3.66

g/l

0.20

305

2378

Flat foot [pes planus] (acquired)

184

1332

1.40

4.47

1.8

2.6

3.52

3.60

g/l

0.32

166

1219

Other disorders of cornea

224

1675

1.36

4.46

2.0

2.3

3.68

3.69

g/l

0.05

208

1536

Spasmodic torticollis

435

1.72

4.46

1.4

2.1

3.53

3.73

g/l

0.71

407

Acute suppurative otitis media

350

2580

1.27

4.44

3.0

2.1

3.60

3.70

g/l

0.76

327

2422

Benign neoplasm: Liver/bile ducts

347

1.80

4.39

2.2

2.0

3.85

3.73

g/l

0.28

328

Status post-ami

703

4530

1.19

4.37

1.7

2.4

3.71

3.80

g/l

0.89

632

4039

Epiphora

356

1.80

4.36

2.3

2.4

3.65

3.72

g/l

0.17

326

Convalescence

111

735

1.54

4.36

2.1

3.39

3.76

g/l

2.27

671

Other noninflammatory disorders of vagina

158

1120

1.43

4.36

2.3

3.50

3.67

g/l

0.92

141

1013

Other neurotic disorders

106

696

1.55

4.34

1.6

2.6

3.76

3.77

g/l

0.04

635

Single delivery by forceps and vacuum extractor

834

0.63

4.34

1.6

3.80

3.64

g/l

0.53

790

Disorders of refraction and accommodation

511

4213

1.22

4.33

2.0

2.2

3.55

3.69

g/l

1.99

474

3908

Lichen planus, including avohilmo

447

3658

1.23

4.32

2.5

2.3

3.62

3.69

g/l

0.43

410

3333

Benign neoplasm of meninges

255

1954

1.32

4.32

1.9

2.4

3.41

3.69

g/l

3.39

226

1772

Retinal haemorrhage

440

1.71

4.32

4.0

2.7

4.07

3.64

g/l

0.63

401

Senility

126

2.37

4.32

1.7

2.0

3.37

3.70

g/l

0.65

114

Triptan medication for migraine, min. 3 purchases

926

6000

1.16

4.31

2.2

3.51

3.66

g/l

3.30

871

5588

Other predominantly sexually transmitted diseases, not elsewhere classified

238

1801

1.33

4.31

2.2

3.52

3.69

g/l

1.13

218

1699

Other lesions of median nerve

425

1.72

4.30

1.2

2.3

3.55

3.80

g/l

0.83

380

Lichen ruber planus, wide definition including periferal and oral lichen planus

527

4386

1.21

4.29

2.4

3.64

3.70

g/l

0.31

482

4001

Other and unspecified follicular disorders

532

1.63

4.28

3.0

2.4

3.76

3.80

g/l

0.11

502

Secondary parkinsonism, excluding more controls

335

1.80

4.27

2.9

2.1

3.65

3.86

g/l

0.33

308

Hyperfunction of pituitary gland

516

1.63

4.27

2.7

2.0

3.49

3.67

g/l

0.64

486

Contact with heat and hot substances

102

666

1.56

4.27

1.9

2.3

3.85

3.74

g/l

0.38

621

All dysplastic lesions of the cervix uteri, vagina or vulva

415

3285

1.24

4.25

2.2

2.0

3.52

3.59

g/l

0.51

383

3059

Viral infections of the central nervous system

140

976

1.45

4.25

2.3

3.65

3.68

g/l

0.06

127

900

Benign neoplasm: Parotid gland

188

1382

1.38

4.23

2.0

2.4

3.87

3.73

g/l

0.52

174

1270

Lichen planus

309

2434

1.28

4.23

2.8

2.3

3.67

3.66

g/l

0.03

282

2216

Corns and callosities

152

1078

1.43

4.23

2.3

3.46

3.76

g/l

1.98

140

992

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

117

788

1.50

4.22

1.9

2.3

3.70

3.73

g/l

0.11

109

734

Benign neoplasm: Spinal meninges

175

2.16

4.21

1.3

2.0

3.44

3.83

g/l

0.85

158

Benign neoplasm: Kidney

583

1.60

4.20

2.1

2.7

3.41

3.70

g/l

1.76

536

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

302

1477

1.29

4.20

1.5

1.8

3.46

3.54

g/l

0.70

286

1418

Malignant neoplasm of head and neck, including Hilmo

221

1665

1.34

4.20

2.7

1.4

3.57

3.78

g/l

1.39

204

1483

Other disorders of bone density and structure

301

1.84

4.16

1.9

2.1

3.47

3.71

g/l

0.65

283

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

157

1124

1.42

4.15

1.9

1.4

4.08

3.76

g/l

2.11

140

996

Maternal care for other conditions predominantly related to pregnancy

254

1900

1.31

4.15

2.0

3.54

3.59

g/l

0.28

242

1807

Status epilepticus

490

1.64

4.14

1.6

2.6

3.63

3.78

g/l

0.39

445

Meralgia paraesthetica

483

1.65

4.13

1.4

2.4

3.75

3.80

g/l

0.10

447

Arterial embolism and thrombosis of lower extremity artery

609

1.58

4.13

1.4

2.6

3.63

3.81

g/l

0.62

554

Other and unspecified mononeuropathies, also in other diseases

422

1.70

4.13

2.0

2.3

3.66

3.86

g/l

0.52

385

Disorders of synovium and tendon in diseases classified elsewhere

266

1.89

4.12

1.8

2.1

3.70

3.83

g/l

0.23

247

Malignant neoplasm of bladder

165

1192

1.40

4.11

1.9

1.4

3.83

3.80

g/l

0.07

148

1047

Lateral epicondylitis

240

1835

1.32

4.09

1.8

2.3

3.55

3.75

g/l

1.31

223

1697

Campylobacter enteritis

355

1.76

4.08

2.1

2.4

3.69

3.73

g/l

0.05

329

Subacute thyroiditis

508

1.63

4.08

2.6

2.3

3.64

3.76

g/l

0.39

468

Other noninflammatory disorders of uterus, except cervix

482

2655

1.22

4.05

2.4

2.3

3.73

3.69

g/l

0.14

432

2390

Other disorders of electrolyte and fluid balance, not elsewhere classified

118

2.39

4.05

1.6

3.66

3.78

g/l

0.13

104

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

282

3580

0.78

4.05

1.8

1.5

3.77

3.75

g/l

0.06

259

3224

Ectropion of eyelid

116

791

1.50

4.03

1.6

2.5

3.89

3.75

g/l

0.52

702

Contusion of other and unspecified parts of foot

555

1.59

4.03

2.0

2.3

3.53

3.63

g/l

0.33

521

Scar conditions and fibrosis of skin

509

1.62

4.03

2.0

2.2

3.64

3.79

g/l

0.41

471

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

583

4046

1.19

4.00

2.2

1.4

3.91

3.77

g/l

0.94

533

3625

Disorder of external ear, unspecified

488

1.63

3.98

2.7

2.6

3.82

3.75

g/l

0.10

455

Burns and corrosions of multiple and unspecified body regions

262

1.88

3.97

1.9

2.7

3.84

3.55

g/l

1.17

248

Congenital iodine-deficiency syndrome/hypothyroidism

458

1.66

3.97

3.2

1.9

3.48

3.77

g/l

0.89

415

Uterine polyps

573

2809

1.20

3.96

1.9

2.2

3.67

3.68

g/l

0.04

515

2543

Acne, including avohilmo

224

1371

1.33

3.96

1.7

1.8

3.71

3.65

g/l

0.32

212

1295

Benign neoplasm: Skin of ear and external auricular canal

100

665

1.54

3.93

2.4

2.5

3.99

3.76

g/l

0.31

607

Viral infections of the central nervous system, including avohilmo

149

1067

1.41

3.93

2.2

2.4

3.67

3.71

g/l

0.08

135

985

Benign neoplasm: Liver

300

1.81

3.92

2.2

2.1

3.82

3.70

g/l

0.27

284

Malignant neoplasm of digestive organs

928

6210

1.15

3.91

2.2

1.4

3.81

3.75

g/l

0.52

832

5571

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

266

2078

1.29

3.84

2.1

3.52

3.68

g/l

1.17

244

1963

Haemangioma and lymphangioma, any site

190

1421

1.35

3.84

2.7

2.4

3.58

3.69

g/l

0.38

178

1312

Benign neoplasm of eye and adnexa

250

1944

1.30

3.84

1.8

2.4

3.68

3.71

g/l

0.08

223

1783

Dissection of aorta

541

1.59

3.83

2.2

2.6

3.66

3.75

g/l

0.26

496

Carcinoma in situ of skin of ear and external auricular canal

304

1.82

3.83

1.8

2.4

3.53

3.68

g/l

0.35

266

Assault by bodily force

110

748

1.49

3.81

1.9

2.2

3.74

3.73

g/l

0.03

102

717

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

535

4509

1.19

3.79

1.8

2.3

3.68

3.70

g/l

0.14

491

4195

Allergic contact dermatitis due to drugs in contact with skin

319

1.77

3.77

2.1

3.73

3.71

g/l

0.04

298

Acquired absence of limb

142

2.21

3.76

2.3

1.8

4.00

3.75

g/l

0.37

132

Congenital malformations of cardiac septa

108

711

1.49

3.75

1.6

2.3

3.65

3.71

g/l

0.23

664

Complications peculiar to reattachment and amputation

2.55

3.75

1.9

2.6

3.73

3.85

g/l

0.11

Pre-eclampsia or eclampsia

337

2720

1.25

3.73

2.4

2.2

3.53

3.63

g/l

0.77

315

2521

Malignant neoplasm of colon

364

2971

1.24

3.68

2.8

1.4

3.86

3.76

g/l

0.56

329

2643

Other female pelvic inflammatory diseases

309

2478

1.26

3.66

1.7

2.4

3.70

3.62

g/l

0.24

257

2259

Benign neoplasm: Skin of eyelid, including canthus

371

3038

1.23

3.65

3.2

2.3

3.54

3.70

g/l

1.81

330

2766

Pedestrian injured in transport accident

143

1032

1.40

3.64

1.7

2.3

3.72

3.70

g/l

0.03

131

952

Pre-eclampsia or poor fetal growth

419

3451

1.21

3.63

2.3

2.1

3.48

3.61

g/l

1.39

392

3214

Single spontaneous delivery

666

4091

0.85

3.63

2.6

2.1

3.61

3.65

g/l

0.25

613

3654

Disturbance of activity and attention

112

752

1.46

3.62

1.4

1.6

3.39

3.65

g/l

2.25

106

724

Amyloidosis of skin

7.27

3.61

3.0

1.1

2.66

3.91

g/l

—

Malnutrition

316

1.76

3.61

1.7

2.1

3.45

3.71

g/l

0.68

286

Haemangioma, any site

178

1333

1.35

3.60

2.5

3.61

3.70

g/l

0.25

166

1229

Pneumonitis due to solids and liquids

203

1551

1.33

3.58

2.2

3.94

3.76

g/l

0.69

171

1406

Focal epilepsy, strict definition

426

3541

1.21

3.57

2.0

2.3

3.58

3.74

g/l

1.29

378

3244

Degeneration of nervous system due to alcohol

340

1.73

3.57

1.2

2.7

3.98

3.81

g/l

0.40

314

Procedures for purposes other than remedying health state

309

1.76

3.57

1.9

1.7

3.37

3.73

g/l

1.50

290

HSIL lesion of the cervix uteri, vagina or vulva

270

2136

1.27

3.57

2.1

2.0

3.67

3.62

g/l

0.24

246

1993

Other congenital malformations of the digestive system, including avohilmo

585

1.53

3.55

1.5

2.5

3.61

3.70

g/l

0.28

541

Other facial nerve disorders

378

1.68

3.54

2.1

3.75

3.78

g/l

0.04

346

Contusion of toe(s) without damage to nail

272

1.80

3.54

1.2

2.5

3.39

3.72

g/l

1.21

261

Crohn disease (strict definition, all UC cases excluded)

582

1.53

3.54

1.7

2.4

3.65

3.74

g/l

0.26

543

Sixth [abducent] nerve palsy

536

1.56

3.53

2.6

4.04

3.72

g/l

0.38

486

Benign neoplasm: Pancreas

506

1.59

3.51

2.5

2.8

3.48

3.76

g/l

1.21

463

Viral encephalitis, not elsewhere classified/unspecified

274

1.80

3.50

3.3

2.4

4.05

3.74

g/l

0.29

252

Sequelae of injuries of neck and trunk

395

1.65

3.49

3.2

2.6

4.06

3.76

g/l

0.47

368

Hyperkinetic disorders

117

798

1.44

3.48

1.4

1.6

3.42

3.64

g/l

1.80

111

766

Focal epilepsy

451

3778

1.20

3.48

2.0

2.3

3.58

3.74

g/l

1.40

401

3461

Sequelae of injuries of head

103

707

1.48

3.47

2.7

2.4

4.03

3.73

g/l

0.84

657

Degeneration of the brain due to alcohol

343

1.71

3.47

1.2

2.7

3.98

3.78

g/l

0.51

316

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

5.66

3.45

2.8

1.1

2.63

3.86

g/l

—

conjunctival haemorrhage

186

1413

1.34

3.45

2.4

2.3

3.51

3.73

g/l

1.98

171

1291

Use of rivastigmine

317

3877

0.81

3.45

2.5

2.3

3.73

3.69

g/l

0.16

269

3418

Polyp of the female genital tract

591

2853

1.18

3.43

1.9

2.2

3.61

3.68

g/l

0.55

538

2581

Other disorders of the genitourinary system

303

2448

1.25

3.43

2.2

2.3

3.67

3.68

g/l

0.04

275

2208

Nonspecific lymphadenitis

106

734

1.46

3.41

1.8

2.2

3.40

3.72

g/l

1.83

101

688

Delivery

672

4093

0.86

3.39

2.5

2.1

3.61

3.65

g/l

0.24

621

3656

Other and unspecified mononeuropathies of upper limb

375

1.66

3.39

1.6

2.4

4.03

3.80

g/l

0.31

353

120

1667

0.71

3.38

1.3

2.3

4.54

3.75

g/l

5.40

1526

Brain meningioma, including Hilmo

114

804

1.44

3.36

2.2

1.4

3.54

3.69

g/l

0.69

105

707

Acute alcohol intoxication, ICD10

400

3327

1.21

3.36

1.4

2.4

3.93

3.73

g/l

2.31

363

3114

Other disorders of Eustachian tube

424

1.61

3.32

1.6

2.3

3.47

3.78

g/l

1.16

394

Strabismus

503

4261

1.18

3.32

2.2

2.3

3.69

g/l

0.02

465

3917

Medial epicondylitis

447

1.59

3.32

1.4

2.2

3.46

3.82

g/l

1.67

421

Vascular dementia

269

2076

1.26

3.31

2.6

2.3

3.81

3.66

g/l

0.63

229

1838

Melanoma in situ of trunk

273

1.79

3.29

2.3

2.7

3.34

3.75

g/l

1.22

250

Chorioretinal inflammation

410

1.62

3.28

1.6

2.2

3.48

3.65

g/l

0.26

382

Paralytic strabismus

163

1225

1.35

3.28

2.1

2.4

3.86

3.72

g/l

0.26

149

1126

Vulvovaginal ulceration/inflammation in other diseases

106

740

1.45

3.27

1.8

2.3

3.45

3.67

g/l

1.21

694

Malignant neoplasm of liver and intrahepatic bile ducts

490

1.56

3.26

1.9

1.4

4.21

3.77

g/l

1.65

437

Macular cyst

572

1.52

3.25

2.3

2.7

3.58

3.70

g/l

0.34

524

Reduction defects of unspecified limb

9.30

3.24

1.0

2.95

2.94

g/l

—

Appendectomy

1313

11314

1.11

3.22

2.4

2.3

3.71

g/l

0.01

1206

10452

Prepatellar bursitis

620

1.49

3.22

2.5

2.3

3.70

3.81

g/l

0.25

572

Postpartum hemorraghe, parous women as controls

184

2003

0.76

3.22

1.9

2.1

3.51

3.59

g/l

0.34

170

1901

Schizophrenia or delusion, excluding more controls

518

4367

1.18

3.21

2.0

2.4

3.67

3.71

g/l

0.28

466

4056

Alzheimer’s disease (Atypical or mixed)

207

2602

0.78

3.19

1.8

2.2

3.64

3.69

g/l

0.22

174

2283

Malignant neoplasm of small intestine, including Hilmo

477

1.56

3.19

2.1

1.4

3.66

3.74

g/l

0.17

425

Congenital malformations of heart and great arteries

214

1622

1.29

3.18

2.1

2.3

3.59

3.74

g/l

1.13

195

1509

Trigeminal neuralgia

125

905

1.40

3.18

2.4

2.3

3.70

3.76

g/l

0.15

116

829

Hereditary angioödema type 1

6.90

3.18

10.1

1.0

6.87

3.96

g/l

—

Other problems related to primary support group, including family circumstances

141

1009

1.37

3.18

1.8

2.1

3.56

3.66

g/l

0.48

132

950

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

170

1289

1.33

3.18

2.2

2.4

3.60

3.74

g/l

0.59

154

1183

Injury of nerves and spinal cord at neck level

321

1.69

3.16

2.6

2.8

3.45

3.74

g/l

0.88

294

Residual foreign body in soft tissue

622

1.48

3.16

2.0

2.4

3.66

3.78

g/l

0.29

583

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

283

1.74

3.16

3.3

2.4

4.05

3.73

g/l

0.31

261

Malignant neoplasm of head and neck

179

1370

1.32

3.16

2.1

1.4

3.54

3.77

g/l

1.44

165

1223

Abnormal spermatozoa

210

2665

0.78

3.15

2.0

2.5

3.92

3.75

g/l

0.39

193

2448

Other and unspecified mononeuropathies of lower limb

407

1.61

3.14

1.7

2.1

3.47

3.78

g/l

1.44

373

Haemorrhagic disorder due to circulating anticoagulants

247

1.81

3.14

1.9

2.4

4.04

3.76

g/l

0.56

222

Polypectomy (DHB20)

144

1070

1.36

3.13

2.7

2.4

3.83

3.77

g/l

0.23

135

991

Brain meningioma

110

782

1.43

3.13

2.3

1.4

3.55

3.69

g/l

0.61

101

688

Melanocytic naevi of upper limb, including shoulder

314

1.69

3.13

1.9

2.3

3.47

3.80

g/l

0.99

295

Physiological and behavioural disorders associated with sexual development and orientation

8.12

3.12

1.0

5.8

3.60

3.76

g/l

—

Asthma mixed form (mode)

607

1.48

3.12

2.0

1.7

3.55

3.72

g/l

0.58

543

Maternal care related to the fetus and amniotic cavity and possible delivery problems

485

3343

0.85

3.11

2.6

2.1

3.65

3.62

g/l

0.17

460

3119

Sequelae of injuries of upper limb

188

1452

1.31

3.10

2.6

2.5

3.91

3.72

g/l

0.32

170

1348

Alzheimer disease

800

6466

0.88

3.10

1.9

2.3

3.82

3.71

g/l

0.94

671

5748

Endocrine disorders, other/unspecified

246

0.36

3.10

1.4

2.2

4.44

3.80

g/l

—

233

Myocardial infarction, with ST-elevation

441

3736

1.19

3.09

1.8

2.3

3.79

3.75

g/l

0.27

406

3366

Medical abortion

1237

6039

1.11

3.07

1.8

2.4

3.64

3.61

g/l

0.27

1109

5464

Corneal ulcer

361

3003

1.21

3.07

2.3

2.2

3.69

3.70

g/l

0.03

333

2766

Postpartum hemorraghe, all women as controls

184

2315

0.77

3.06

1.9

2.0

3.51

3.59

g/l

0.35

170

2196

Other and unspecified disorders of skin and subcutaneous tissue

137

1015

1.37

3.05

1.8

2.4

3.37

3.77

g/l

1.65

110

932

Benign neoplasm: Cerebral meninges

226

1794

1.28

3.04

2.0

2.4

3.39

3.69

g/l

3.55

204

1633

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

175

1.92

3.04

2.6

2.2

3.77

3.58

g/l

0.41

166

Graves disease, strict definition

182

1405

1.31

3.02

2.4

2.2

3.66

3.69

g/l

0.10

167

1307

Arthropathy in Crohn disease

114

2.18

3.01

1.0

2.3

3.80

3.64

g/l

0.25

109

Inflammatory diseases of prostate (prostatitis)

285

2324

1.24

3.00

2.1

2.5

3.68

3.88

g/l

1.49

268

2148

Palindromic rheumatism

121

2.14

2.99

1.4

1.9

3.66

3.44

g/l

0.41

111

Noninflammatory disorders of female genital tract

690

3020

1.15

2.95

2.3

2.2

3.67

g/l

0.02

626

2741

Other diseases of gallbladder

106

758

1.42

2.95

2.6

2.5

3.63

3.65

g/l

0.06

685

Graves ophthalmopathy, strict

305

1.68

2.93

1.1

2.0

4.12

3.80

g/l

0.26

285

Schizophrenia

179

2298

0.77

2.92

2.4

2.3

3.68

3.72

g/l

0.14

160

2149

Benign neoplasm of breast

243

1954

1.26

2.92

2.2

3.57

3.65

g/l

0.34

217

1764

Recurrent and persistent haematuria

109

2.19

2.92

1.3

2.5

3.92

3.56

g/l

0.65

101

Tracheo-bronchomalasia

4.24

2.92

1.7

3.8

3.61

3.25

g/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

392

1.59

2.90

2.1

2.3

3.77

3.74

g/l

0.05

355

Focal brain injury

126

929

1.37

2.89

2.1

2.4

3.88

3.75

g/l

0.32

109

858

Conductive hearing loss, unspecified

169

1303

1.31

2.87

2.2

2.3

3.73

3.74

g/l

0.05

156

1200

Alzheimer’s disease (Early onset), excluding more controls

609

0.58

2.85

1.2

2.2

4.00

3.74

g/l

0.62

542

Dislocation of lens

239

1.76

2.85

2.7

2.5

3.42

3.68

g/l

0.85

225

Congenital obstruction of the pelviureteric junction

2.25

2.84

3.3

2.4

3.75

3.62

g/l

0.22

Examination and encounter for administrative purposes

156

1191

1.32

2.84

2.5

2.4

4.10

3.89

g/l

0.36

146

1096

Benign neoplasm: Prostate

118

2.15

2.83

3.7

3.0

3.81

3.69

g/l

0.12

104

Other factor of the environment

159

1.94

2.82

3.4

1.9

3.76

3.83

g/l

0.05

149

Atopic conjunctivitis

498

1.50

2.82

1.5

2.0

3.62

3.70

g/l

0.24

465

Other peripheral vertigo

212

1688

1.27

2.81

1.8

2.5

3.47

3.70

g/l

2.19

190

1546

Ventricular septal defect, a heart condition

158

1.92

2.81

1.5

1.8

3.51

3.58

g/l

0.13

150

Benign neoplasm: Larynx

492

1.51

2.80

2.5

2.6

3.65

3.80

g/l

0.38

452

Ingrowing nail

689

1.43

2.80

2.1

2.4

3.79

3.72

g/l

0.16

639

Benign neoplasm of other and unspecified intrathoracic organs

160

1.95

2.79

2.8

2.2

3.56

3.63

g/l

0.12

147

Leiomyoma of uterus

1265

6446

1.10

2.79

2.3

2.2

3.58

3.64

g/l

0.58

1127

5845

HSIL lesion of the cervix uteri

224

1792

1.26

2.79

1.9

2.1

3.68

3.63

g/l

0.24

207

1685

Mental and behavioural disorders due to cannabinoids

173

1.87

2.78

1.7

1.6

4.05

3.70

g/l

0.77

167

Malignant neoplasm of oral cavity, including Hilmo

657

1.44

2.78

2.3

1.4

3.57

3.78

g/l

0.82

587

Other disorders of conjunctiva

334

2791

1.21

2.78

2.7

2.3

3.67

3.71

g/l

0.12

310

2543

All dysplastic lesions of the cervix uteri

329

2696

1.21

2.77

2.1

3.56

3.59

g/l

0.20

307

2527

Other diseases of spinal cord

420

1.55

2.77

2.6

2.7

3.61

3.78

g/l

0.51

390

Ulcerative rectosigmoiditis

144

1091

1.33

2.77

1.9

2.4

3.86

3.67

g/l

0.87

131

1021

Lung diseases due to external agents

338

2829

1.21

2.76

2.8

2.3

3.87

3.72

g/l

0.84

295

2562

Vascular dementia (subcortical)

101

727

1.42

2.76

3.3

2.2

4.01

3.71

g/l

0.86

645

Non-small cell lung cancer, including Hilmo

354

2789

1.20

2.76

2.0

1.4

3.96

3.77

g/l

0.92

321

2490

Vertigo of central origin

257

1.72

2.75

2.0

2.7

3.28

3.74

g/l

1.22

232

Malignant neoplasm of endocrine gland, including Hilmo

154

1180

1.32

2.75

2.7

1.4

3.60

3.70

g/l

0.50

141

1055

Pre-eclampsia

294

2427

1.22

2.74

2.6

2.2

3.53

3.61

g/l

0.48

272

2253

Laparoscopic right hemicolectomy

150

1149

1.33

2.74

2.4

2.5

3.92

3.73

g/l

0.45

130

1043

Proteinuria and renal glomerular damage; focal glomerulonephritis

4.66

2.72

1.3

3.0

3.74

3.61

g/l

—

Unspecific neurodegenerative disorder

1055

7973

0.90

2.71

2.0

2.4

3.78

3.72

g/l

0.53

872

7173

Hereditary sideroblastic anaemia

2.82

2.71

2.8

1.5

3.77

3.32

g/l

0.63

Foreign body entering into or through eye or natural orifice

147

1122

1.32

2.70

2.6

2.3

3.74

3.72

g/l

0.06

133

1051

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

6.59

2.69

1.0

2.92

4.17

g/l

—

Colorectal cancer

556

4652

1.15

2.69

2.7

1.4

3.83

3.75

g/l

0.55

500

4146

Blindness, monocular

141

1.99

2.68

4.3

2.0

4.47

3.78

g/l

0.43

131

Lifestyle-related condition

148

1.95

2.67

3.6

1.9

3.71

3.88

g/l

0.12

137

Other drug-induced secondary parkinsonism

156

1.93

2.65

2.3

3.26

3.68

g/l

0.96

145

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

277

2282

1.22

2.65

2.1

2.2

3.52

3.59

g/l

0.52

257

2101

Other puerperal infections

537

1.46

2.64

1.7

3.38

3.68

g/l

1.69

515

Personal history of certain other diseases

127

2.00

2.63

1.2

1.6

3.75

3.71

g/l

0.06

118

Granuloma annulare

200

1.80

2.62

1.9

3.45

3.86

g/l

1.06

187

Seminoma of testis, including Hilmo

2.36

2.62

1.6

1.4

3.40

3.53

g/l

0.26

Moyamoya

7.81

2.61

1.2

1.0

2.68

3.43

g/l

—

Pyoderma

253

1.70

2.61

1.9

2.3

3.75

3.71

g/l

0.06

237

Osteochondrodysplasia with defects of growth of tubular bones and spine

5.84

2.60

1.0

1.2

3.62

3.18

g/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1426

8864

1.09

2.59

2.2

2.3

3.57

3.68

g/l

2.46

1331

8191

Triptan medication for migraine, single purchase ok

1426

8864

1.09

2.59

2.2

2.3

3.57

3.68

g/l

2.46

1331

8191

Chromophobe cell carcinoma of kidney

2.39

2.59

2.3

1.2

3.01

3.72

g/l

2.26

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.98

2.59

11.9

1.1

3.30

3.97

g/l

—

Acute alcohol intoxication

536

4681

1.15

2.57

1.5

2.5

3.88

3.75

g/l

1.55

484

4349

Other acquired deformities of musculoskeletal system and connective tissue

651

1.42

2.57

2.4

2.3

4.08

3.66

g/l

0.60

601

Other changes in lacrimal passages

4.23

2.56

2.9

1.6

3.16

3.63

g/l

—

Use of disulfiram, acamprosate or naltrexone

151

1166

1.31

2.56

1.6

2.3

3.82

3.75

g/l

0.21

135

1099

Meningitis

668

1.41

2.55

3.1

2.3

3.92

3.66

g/l

0.36

622

Delivery, wide proxy

561

3403

0.87

2.54

2.4

2.0

3.70

3.63

g/l

0.35

514

3003

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

112

831

1.37

2.54

1.7

1.4

4.14

3.75

g/l

2.00

731

Melanoma in situ of other and unspecified parts of face

249

1.71

2.53

2.2

2.6

3.48

3.75

g/l

0.71

226

Injuries involving multiple body regions

486

1.48

2.53

2.3

3.85

3.73

g/l

0.34

453

Septal defects

671

1.40

2.52

1.7

2.3

3.53

3.72

g/l

0.95

627

Myopia

189

1504

1.26

2.51

2.0

2.3

3.59

3.74

g/l

0.91

179

1407

Benign neoplasm: Choroid

156

1216

1.30

2.51

1.7

2.6

3.42

3.73

g/l

2.22

137

1114

Unspecified mental disorder

737

6581

1.12

2.47

2.0

2.3

3.70

3.71

g/l

0.04

680

6068

Diseases of appendix

1570

12982

1.08

2.47

2.6

2.3

3.66

3.73

g/l

1.05

1439

11969

Bitten or struck by other mammals

188

1500

1.26

2.46

3.0

2.4

3.39

3.70

g/l

3.49

178

1395

Convergent concomitant strabismus

588

1.43

2.46

2.3

2.2

3.76

3.69

g/l

0.12

548

Thyroiditis, unspecified

197

1.77

2.45

1.3

1.8

3.59

3.86

g/l

0.62

184

Presbycusis

402

3413

1.17

2.44

2.5

2.2

3.73

3.76

g/l

0.10

346

3035

Other maternal disorders predominantly related to pregnancy

758

5303

0.89

2.44

2.3

3.53

3.62

g/l

1.26

708

4903

Malignant neoplasm of thymus, including Hilmo

2.55

2.44

4.7

1.2

3.19

3.66

g/l

1.33

Respiratory tuberculosis, confirmed

274

1.64

2.43

1.8

2.4

3.69

3.77

g/l

0.12

247

Systemic sclerosis,strict definition

125

1.99

2.42

1.4

1.8

3.14

3.66

g/l

2.14

118

Respiratory tuberculosis, confirmed, including avohilmo

283

1.63

2.40

1.9

2.4

3.68

3.75

g/l

0.10

255

Other and unspecified primary disorders of muscles

2.17

2.39

1.4

2.6

3.48

3.57

g/l

0.27

Congenital varicose veins

2.93

2.39

2.4

2.1

3.44

3.79

g/l

0.58

Malignant neoplasm of small intestine

347

1.56

2.38

2.5

1.4

3.66

3.74

g/l

0.13

309

Dentofacial anomalies [including malocclusion]

1344

9676

1.09

2.38

2.3

3.56

3.68

g/l

2.91

1235

8948

Car occupant injured in other and unspecified transport accidents

316

2668

1.19

2.37

2.0

2.2

3.81

3.74

g/l

0.29

290

2477

Other and unspecified abdominal hernia

679

1.39

2.37

1.6

2.1

3.79

3.72

g/l

0.23

623

Ménière disease

209

1699

1.24

2.36

1.9

2.5

3.66

3.71

g/l

0.17

190

1552

Chondromalacia

380

1.53

2.35

1.5

2.2

3.62

3.75

g/l

0.33

363

Explicit viral Sepsis

6.79

2.34

1.2

1.0

3.12

4.08

g/l

—

Inguinal or femoral hernia, bilateral

251

2081

1.22

2.34

2.7

2.4

3.75

g/l

0.02

224

1907

Acute appendicitis

1437

12325

1.08

2.34

2.6

2.3

3.67

3.73

g/l

0.84

1322

11379

Inguinal hernia, bilateral

247

2045

1.22

2.34

2.7

2.4

3.76

3.74

g/l

0.07

220

1873

Occupational exposure to risk-factors

522

0.58

2.33

3.7

2.7

2.88

3.73

g/l

3.20

487

Explicit viral Sepsis, including avohilmo

6.56

2.32

1.2

1.0

3.12

4.08

g/l

—

Dronedarone medication

464

1.47

2.31

2.3

2.6

3.59

3.84

g/l

0.88

413

Nontoxic single thyroid nodule

150

1177

1.29

2.31

2.4

2.3

3.52

3.74

g/l

0.92

140

1078

Malignant neoplasm of pancreas

1221

0.73

2.30

1.7

1.4

3.62

3.76

g/l

0.43

1082

Acute appendicitis, no complications

1061

9636

1.10

2.30

2.6

2.3

3.67

3.73

g/l

0.64

982

8945

Effects of foreign body entering through natural orifice

467

4077

1.15

2.30

2.2

2.4

3.63

3.76

g/l

1.38

427

3789

Disorders of lacrimal system and orbit in diseases classified elsewhere

342

1.55

2.29

1.1

2.0

4.12

3.74

g/l

0.33

320

Neovascular glaucoma

683

1.38

2.29

2.4

2.3

3.88

3.69

g/l

0.41

619

Other acute skin changes due to ultraviolet radiation

531

1.44

2.29

2.0

2.3

3.82

3.74

g/l

0.21

487

hereditary angioödema type 3

6.24

2.29

1.0

3.44

3.31

g/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

387

3334

1.17

2.29

2.1

2.3

3.57

3.74

g/l

1.23

339

3057

Malignant neoplasm of thyroid gland, including Hilmo

135

1046

1.30

2.28

2.6

1.4

3.63

3.68

g/l

0.19

122

935

Hypertrophic disorders of skin

665

1.38

2.28

2.5

2.2

3.73

3.75

g/l

0.05

621

Perforation of tympanic membrane

198

1608

1.24

2.26

2.3

3.51

3.73

g/l

1.66

180

1469

Carcinoma in situ of other and unspecified sites

106

798

1.35

2.26

2.9

2.5

3.71

3.72

g/l

0.03

732

Glaucoma secondary to other eye disorders

685

1.38

2.25

2.4

2.6

3.88

3.68

g/l

0.44

621

Varicose veins of other sites

124

952

1.32

2.25

2.7

2.3

3.69

3.70

g/l

0.03

108

882

Open wound of wrist and hand

900

7893

1.10

2.25

2.4

2.3

3.66

3.75

g/l

1.29

839

7318

Graves ophthalmopathy

344

1.54

2.24

1.1

2.0

4.12

3.77

g/l

0.30

320

Contact with and exposure to communicable diseases

382

3275

1.16

2.24

2.2

2.1

3.51

3.65

g/l

1.26

371

3086

Abdominal aortic aneurysm (AAA)

243

2002

1.21

2.23

1.8

2.3

3.83

3.79

g/l

0.18

217

1788

Other disorders of breast

243

2019

1.21

2.21

2.3

3.52

3.64

g/l

0.27

213

1845

Alport

4.66

2.21

1.5

3.8

3.18

4.08

g/l

—

Burn and corrosion of wrist and hand

426

1.47

2.21

1.6

2.3

3.45

3.75

g/l

0.94

401

Use of galantamine

139

1763

0.78

2.20

1.6

2.4

3.90

3.72

g/l

0.83

107

1558

Non-small cell lung cancer, adenocarcinoma

143

1124

1.29

2.20

1.8

1.4

3.86

3.76

g/l

0.28

129

995

Hepatocellular carcinoma

346

1.53

2.19

2.2

1.4

4.29

3.69

g/l

2.13

305

Appendicitis, broad definition

1545

12884

1.08

2.19

2.6

2.3

3.66

3.73

g/l

1.09

1418

11881

Carcinoma in situ, bladder

725

1.36

2.18

3.1

2.6

3.73

g/l

0.01

666

Injury of other and unspecified intrathoracic organs

133

1038

1.30

2.16

1.9

2.3

3.70

3.75

g/l

0.20

125

955

Diseases of middle ear and mastoid

1064

7960

1.09

2.15

2.5

2.2

3.64

3.69

g/l

0.51

995

7326

Corneal degeneration

276

1.60

2.14

1.4

2.4

3.93

3.61

g/l

1.27

253

Malignant neoplasm of stomach, including Hilmo

125

969

1.30

2.13

1.3

1.4

3.48

3.76

g/l

2.16

114

851

Otitis media, unspecified

143

1036

1.28

2.12

2.8

2.1

3.50

3.71

g/l

1.40

138

963

Acute nasopharyngitis (common cold)

192

1555

1.23

2.09

1.9

2.1

3.76

3.83

g/l

0.32

181

1462

Pedal cyclist injured in noncollision transport accidents

203

1668

1.23

2.09

1.8

2.3

3.56

3.73

g/l

1.27

183

1554

Abrasion of teeth

739

6679

1.11

2.08

2.5

2.4

3.51

3.70

g/l

3.76

679

6138

Felty syndrome

2.15

2.08

1.7

2.2

4.02

3.91

g/l

0.06

Respiratory tuberculosis, bacteriologically and histologically confirmed

286

1.57

2.08

1.8

2.5

3.69

3.74

g/l

0.08

257

Other and unspecified injuries of thorax

231

1.63

2.06

2.7

2.4

3.71

3.74

g/l

0.04

211

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

109

833

1.32

2.06

2.1

2.4

3.60

3.68

g/l

0.34

104

789

Maternal care for known or suspected abnormality of pelvic organs

217

1768

0.83

2.05

2.7

2.1

3.58

3.61

g/l

0.07

204

1668

Atrial septal defect

389

1.47

2.05

1.9

2.1

3.78

3.73

g/l

0.10

363

Other and unspecified disorders of orbit

2.24

2.04

1.5

2.6

4.05

4.01

g/l

0.03

Benign lipomatous neoplasm

638

5730

1.12

2.04

2.5

2.4

3.53

3.69

g/l

2.02

590

5237

Hypertrophic scar

602

1.38

2.04

2.6

2.2

3.72

3.77

g/l

0.11

560

Other strabismus

366

3161

1.16

2.02

2.2

2.3

3.67

3.70

g/l

0.10

340

2919

Pilonidal cyst

115

889

1.30

2.00

2.0

2.1

3.98

3.78

g/l

0.76

107

846

Benign neoplasm: Skin of other and unspecified parts of face

234

1961

1.20

2.00

3.5

2.4

3.51

3.72

g/l

1.67

208

1789

Vascular dementia (undefined)

107

814

1.32

1.99

2.1

3.72

g/l

0.01

713

Alkalosis

3.14

1.98

2.1

2.6

3.68

3.67

g/l

—

All dysplastic lesions of the vagina

338

1.50

1.97

2.4

2.0

3.52

3.73

g/l

0.64

319

Malignant neoplasm of endocrine gland

129

1018

1.28

1.94

2.2

1.4

3.65

3.71

g/l

0.22

120

910

Malignant neoplasm of bronchus and lung, including Hilmo

499

3692

1.13

1.94

2.1

1.5

3.99

3.78

g/l

1.48

455

3301

Fall on and from ladder

162

1315

1.24

1.93

3.4

2.5

3.69

3.79

g/l

0.20

149

1215

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

127

1002

1.28

1.92

2.4

1.4

3.47

3.76

g/l

2.03

114

893

Suppurative and unspecified otitis media

539

4256

1.12

1.91

2.8

2.1

3.61

3.70

g/l

0.86

508

3950

Pleural plaque without asbestos

759

1.33

1.91

2.0

2.5

4.02

3.78

g/l

0.42

684

Alzheimer disease, including avohilmo

943

7100

0.91

1.89

2.0

2.3

3.78

3.73

g/l

0.39

793

6339

Benign neoplasm: Other parts of oropharynx

137

1.81

1.88

3.2

1.8

4.08

3.68

g/l

0.38

128

Cysts of oral region, not elsewhere classified

112

873

1.30

1.88

3.0

2.4

3.67

3.74

g/l

0.27

102

809

Schizoaffective disorder

116

908

1.29

1.87

1.8

2.3

3.62

3.66

g/l

0.12

106

854

Recurrent dislocation of patella

333

1.48

1.87

1.5

2.0

3.65

3.44

g/l

0.67

319

Carcinoma in situ of skin of lip

2.32

1.86

1.2

1.4

3.47

3.77

g/l

0.63

Contraceptive management

521

4080

0.89

1.86

2.3

2.2

3.70

3.73

g/l

0.07

487

3849

Other disorders of skin and subcutaneous tissue related to radiation

3.30

1.86

1.1

3.76

4.11

g/l

—

Oral lichen planus

452

1.42

1.86

2.7

2.4

3.55

3.73

g/l

0.33

418

Contact with other hot metals

183

1.67

1.85

1.5

2.4

3.91

3.56

g/l

0.90

169

Hereditary lymphedema, including avohilmo

2.96

1.85

1.0

1.6

3.91

3.79

g/l

—

Malignant neoplasm of stomach

107

831

1.30

1.85

1.3

1.4

3.43

3.79

g/l

2.87

734

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

538

4671

1.12

1.84

3.0

1.4

3.82

3.76

g/l

0.33

492

4215

Tuberculosis, IBD comorbidity

157

1279

1.24

1.83

2.2

3.68

3.75

g/l

0.24

136

1149

Use of peginterferon beta-1a

2.85

1.82

1.9

1.3

2.76

3.72

g/l

—

Glaucoma suspect

764

8354

0.91

1.81

2.3

2.4

3.64

3.72

g/l

0.67

693

7543

Benign mammary dysplasia

287

2472

1.17

1.80

2.6

2.3

3.55

3.65

g/l

0.65

257

2224

Other sideroblastic anaemias

2.34

1.79

1.2

1.4

4.33

3.69

g/l

0.33

Other disorders of male genital organs

488

1.39

1.79

1.6

2.5

3.72

3.82

g/l

0.24

452

Foreign body in alimentary tract

106

827

1.30

1.79

1.6

2.4

3.74

3.70

g/l

0.14

760

Use of levodopa decarboxylase inhibitor

356

3119

1.15

1.78

2.0

2.4

3.58

3.73

g/l

1.47

314

2803

Follow-up care involving plastic surgery

506

1.38

1.78

1.7

2.0

3.48

3.74

g/l

0.71

466

Amblyopia ex anopsia

455

1.40

1.77

1.4

2.1

3.57

3.74

g/l

0.50

427

Embedded teeth, including avohilmo

756

1.30

1.77

2.6

1.9

3.58

3.70

g/l

0.38

713

Endometriosis of pelvic peritoneum

240

1852

1.18

1.76

1.5

2.3

3.47

3.67

g/l

1.64

218

1699

Chalazion

211

1776

1.20

1.75

3.1

2.4

3.52

3.73

g/l

1.63

192

1642

Other intracranial haemorrhages

560

1.36

1.75

2.1

2.5

3.74

3.81

g/l

0.13

504

Benign neoplasm: other/unspecified salivary gland

433

1.41

1.73

1.5

2.4

3.95

3.75

g/l

0.40

394

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

694

0.70

1.72

1.9

2.2

3.53

3.67

g/l

0.46

644

Congenital malformations of genital organs

111

869

1.28

1.71

1.7

2.0

3.60

3.65

g/l

0.17

104

821

Malignant neoplasm of oral cavity

510

1.37

1.71

2.0

1.4

3.58

3.73

g/l

0.39

455

Other specified disorders of external ear

623

1.33

1.71

2.0

2.6

3.98

3.80

g/l

0.48

579

Oral lichen planus, including avohilmo , including avohilmo

147

1200

1.24

1.70

2.5

3.61

3.70

g/l

0.31

133

1104

Myositis ossificans

2.70

1.69

2.1

2.5

4.22

3.72

g/l

—

Other diseases of peritoneum

711

1.31

1.69

1.7

2.5

3.64

3.69

g/l

0.12

652

Tuberculosis, wide, including avohilmo

165

1365

1.22

1.68

2.2

2.4

3.70

3.75

g/l

0.16

143

1227

Colorectal neuroendocrine tumor and carcinoma

165

1.67

1.68

4.4

1.3

3.23

3.72

g/l

2.11

150

Other diseases of biliary tract

195

1639

1.20

1.67

2.3

2.4

3.59

3.68

g/l

0.57

176

1489

Other contact dermatitis

136

1102

1.24

1.67

1.8

2.5

3.78

3.66

g/l

0.28

118

1014

Colon adenocarcinoma

273

2360

1.16

1.66

2.8

1.4

3.85

3.74

g/l

0.46

243

2092

Parkinson's disease, including avohilmo

400

3551

1.13

1.66

1.8

2.4

3.57

3.76

g/l

2.20

351

3197

Maze procedure for atrial fibrillation

2.05

1.65

1.3

1.9

4.25

3.65

g/l

0.75

Injury of muscle and tendon at shoulder and upper arm level

829

7636

1.09

1.64

2.3

2.4

3.67

3.76

g/l

1.41

759

7052

Benign neoplasm: Endocrine pancreas

106

1.86

1.64

1.7

2.4

3.73

3.90

g/l

0.16

100

Mixed conductive and sensorineural hearing loss

285

2475

1.16

1.64

2.5

2.3

3.61

3.76

g/l

0.74

250

2250

Cytomegaloviral hepatitis

2.63

1.63

1.9

2.3

3.71

3.80

g/l

—

Malignant neoplasm of hypopharynx, including Hilmo

1.97

1.63

4.1

1.2

3.57

3.74

g/l

0.23

Other and unspecified intracranial injuries

429

1.39

1.63

1.9

2.4

4.05

3.70

g/l

0.66

393

Other and unspecified degenerative diseases of nervous system

525

1.36

1.62

2.1

2.5

3.80

3.67

g/l

0.29

477

Neuroendocrine tumor and carcinoma of rectum

2.30

1.61

4.6

1.1

3.30

3.68

g/l

0.72

Malignant neoplasm of ureter, including Hilmo

129

1.76

1.61

2.4

1.4

4.05

3.78

g/l

0.57

115

Renal cell carcinoma of kidney

490

1.36

1.61

2.2

1.5

3.60

3.74

g/l

0.37

429

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

447

1.38

1.61

1.6

2.3

3.53

3.71

g/l

0.65

416

Benign neoplasm: Heart

2.22

1.61

1.5

1.9

3.98

3.48

g/l

0.44

Papillary adenocarcinoma of thyroid gland

708

1.30

1.60

1.9

1.4

3.65

3.67

g/l

0.04

639

Dislocation, sprain and strain of joints and ligaments of knee

1139

9601

1.07

1.59

1.9

2.4

3.66

3.72

g/l

0.77

1044

8916

Malignant neoplasm of respiratory system and intrathoracic organs

491

3662

1.12

1.58

2.1

1.5

3.88

3.78

g/l

0.57

444

3282

Glaucoma-related operations

139

1140

1.23

1.58

2.6

2.5

3.93

3.75

g/l

0.37

124

1019

Oligomenorrhoea

355

1.42

1.58

1.8

2.3

3.88

3.70

g/l

0.43

328

Transient global amnesia

153

1841

0.82

1.58

2.6

2.4

3.29

3.72

g/l

6.28

133

1692

Vasomotor rhinitis (mode)

140

1149

1.23

1.56

2.2

2.6

3.57

3.71

g/l

0.45

123

1055

Benign neoplasm of male genital organs

332

1.44

1.56

2.6

2.7

3.80

3.58

g/l

0.30

305

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.26

1.55

1.2

3.77

3.61

g/l

0.16

Disorders of endocrine glands in diseases classified elsewhere

3.52

1.55

1.0

1.1

3.94

3.76

g/l

—

Erectile dysfunction

189

1599

1.19

1.55

2.4

3.72

3.75

g/l

0.09

173

1458

Other specified and unspecified disorders of lens

170

1.64

1.54

1.5

2.5

3.43

3.61

g/l

0.28

155

Tuberculosis, wide

161

1342

1.21

1.54

2.2

2.4

3.68

3.75

g/l

0.28

139

1206

Benign neoplasm: Skin of trunk

633

1.31

1.54

3.0

2.4

3.47

3.69

g/l

0.86

587

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

266

2312

1.16

1.53

2.6

2.3

3.54

3.72

g/l

1.40

244

2142

Maternal care for (suspected) damage to fetus from alcohol

2.95

1.52

1.2

1.4

4.00

3.42

g/l

—

Caught, crushed, jammed or pinched in or between objects

616

1.31

1.52

1.5

2.4

3.64

3.72

g/l

0.22

579

Transient acantholytic dermatosis [Grover]

2.56

1.52

1.2

2.3

3.78

3.49

g/l

—

Parkinson's disease, strict definition

356

3160

1.13

1.51

1.8

2.4

3.59

3.74

g/l

1.38

315

2850

HSIL lesion of the vulva

251

1.50

1.51

3.8

2.1

3.46

3.76

g/l

0.80

235

Tonsillectomy and adenotomy

689

5227

0.92

1.50

1.9

2.1

3.47

3.69

g/l

5.84

642

4917

Separation of retinal layers (serosa)

601

1.31

1.49

2.3

2.5

3.87

3.72

g/l

0.36

560

Non-small cell lung cancer, squamous, helper endpoint

970

0.77

1.49

1.8

2.4

4.37

3.74

g/l

0.83

872

Contact with other hot fluids

334

1.42

1.49

1.5

2.3

3.72

3.81

g/l

0.18

316

Other or unspecified paralytic strabismus

1.89

1.49

1.1

2.6

3.44

3.79

g/l

0.39

Long labour

220

2170

0.86

1.49

2.4

2.1

3.49

3.58

g/l

0.47

210

2044

Ankle and foot

117

1.75

1.48

1.5

2.2

3.48

3.85

g/l

0.53

109

Vascular dementia (other)

125

1.73

1.48

1.7

2.4

3.67

3.53

g/l

0.31

111

Alzheimer’s disease, strict definition

622

5482

0.91

1.47

1.9

2.3

3.85

3.71

g/l

1.06

526

4860

Chronic postrheumatic arthropathy [Jaccoud]

3.34

1.47

2.2

1.9

3.96

3.57

g/l

—

Generalized epilepsy, strict definition

203

1.55

1.47

1.7

2.2

3.66

3.76

g/l

0.15

194

Benign neoplasm: Lip

328

1.43

1.46

3.6

2.3

4.22

3.72

g/l

0.37

298

Macular hole

141

1169

1.22

1.46

1.9

2.6

3.88

3.62

g/l

0.93

126

1064

Malignant neoplasm of thyroid gland

117

950

1.24

1.46

2.2

1.4

3.67

3.69

g/l

0.08

108

851

Secondary parkinsonism+Parkinsonism in other disease

456

1.36

1.46

2.9

2.6

3.61

3.68

g/l

0.11

417

Seminoma of testis

2.01

1.45

1.8

1.4

3.51

3.61

g/l

0.17

Other and unspecified injuries of shoulder and upper arm

430

1.36

1.45

1.9

2.5

3.57

3.70

g/l

0.30

397

Pregnancy, childbirth and the puerperium

507

2925

0.90

1.45

1.9

2.1

3.76

3.64

g/l

0.60

458

2559

Other articular cartilage disorders

296

1.44

1.42

2.2

2.3

3.70

3.50

g/l

0.51

272

Hereditary corneal dystrophies

616

1.30

1.42

1.8

2.6

3.58

3.71

g/l

0.47

562

Other fall from one level to another

411

3690

1.12

1.41

2.3

3.62

3.74

g/l

1.18

380

3417

Disturbances of smell and taste

651

1.29

1.41

3.4

2.8

3.58

3.71

g/l

0.32

601

Maternal care for other known or suspected fetal problems

164

1223

0.84

1.41

1.5

1.9

3.47

3.52

g/l

0.12

158

1169

Benign neoplasm: Orbit, unspecified

1.86

1.41

3.3

2.2

3.37

3.46

g/l

0.16

Fibrosis and sclerosis of liver

3.25

1.41

1.4

1.5

3.90

3.59

g/l

—

Benign neoplasm of bone and articular cartilage

140

1163

1.21

1.41

1.8

2.4

3.50

3.71

g/l

1.20

121

1081

Calculus of lower urinary tract

118

965

1.24

1.41

2.2

2.6

3.87

3.75

g/l

0.38

106

884

Malignant neoplasm of nasopharynx

2.29

1.40

1.2

3.66

3.79

g/l

—

Cerebral aneurysm, nonruptured

172

1457

1.19

1.40

1.9

2.4

3.61

3.71

g/l

0.49

156

1346

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.90

1.40

1.7

2.2

4.04

3.97

g/l

0.03

Lesion of radial nerve

511

1.33

1.40

2.2

2.3

3.62

3.82

g/l

0.46

473

Lack of expected normal physiological development

2.26

1.39

1.0

1.1

3.21

3.91

g/l

—

Varus deformity, not elsewhere classified

135

1.66

1.38

1.4

2.5

3.46

3.40

g/l

0.07

125

Dislocation, sprain and strain of joints and ligaments of head

434

1.35

1.37

1.8

1.9

3.76

3.68

g/l

0.15

404

Benign lipomatous neoplasm of other sites/unspecified

184

1572

1.18

1.37

2.9

2.3

3.39

3.74

g/l

3.64

175

1433

Other rupture of muscle

1.91

1.37

1.0

2.1

3.75

3.46

g/l

0.39

Benign neoplasm: Long bones of lower limb

383

1.37

1.7

2.1

3.30

3.71

g/l

1.59

362

Discharge from other and unspecified firearms

0.00

1.37

0.0

2.3

—

3.80

—

All dysplastic lesions of the vulva

601

1.29

1.36

2.5

2.3

3.30

3.72

g/l

2.36

560

Pedal cyclist injured in transport accident

403

3626

1.12

1.36

2.1

2.3

3.62

3.72

g/l

0.88

368

3364

Endometriosis ASRM stages 1,2

249

2175

1.15

1.36

1.5

2.1

3.50

3.62

g/l

0.87

225

2018

Disorders of globe

419

1.36

1.35

2.7

2.6

4.31

3.67

g/l

0.54

383

Secondary parkinsonism

445

1.34

1.35

2.9

2.6

3.65

3.70

g/l

0.07

406

Pyogenic granuloma

208

1.51

1.35

1.9

2.5

3.36

3.79

g/l

1.28

195

Outcome of delivery

168

869

1.19

1.34

1.8

1.9

3.56

3.66

g/l

0.58

162

833

Undefined dementia

223

2364

0.87

1.34

2.1

2.3

3.63

3.74

g/l

0.58

193

2058

Single delivery by caesarean section

161

1088

0.84

1.33

2.2

1.6

3.79

3.64

g/l

0.48

153

1035

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

160

1355

1.19

1.33

2.0

2.5

3.55

3.70

g/l

0.38

148

1248

Other acantholytic disorders

2.12

1.33

1.4

2.6

3.56

3.68

g/l

0.09

Alcohol withdrawal state with delirium

132

1099

1.21

1.32

1.3

2.3

4.19

3.79

g/l

2.37

112

1025

Glaucoma

1459

11733

1.06

1.32

2.3

2.4

3.64

3.73

g/l

1.32

1308

10611

Tooth eruption problems

130

1041

1.21

1.32

2.3

1.8

3.59

3.66

g/l

0.28

123

982

Endometriosis diagnosis and infertility diagnosis occurring together

131

1089

1.21

1.32

1.6

2.3

3.55

3.68

g/l

0.57

117

1028

Deep bite

149

1099

1.20

1.31

2.4

2.3

3.41

3.73

g/l

2.55

135

1031

Lichen sclerosus et atrophicus

224

1950

1.16

1.31

2.2

3.60

3.70

g/l

0.72

202

1750

Small plaque parapsoriasis

2.14

1.30

1.9

2.0

4.79

3.83

g/l

—

Any dementia, excluding more controls

1002

6443

1.07

1.29

2.2

2.5

3.81

3.70

g/l

1.08

859

5791

Whooping cough, including avohilmo

138

1.61

1.27

1.4

2.3

3.29

3.55

g/l

0.83

133

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

109

894

1.23

1.27

2.1

2.3

3.60

3.71

g/l

0.48

104

844

Reduction defects of lower limb, including avohilmo

2.30

1.26

3.3

3.4

3.71

3.45

g/l

—

Vascular dementia (mixed)

382

1.36

1.25

2.4

2.1

3.75

3.68

g/l

0.07

341

Endometriosis of ovary

277

2310

1.13

1.24

1.8

2.2

3.51

3.67

g/l

1.27

246

2106

Peritonsillar abscess

321

2870

1.12

1.24

3.1

2.2

3.74

3.72

g/l

0.10

301

2668

Benign neoplasm of brain and other parts of central nervous system

121

1007

1.21

1.24

2.2

2.5

3.47

3.73

g/l

1.64

102

926

LSIL lesion of the vagina

180

1.52

1.23

1.2

1.8

3.42

3.86

g/l

0.95

172

Gestational diabetes (for exclusion)

314

2419

0.89

1.23

1.8

2.0

3.64

3.54

g/l

0.90

294

2306

Radial styloid tenosynovitis [de Quervain]

664

1.26

1.22

2.6

2.3

3.43

3.75

g/l

1.89

622

Aneurysms, operations, SAH

348

3136

1.11

1.19

1.9

2.3

3.66

3.70

g/l

0.16

307

2870

Calcaneal spur

157

1.55

1.19

1.9

1.8

3.62

3.91

g/l

0.46

145

Hypertrophy of breast in women and men

318

2851

1.12

1.19

1.9

2.3

3.62

3.65

g/l

0.17

293

2635

Struck by thrown, projected or falling objec

632

1.26

1.18

1.5

2.5

3.58

3.73

g/l

0.45

595

Pleural plaque

236

2084

1.14

1.17

2.2

2.3

3.78

3.79

g/l

0.00

212

1879

Parkinson's disease

375

3399

1.11

1.17

1.8

2.3

3.58

3.74

g/l

1.56

331

3066

Non-small cell lung cancer

228

1985

1.14

1.16

1.8

1.4

4.07

3.79

g/l

0.97

206

1754

Dysplasia of cervi uteri

341

2156

1.11

1.15

2.2

2.1

3.52

3.65

g/l

1.08

310

1970

Disorders of eyelid in diseases classified elsewhere

457

1.30

1.15

1.2

2.6

3.74

3.77

g/l

0.06

422

Ductal carcinoma of pancreas

114

0.43

1.15

1.0

1.2

4.82

3.74

g/l

—

Ovarian dysfunction, other/unspecified

2.00

1.13

2.7

2.2

3.45

3.65

g/l

—

Pathological resorption of teeth

521

1.28

1.12

1.1

2.5

3.81

3.73

g/l

0.17

489

Vertical strabismus

477

1.29

1.11

1.9

2.5

3.52

3.69

g/l

0.42

443

Other benign neoplasm of uterus: Corpus uteri

112

1.64

1.11

4.1

2.1

3.57

3.94

g/l

0.21

105

Gonococcal infection, including avohilmo

433

1.30

1.11

2.1

1.9

3.84

3.73

g/l

0.27

405

Malignant neoplasm of other and unspecified urinary organs

2.02

1.11

1.0

1.3

4.40

3.71

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

195

2062

0.87

1.10

1.6

2.0

3.73

3.59

g/l

0.70

188

1956

Vestibular neuronitis

176

1530

1.16

1.10

2.3

2.5

3.62

3.72

g/l

0.49

160

1406

Malignant neoplasm of nasal cavity and sinuses

1.73

1.10

5.5

1.3

3.45

3.71

g/l

0.34

Bacterial meningitis

470

1.29

1.09

3.8

2.5

3.85

3.69

g/l

0.14

437

Unspecified dementia

222

2250

0.88

1.08

2.1

2.3

3.63

3.66

g/l

0.10

192

1988

Labour and delivery complicated by fetal stress [distress]

168

1262

0.86

1.08

1.7

1.8

3.46

3.52

g/l

0.33

162

1205

Arthropod-borne viral fevers and viral haemorrhagic fevers

132

1542

0.85

1.06

3.3

2.4

3.42

3.76

g/l

3.49

123

1429

Tuberculosis of other organs, strict, including avohilmo

411

1.31

1.05

2.7

2.5

3.76

3.77

g/l

0.02

369

Unattended death

151

0.52

1.05

4.5

1.8

3.23

3.55

g/l

—

136

Pregnancy with abortive outcome

1235

6102

1.06

1.05

2.0

2.3

3.63

3.62

g/l

0.11

1115

5510

Tuberculosis of other organs, strict

403

1.31

1.04

2.7

2.5

3.77

3.76

g/l

0.01

361

Wilms' tumor, including Hilmo

1.73

1.04

1.0

1.2

3.52

g/l

0.00

Antepartum haemorrhage, not elsewhere classified

697

1.22

1.03

2.4

2.0

3.60

3.56

g/l

0.07

666

Severe visual impairment, monocular

155

1.51

1.03

1.2

2.5

3.49

3.78

g/l

0.36

144

LSIL lesion of the cervix uteri, vagina or vulva

181

1584

1.15

1.03

2.7

2.1

3.33

3.64

g/l

3.46

168

1479

Accidental poisoning by and exposure to alcohol

177

0.56

1.02

1.7

2.6

4.41

3.55

g/l

—

167

Tuberculosis of other organs

343

1.33

1.02

2.7

2.4

3.78

3.74

g/l

0.06

308

Ill-defined and unknown causes of mortality

181

2059

0.87

1.02

2.3

2.4

3.58

3.74

g/l

0.76

162

1852

Burn and corrosion of trunk

387

1.30

1.01

1.3

2.6

3.86

3.74

g/l

0.28

362

Typhoid and paratyphoid fevers, including avohilmo

1.75

1.01

1.2

1.4

4.22

3.54

g/l

0.73

Other vitreous opacities

674

1.23

1.00

3.2

2.6

3.73

3.71

g/l

0.03

623

Foreign body in respiratory tract

710

1.22

1.00

2.6

2.4

3.74

3.67

g/l

0.16

656

Malignant neoplasm of hypopharynx

1.91

0.99

1.0

1.2

3.67

3.79

g/l

—

Other complications of labour and delivery, not elsewhere classified

676

0.80

0.99

1.5

1.6

3.34

3.57

g/l

1.01

644

Malignant neoplasm of nasopharynx, including Hilmo

1.90

0.98

1.2

1.3

3.52

3.77

g/l

—

Dementia, including avohilmo

1310

8516

1.05

0.98

2.1

2.4

3.78

3.71

g/l

0.69

1111

7684

Foreign body or object entering through skin

794

1.20

0.98

3.0

2.4

3.85

3.73

g/l

0.25

744

104

874

1.19

0.98

2.0

2.4

3.48

3.73

g/l

1.24

756

Perforation of oesophagus

1.70

0.97

1.1

2.3

3.39

3.51

g/l

0.22

Other appendicitis

142

1230

1.16

0.96

3.2

2.4

3.55

3.73

g/l

1.02

127

1150

Benign neoplasm: Scrotum

1.88

0.94

1.3

4.50

3.50

g/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

123

1057

1.17

0.94

1.9

2.5

3.40

3.67

g/l

2.10

118

964

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

678

0.79

0.94

2.4

2.5

3.92

3.69

g/l

0.25

626

Abscess of Bartholin gland

278

1.34

0.93

3.2

2.1

3.59

3.66

g/l

0.14

262

Exposure to other specified electric current

220

0.63

0.92

2.3

2.1

3.39

3.61

g/l

0.33

209

Female infertility

403

2220

1.09

0.91

2.0

2.2

3.67

3.66

g/l

0.04

374

2042

Malignant neoplasm of ovary, including Hilmo

981

0.83

0.91

3.0

1.4

3.40

3.65

g/l

1.58

872

Degenerative diseases of the nervous system

936

7093

0.95

0.90

1.9

2.3

3.83

3.72

g/l

1.15

793

6340

Interstitial cystitis (chronic), drug-induced

1.97

0.90

1.1

1.7

3.69

3.79

g/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.65

0.90

1.8

2.2

3.61

3.54

g/l

0.08

Eustachian salpingitis and obstruction

812

1.19

0.88

2.3

2.1

3.83

3.69

g/l

0.16

764

Gonococcal infection

422

1.27

0.88

2.2

1.9

3.79

3.74

g/l

0.12

395

2.05

0.88

6.2

3.0

4.00

3.82

g/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

105

1226

0.85

0.88

3.1

2.3

3.33

3.71

g/l

3.64

1142

Contact with machinery

164

1855

0.88

2.2

2.3

3.65

3.78

g/l

0.39

150

1726

Unequal limb length (acquired)

1.88

0.88

2.6

4.44

3.25

g/l

—

Acute poliomyelitis, including avohilmo

192

0.62

0.88

1.6

2.1

3.58

3.71

g/l

0.16

176

Necrobiosis lipoidica, not elsewhere classified

1.70

0.87

3.3

2.3

3.88

4.08

g/l

0.12

Erythema intertrigo

379

1.28

0.87

2.4

2.8

3.74

3.64

g/l

0.29

350

Dengue, including avohilmo

2.01

0.86

4.8

1.5

3.58

g/l

—

False labour

256

1756

0.90

0.86

1.8

2.0

3.54

3.55

g/l

0.03

250

1678

Acute poliomyelitis

191

0.62

0.86

1.6

2.1

3.58

3.70

g/l

0.15

175

Other mental disorders due to brain damage and dysfunction and to physical disease

283

2582

1.10

0.85

2.7

2.3

3.83

3.66

g/l

0.47

243

2337

Anomalies of pupillary function

248

1.34

0.84

2.6

2.2

3.45

3.76

g/l

0.73

233

Carcinoma in situ of breast, lobular

105

1.56

0.84

4.1

2.3

3.22

3.97

g/l

1.28

100

Heterophoria

116

1003

1.16

0.83

2.8

2.3

3.65

3.72

g/l

0.11

111

932

Whooping cough

1.76

0.83

1.0

3.3

3.21

3.61

g/l

—

Contact urticaria

1.92

0.83

1.7

1.4

3.93

3.89

g/l

—

Hypertrophy of breast

261

2374

1.10

0.83

1.5

2.3

3.62

3.63

g/l

0.05

239

2194

Universal erythroderma, KELA reimbursement

189

1.39

0.82

1.4

2.4

3.67

3.68

g/l

0.03

175

Specific developmental disorder of motor function

1.89

0.82

1.0

2.3

3.37

3.65

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

138

1212

1.14

0.81

1.8

2.2

3.55

3.65

g/l

0.57

132

1119

Other osteochondropathies

101

868

1.17

0.80

2.5

2.2

4.19

3.74

g/l

0.99

809

Other helminthiases

0.00

0.80

0.0

3.0

—

3.66

—

Pregnancy hypertension

580

4870

1.07

0.80

2.4

2.2

3.58

3.61

g/l

0.26

548

4499

LSIL lesion of the cervix uteri

129

1129

1.15

0.79

2.8

2.3

3.35

3.64

g/l

2.42

120

1072

Aggressive periodontitis

322

1.29

0.79

2.3

2.5

4.05

3.71

g/l

0.85

300

Pedal cyclist injured in other and unspecified transport accidents

188

1687

1.12

0.79

2.3

3.65

3.73

g/l

0.42

173

1563

Superficial injuries involving multiple body regions

331

1.28

0.78

3.0

2.3

3.77

3.65

g/l

0.22

311

Divergent concomitant strabismus

113

982

1.16

0.78

2.0

2.3

3.65

3.72

g/l

0.26

106

909

Abnormal findings in secretions and smears from cervix uteri vagina vulva

755

5263

1.06

0.77

2.2

3.52

3.62

g/l

1.62

700

4837

Reduction defects of lower limb

2.24

0.77

4.4

2.7

3.82

3.40

g/l

—

Thromboangiitis obliterans

1.75

0.77

1.1

2.7

3.26

3.58

g/l

—

Erosion and ectropion of cervix uteri

459

1.23

0.76

3.1

2.2

3.69

3.73

g/l

0.09

416

Pedestrian injured in collision with car, pick-up truck or van

325

1.27

0.74

1.6

2.3

4.33

3.73

g/l

0.61

301

Gastrointestinal stromal tumor and sarcoma

176

1.38

0.74

1.2

1.4

3.72

3.76

g/l

0.06

158

Burn and corrosion confined to eye and adnexa

254

1.31

0.74

2.3

2.4

3.75

3.65

g/l

0.23

244

Other benign neoplasms of connective and other soft tissue

175

1572

1.12

0.74

2.7

2.4

3.76

3.71

g/l

0.12

156

1446

Other chromosome abnormalities, not elsewhere classified

2.03

0.73

1.2

2.9

2.78

3.65

g/l

—

Postmenopausal atrophic vaginitis

520

2659

1.07

0.73

2.4

2.3

3.47

3.69

g/l

3.19

473

2406

Anomalies of dental arch relationship, including avohilmo

267

2214

1.09

0.72

2.2

2.3

3.43

3.70

g/l

3.42

238

2073

Right side

101

1.53

0.72

1.4

1.7

3.70

3.93

g/l

0.22

Benign neoplasm of other and unspecified female genital organs

686

0.82

0.72

1.9

2.4

3.44

3.73

g/l

1.20

626

Fractures involving multiple body regions

1.98

0.72

1.6

1.2

4.28

3.77

g/l

—

Alzheimer’s disease (Late onset)

596

5185

0.94

0.71

1.9

2.3

3.84

3.70

g/l

1.11

502

4586

Acute appendicitis, with complications

376

3504

1.08

0.71

2.4

2.3

3.68

3.73

g/l

0.32

340

3239

Malignant neoplasm of bronchus and lung

414

3236

1.07

0.70

1.9

1.4

3.96

3.78

g/l

1.04

373

2892

Frontotemporal dementia

102

1.51

0.69

2.2

1.9

4.63

3.91

g/l

—

Colorectal adenocarcinoma

437

4047

1.07

0.68

2.6

1.4

3.80

3.76

g/l

0.19

385

3616

Gender identity disorders

1.53

0.68

1.0

2.0

3.81

3.51

g/l

—

Injury of muscle and tendon at wrist and hand level

240

2202

1.09

0.68

2.0

2.4

3.68

3.77

g/l

0.55

228

2040

Hypermetropia

109

956

1.14

0.68

2.2

2.3

3.52

3.73

g/l

1.13

883

Other nonscarring hair loss

119

1.45

0.68

1.5

2.3

3.54

3.95

g/l

0.54

112

Acute drug-induced interstitial lung disorder

128

1.43

0.67

9.0

2.0

4.06

3.88

g/l

0.15

118

Dementia due to Parkinson's disease

516

0.81

0.67

1.3

2.4

3.91

3.73

g/l

0.19

464

Other ill-defined and unspecified causes of mortality

170

1878

0.90

0.66

2.2

2.4

3.62

3.73

g/l

0.46

152

1688

Lesion of sciatic nerve

765

0.84

0.66

1.3

2.4

3.71

3.77

g/l

0.09

681

Postpartum haemorrhage due to retained placenta

1002

0.87

0.65

2.0

1.9

3.45

3.59

g/l

0.53

955

Von Willebrand disease

137

1.40

0.65

2.4

2.1

3.20

3.94

g/l

1.60

130

L01XE Protein kinase inhibitors

109

962

1.14

0.65

3.0

2.6

3.52

3.75

g/l

0.75

103

888

Persistent delusional disorders

107

1212

0.88

0.65

2.2

2.4

3.71

3.70

g/l

0.02

1106

Excessive vomiting in pregnancy

813

1.15

0.63

2.1

2.3

3.49

3.70

g/l

0.98

766

Convergence insufficiency and excess

121

1.42

0.63

1.3

1.9

3.28

3.72

g/l

1.01

114

Other congenital malformations of respiratory system

1.72

0.62

1.0

1.5

4.20

3.84

g/l

—

Complications predominantly related to the puerperium

335

3129

1.07

0.62

2.1

2.2

3.59

3.62

g/l

0.11

317

2912

Tetralogy of Fallot, a congenital heart defect.

1.69

0.62

1.6

2.4

3.88

3.62

g/l

—

Disorder of visual pathways, unspecified

0.00

0.61

0.0

1.6

—

3.42

—

Mental retardation, excluding more controls

305

1.24

0.61

1.7

2.4

3.53

3.77

g/l

0.67

283

Communicating hydrocephalus

327

1.23

0.59

1.5

2.7

3.57

3.72

g/l

0.29

300

Infliximab

157

1.35

0.59

1.2

1.8

4.26

3.64

g/l

1.21

151

Female infertility, cervical, vaginal, other or unspecified origin

362

2168

1.07

0.59

2.1

2.2

3.65

g/l

0.01

337

1994

Malignant neoplasm of breast, ER-negative, including Hilmo

392

3450

1.06

0.59

2.0

1.4

3.64

g/l

0.01

348

3060

Short Achilles tendon (acquired)

332

0.78

0.59

2.7

2.5

3.35

3.80

g/l

1.01

310

Embolic stroke

856

1.14

0.59

1.9

2.4

3.58

3.80

g/l

0.96

780

Nontoxic diffuse goitre

502

1.18

0.58

3.0

2.3

3.60

3.76

g/l

0.49

455

Dementia in other diseases classified elsewhere

101

895

1.14

0.58

1.6

2.4

3.92

3.68

g/l

0.69

810

Malignant neoplasm of adrenal gland, including Hilmo

1.50

0.58

2.3

1.2

3.49

3.85

g/l

0.68

Fistulae involving female genital tract

256

1.26

0.58

2.1

2.2

4.05

3.80

g/l

0.32

233

ILD medications: nintedanib

0.57

1.0

1.5

3.26

3.48

g/l

—

Intermittent heterotropia

566

1.17

0.57

2.0

2.2

3.42

3.69

g/l

1.06

525

Motor disorders

1.71

0.57

1.0

2.2

3.37

3.60

g/l

—

Kela-code for severe mental illness

622

5935

1.05

0.57

2.0

2.3

3.72

3.71

g/l

0.09

570

5468

Diastasis of muscle

0.56

1.2

2.0

2.80

3.55

g/l

—

Unspecified jaundice

803

1.14

0.56

1.6

2.4

3.93

3.85

g/l

0.16

729

Prolapse and hernia of ovary and fallopian tube

693

1.15

0.56

1.8

2.1

3.49

3.78

g/l

0.73

592

Myocardial infarction, unclassifiable

486

4572

0.95

0.56

1.8

2.2

3.64

3.77

g/l

1.24

434

4073

Acute and transient psychotic disorders

173

1582

1.10

0.56

2.2

2.3

3.68

3.73

g/l

0.17

155

1479

Sequelae of infectious and parasitic diseases

121

1087

1.12

0.56

2.9

2.2

3.60

3.76

g/l

0.73

113

995

Frontotemporal dementia, wide, incl. Pick's disease

116

1.41

0.56

2.1

1.9

4.62

3.89

g/l

0.42

105

Other and unspecified disease of Bartholin gland

440

1.19

0.56

1.9

2.4

3.54

3.71

g/l

0.65

407

Benign neoplasm: Short bones of lower limb

124

0.64

0.55

1.5

2.5

3.31

3.81

g/l

—

118

Cervical polyps

165

1508

1.10

0.55

2.1

2.3

3.46

3.67

g/l

1.56

157

1366

Congenital malformations of eye, ear, face and neck

655

1.15

0.54

3.4

2.2

3.90

3.67

g/l

0.38

609

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

1.57

0.54

1.0

1.6

2.93

3.81

g/l

—

Pterygium

507

1.17

0.53

2.3

2.6

3.46

3.75

g/l

0.97

468

Drug-induced tremor

100

1.42

0.53

1.4

2.4

3.82

3.56

g/l

0.38

Hydatidiform mole

146

0.68

0.52

6.5

2.1

3.10

3.96

g/l

—

139

Presbyopia

123

1111

1.11

0.52

1.5

2.4

3.49

3.72

g/l

1.46

114

1049

Toxic effects of substances chiefly nonmedicinal as to source

147

1611

0.91

0.52

1.6

2.3

3.60

3.74

g/l

0.73

135

1500

Malignant neoplasm of pancreas, including Hilmo

141

1547

0.91

0.52

2.1

1.4

3.65

3.73

g/l

0.35

128

1380

Burns and corrosions confined to eye and internal organs

305

1.22

0.52

2.5

2.3

3.75

3.65

g/l

0.24

290

L02BX Other hormone antagonists and related agents

110

1221

0.90

0.52

1.8

2.6

4.03

3.76

g/l

0.50

1119

Morphin

342

1.21

0.52

1.7

1.8

4.01

3.78

g/l

0.33

306

Anisometropia and aniseikonia

435

1.18

0.51

2.7

2.4

3.40

3.77

g/l

1.49

402

Use of dimethyl fumarate

1.40

0.51

1.0

2.4

3.18

3.60

g/l

—

Use of rasagiline

455

1.17

0.50

1.5

2.8

3.40

3.70

g/l

1.04

415

Congenital malformations of breast, including avohilmo

136

1.33

0.49

1.5

2.1

3.21

3.66

g/l

1.37

131

Carcinoma in situ of cervix uteri

104

936

1.11

0.48

2.0

3.43

3.65

g/l

1.07

880

Abnormalities of forces of labour

113

1022

1.11

0.48

1.7

2.1

3.80

3.58

g/l

1.10

107

982

Benign neoplasm of ovary

318

3001

1.06

0.48

2.3

3.62

3.63

g/l

0.05

293

2702

Supervision of high-risk pregnancy

207

1154

1.08

0.47

1.8

1.9

3.51

3.66

g/l

1.11

196

1102

Poor fetal growth

880

1.12

0.47

1.7

1.9

3.28

3.56

g/l

2.52

839

Diabetes mellitus in pregnancy

276

1868

0.94

0.47

1.5

2.0

3.61

3.56

g/l

0.38

261

1784

Benign neoplasm: Conjunctiva

495

1.16

0.47

1.4

2.6

3.86

3.74

g/l

0.34

462

Malignant neoplasm of palate

1.46

0.47

2.4

1.1

3.79

3.68

g/l

—

Oral leukoplakia, including avohilmo

430

1.17

0.47

1.6

2.4

3.69

g/l

0.01

399

Bullous keratopathy

129

1.34

0.47

2.5

2.3

3.41

3.56

g/l

0.25

115

Retained placenta and membranes, without haemorrhage

147

1599

0.92

0.47

2.6

2.2

3.55

3.58

g/l

0.08

139

1483

Neuroendocrine tumor and carcinoma of stomach

1.46

0.46

1.9

1.2

3.15

3.86

g/l

1.24

Postpartum care and examination

671

0.90

0.46

1.8

1.6

3.19

3.70

g/l

5.76

639

Malignant neoplasm of rectosigmoid junction, including Hilmo

449

1.17

0.46

2.5

1.4

3.82

3.74

g/l

0.16

401

Otosclerosis

139

1275

1.09

0.46

2.0

2.5

3.54

3.72

g/l

0.96

124

1171

Valgus deformity, not elsewhere classified

1.44

0.46

1.1

1.9

3.75

3.37

g/l

0.86

Congenital malformations of breast

129

1.33

0.46

1.5

1.6

3.23

3.68

g/l

1.26

124

Maltreatment syndromes

449

1.16

0.46

2.3

1.9

3.47

3.68

g/l

0.66

429

Complications following abortion and ectopic and molar pregnancy

554

1.14

0.44

1.5

2.6

3.74

3.76

g/l

0.03

511

Open bite that required surgery (Lefort1 or BSSO)

1.46

0.44

1.0

1.8

2.95

3.77

g/l

—

Schizophrenia or delusion

518

4965

1.04

0.44

2.0

2.2

3.67

3.70

g/l

0.23

466

4595

Infections of genitourinary tract in pregnancy

105

1155

0.91

0.43

2.5

2.2

3.44

3.69

g/l

1.35

1067

Respiratory tuberculosis

105

954

1.11

0.43

2.1

2.5

3.68

3.79

g/l

0.36

856

Respiratory tuberculosis, confirmed and not-confirmed

105

954

1.11

0.43

2.1

2.5

3.68

3.79

g/l

0.36

856

Primary amenorrhea

1.62

0.43

2.0

1.5

3.58

3.59

g/l

—

Malignant neoplasm of renal pelvis

1.40

0.43

1.2

1.3

4.11

3.74

g/l

0.30

Non-allergic asthma

142

1308

1.09

0.43

2.2

2.4

3.78

3.71

g/l

0.27

132

1202

Malignant neoplasm of nasal cavity and middle ear

1.45

0.42

5.5

1.3

3.67

3.68

g/l

—

Other congenital malformations of spinal cord

0.00

0.42

0.0

1.1

—

3.56

—

Infections of breast associated with childbirth

295

1.19

0.42

1.3

1.7

3.35

3.75

g/l

1.12

284

Malignant neoplasm of accessory sinuses, including Hilmo

1.37

0.41

4.5

1.3

3.22

3.70

g/l

—

Other benign neoplasm of uterus: Other parts/unspecified

786

1.11

0.41

3.0

2.2

3.84

3.71

g/l

0.22

683

Persons encountering health services in circumstances related to reproduction

898

6206

0.97

0.41

2.2

2.3

3.73

g/l

0.02

843

5798

Other congenital musculoskeletal deformities, including avohilmo

0.00

0.41

0.0

1.0

—

3.79

—

Malignant neoplasm of other and ill-defined digestive organs

114

1.33

0.41

1.3

4.39

3.70

g/l

0.65

102

Benign neoplasm: Pineal gland

0.00

0.41

0.0

1.6

—

3.63

—

Obstetric embolism

0.00

0.40

0.0

1.1

—

3.96

—

Malignant neoplasm of vulva, including Hilmo

205

1.23

0.40

2.5

1.5

3.37

3.73

g/l

0.92

180

Schizophrenia, schizotypal and delusional disorders

521

5010

1.04

0.40

2.1

2.2

3.66

3.70

g/l

0.27

469

4639

Malignant neoplasm of eye and adnexa

115

1.32

0.39

1.9

1.2

3.65

3.76

g/l

0.17

100

Mental and behavioural disorders due to use of volatile solvents

0.00

0.39

0.0

3.2

—

3.58

—

Sequelae of infectious and parasitic diseases, including avohilmo

122

1124

1.09

0.39

2.9

2.2

3.60

3.77

g/l

0.77

114

1027

Pre-eclampsia superimposed on chronic hypertension

1.40

0.38

1.0

1.4

3.76

3.49

g/l

—

Other benign neoplasms of uterus

109

1001

1.09

0.38

3.1

2.2

3.80

3.71

g/l

0.15

880

Benign leiomyoma with endometriosis

295

2805

1.05

0.38

2.2

2.4

3.49

3.62

g/l

1.20

261

2533

Serous carcinoma of ovary

113

0.70

0.38

2.0

1.5

3.40

3.75

g/l

—

100

Embedded and impacted teeth

252

1934

1.06

0.37

2.0

3.69

3.67

g/l

0.04

240

1831

Lesion of plantar nerve

108

993

1.09

0.37

2.3

3.62

3.70

g/l

0.28

900

malignant neoplasm of female genital organs

258

2658

0.95

0.36

2.0

1.4

3.68

3.63

g/l

0.29

232

2339

Crossbite

562

1.12

0.36

1.4

2.1

3.56

3.70

g/l

0.44

538

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

668

5606

1.03

0.36

2.3

2.2

3.57

3.62

g/l

0.40

631

5151

Other congenital malformations of limb(s)

1.44

0.35

1.0

1.9

3.35

3.58

g/l

—

Fitting and adjustment of external prosthetic device

1.38

0.35

1.5

1.3

3.47

3.45

g/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

181

1.22

0.35

2.0

2.1

4.03

3.72

g/l

0.45

168

Ectopic pregnancy

213

2252

0.94

0.35

1.7

2.4

3.68

3.64

g/l

0.16

196

2108

Simple and mucopurulent chronic bronchitis

671

1.11

0.34

1.7

2.4

3.79

3.68

g/l

0.27

598

Endometriosis of intestine

118

1.28

0.33

1.0

2.7

3.70

3.54

g/l

0.24

112

Malignant neoplasm of rectum, including Hilmo

232

2202

1.06

0.33

2.7

1.4

3.72

3.78

g/l

0.28

207

1965

Tooth agenesis EXCLUDE clefts and syndromes

231

0.82

0.33

1.2

1.7

3.31

3.62

g/l

0.61

226

Normal-pressure hydrocephalus

977

0.92

0.32

2.5

2.4

3.68

3.74

g/l

0.17

878

L02BB Anti-androgens

194

2046

0.95

0.31

1.9

2.4

3.81

3.78

g/l

0.07

174

1840

Non-small cell lung cancer, adenocarcinoma, helper endpoint

143

1343

1.07

0.31

1.8

2.5

3.86

3.76

g/l

0.25

129

1224

malignant neoplasm of female genital organs, including Hilmo

318

2906

1.04

0.31

2.3

1.4

3.69

3.63

g/l

0.37

286

2562

Tuberculosis

121

1130

1.07

0.30

2.0

2.4

3.64

3.74

g/l

0.40

108

1009

Cervical root disorders

1.32

0.30

1.0

1.9

3.39

3.72

g/l

0.74

Other disorders of binocular vision

111

1.27

0.30

5.6

2.3

3.01

3.53

g/l

1.05

106

Hydrocephalus

133

1416

0.94

0.29

2.2

2.5

3.59

3.75

g/l

0.77

114

1276

Cyst of Bartholin Gland

439

1.12

0.29

2.5

2.2

3.95

3.67

g/l

0.24

413

Kela-code for behavioural disturbances in mental retardation

110

0.72

0.29

1.6

1.9

2.98

3.68

g/l

—

104

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.24

0.29

3.6

1.2

3.21

3.71

g/l

—

Stenosis and insufficiency of lacrimal passages

176

1669

1.06

0.28

2.2

2.5

3.58

3.70

g/l

0.60

154

1517

Circumscribed brain atrophy

374

1.13

0.28

1.8

2.7

4.04

3.68

g/l

0.60

342

Mental retardation

342

1.13

0.28

1.7

2.1

3.53

3.71

g/l

0.47

322

Antenatal screening

229

1221

1.05

0.28

2.0

1.9

3.79

3.66

g/l

0.59

223

1168

Pneumoconiosis due to dust containing silica

1.27

0.28

2.4

2.6

3.67

3.57

g/l

—

Spinal instabilities

346

1.13

0.28

1.3

2.0

3.21

3.76

g/l

1.99

325

Motorcycle rider injured in noncollision transport accidents

280

1.15

0.27

1.8

2.0

3.57

3.69

g/l

0.19

267

Other specified and unspecified strabismus

131

1.23

0.27

1.9

2.3

5.13

3.81

g/l

0.42

121

Other bursal cyst

206

1.17

0.26

2.2

2.1

3.36

3.80

g/l

1.28

190

Carcinoma in situ of middle ear and respiratory system

0.67

0.26

2.8

2.0

3.36

3.58

g/l

—

Malignant neoplasm of gallbladder

1.24

0.26

1.2

1.1

4.02

3.69

g/l

—

Other noninflammatory disorders of cervix uteri

810

1.08

0.25

2.7

2.3

3.96

3.68

g/l

0.61

724

Disorders of acoustic nerve

435

1.11

0.25

3.2

2.5

3.33

3.76

g/l

2.03

399

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

178

1866

0.95

0.25

2.8

1.4

3.72

3.77

g/l

0.17

155

1671

Benign neoplasm: Short bones of upper limb

198

1.17

0.25

1.7

2.2

3.37

3.83

g/l

0.85

187

Viral infections of central nervous system, not elsewhere classified/unspecified

133

1.21

0.24

1.6

2.3

3.52

3.67

g/l

0.26

125

Mucinous and mucinous cystic tumor, including Hilmo

0.73

0.24

7.8

1.4

3.12

3.70

g/l

—

Chronic myringitis

0.70

0.24

3.2

1.9

3.53

3.55

g/l

—

Impacted teeth

160

1306

1.05

0.24

1.6

1.8

3.76

3.65

g/l

0.34

153

1236

Other and unspecified heterotropia

1.37

0.24

1.8

1.1

3.58

3.61

g/l

—

Injury of urinary and pelvic organs

265

1.14

0.24

4.6

2.4

4.04

3.69

g/l

0.50

246

Mental retardation, wide definition

376

1.11

0.23

1.7

2.1

3.45

3.76

g/l

1.02

354

Any dementia

1091

7408

1.02

0.23

2.2

2.4

3.79

3.72

g/l

0.54

930

6636

Androgenic alopecia

106

1.23

0.23

1.1

2.1

3.92

3.96

g/l

0.05

101

Melanocytic naevi, other sites/unspecified

127

1203

1.06

0.23

1.9

2.4

3.95

3.72

g/l

0.35

122

1117

Dementia due to Parkinsons disease, excluding more controls

380

1.11

0.23

1.3

2.6

3.91

3.78

g/l

0.13

344

Use of levodopa decarbox-comt-inhibitor

608

0.92

0.23

1.1

2.7

3.36

3.77

g/l

2.09

555

Family history of certain disabilities and chronic diseases leading to disablement

457

1.10

0.23

1.6

2.0

3.48

3.79

g/l

1.27

427

Inflammatory disease of cervix uteri

108

1020

1.06

0.22

1.4

2.3

3.65

3.68

g/l

0.08

931

Foreign body on external eye

232

2234

1.04

0.22

2.4

2.3

3.62

3.77

g/l

1.10

214

2097

Female genital prolapse

517

2801

1.03

0.22

2.2

3.62

3.69

g/l

0.35

468

2530

Plasmodium vivax malaria, including avohilmo

0.00

0.22

0.0

1.1

—

3.47

—

Plasmodium vivax malaria

0.00

0.22

0.0

1.1

—

3.47

—

Neurological devices associated with adverse incidents

0.00

0.22

0.0

1.0

—

3.70

—

Myiasis

0.00

0.22

0.0

5.0

—

3.22

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.22

0.0

1.8

—

4.29

—

Pseudohypoparathyroidism

0.00

0.22

0.0

1.0

—

3.01

—

Glanders and melioidosis

0.00

0.22

0.0

1.0

—

3.73

—

Glanders and melioidosis, including avohilmo

0.00

0.22

0.0

1.0

—

3.73

—

Congenital heart conduction disorder

0.00

0.21

0.0

1.0

—

3.81

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

3.59

—

Pinta [carate], including avohilmo

0.00

0.21

0.0

1.0

—

3.48

—

Contact with other specified venomous animals

1.24

0.21

1.1

2.7

3.44

3.61

g/l

0.31

Complications of anaesthesia during pregnancy

0.00

0.21

0.0

1.1

—

3.79

—

Ascariasis, including avohilmo

0.00

0.21

0.0

1.3

—

3.38

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

3.73

—

Underdevelopment of the second kidney

0.00

0.21

0.0

4.5

—

3.82

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.0

—

3.87

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1037

8184

0.98

0.21

2.2

2.3

3.62

3.66

g/l

0.34

963

7518

Birth injury to peripheral nervous system

0.00

0.21

0.0

4.5

—

3.40

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

3.52

—

Cholesteatoma of middle ear

882

0.94

0.20

2.1

2.4

3.67

3.76

g/l

0.27

807

Unicornuate uterus

0.00

0.20

0.0

1.1

—

3.45

—

Endometriosis ASRM stages 3,4

355

3452

1.03

0.20

1.8

2.2

3.47

3.61

g/l

1.40

318

3136

Postpartum haemorrhage due to anatomy

635

0.93

0.20

1.8

1.7

3.45

3.53

g/l

0.28

608

Mild mental retardation

239

0.88

0.19

1.9

2.2

3.80

3.75

g/l

0.07

228

Malignant neoplasm of other and unspecified parts of mouth

1.23

0.19

1.8

1.3

3.19

3.64

g/l

1.06

Colon adenocarcinoma, helper endpoint

273

2815

0.97

0.19

2.8

2.4

3.85

3.72

g/l

0.57

243

2545

Malignant neoplasm of eye, brain and central nervous system

588

1.07

0.19

1.8

1.4

3.76

3.72

g/l

0.08

530

Other menopausal disorders

474

2579

1.02

0.19

2.4

2.3

3.41

3.66

g/l

5.17

441

2355

Malignant neoplasm of breast, HER-negative

354

3310

1.03

0.19

2.0

1.4

3.65

3.64

g/l

0.07

312

2928

Premenstrual syndrome

109

1.20

0.18

1.2

2.4

3.05

3.76

g/l

2.28

104

Dementia

1195

8054

1.01

0.18

2.1

2.4

3.79

3.72

g/l

0.69

1009

7256

Other obstructed labour

899

0.94

0.18

1.8

2.3

4.15

3.62

g/l

0.76

849

Obstructed labour due to maternal pelvic abnormality

213

2203

0.97

0.18

2.2

2.3

3.69

3.66

g/l

0.07

195

2031

Ethmoidectomy

208

2011

1.04

0.18

2.8

2.3

3.59

3.74

g/l

1.07

193

1873

Benign neoplasm of thyroid gland

517

0.93

0.17

2.3

2.4

3.32

3.71

g/l

1.32

479

Alcoholic cardiomyopathy

1.23

0.17

1.3

2.7

3.85

3.64

g/l

—

Other/unspecified mastoiditis and related conditions

0.71

0.17

1.8

2.1

3.14

3.61

g/l

—

Prophylactic surgery

1.16

0.16

5.4

1.3

4.26

3.69

g/l

—

Use of ropinirole

613

1.06

0.16

2.0

2.8

3.52

3.75

g/l

0.84

563

Chronic suppurative otitis media, including avohilmo

120

1151

1.04

0.16

1.6

2.4

3.76

3.77

g/l

0.00

114

1057

Osteitis due to dental implant

130

1.16

0.16

3.4

1.9

3.23

3.93

g/l

1.02

118

Adenocarcinoma and papilloma adenocarcinoma of rectum

172

1776

0.97

0.15

2.9

1.4

3.70

3.77

g/l

0.29

149

1586

Coarctation of the aorta

1.11

0.15

8.6

1.9

3.04

3.57

g/l

—

Primary open-angle glaucoma, strict

647

6352

1.02

0.15

2.2

2.3

3.66

3.72

g/l

0.35

571

5659

Glaucoma, exfoliation

239

2453

0.97

0.14

2.4

2.3

3.68

3.71

g/l

0.07

208

2164

Alcohol abuse counselling and surveillance

179

1.12

0.14

1.3

2.1

4.17

3.65

g/l

0.85

171

Medical treatment for female infertility

172

1757

0.97

0.14

1.8

1.9

3.55

3.54

g/l

0.06

162

1677

Dental pulpitis, including avohilmo

1751

11309

0.99

0.14

2.1

2.3

3.74

3.71

g/l

0.28

1646

10482

Toxic effect of contact with venomous animals

572

0.94

0.13

2.2

2.5

3.62

3.79

g/l

0.45

533

Benign neoplasm: Cranial nerves

451

1.07

0.13

3.2

2.4

3.31

3.73

g/l

1.86

411

Use of selegiline

816

0.95

0.13

2.2

2.4

3.56

3.77

g/l

0.79

742

Pleural plaque with presence of asbestos

153

1577

0.97

0.13

2.4

2.5

3.69

3.74

g/l

0.17

136

1426

Other abnormal products of conception

322

2156

0.98

0.13

2.0

2.1

3.58

3.61

g/l

0.24

307

2046

L02BA Anti-estrogens

291

2850

1.02

0.12

1.9

2.3

3.62

3.63

g/l

0.02

255

2590

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS